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 Chapter 1 
General introduction 
 
Part of the GENERAL INTRODUCTION was published as:  
Nienke Nakken, Daisy J.A. Janssen, Esther H.A. van den Bogaart, 
Emiel F.M. Wouters, Frits M.E. Franssen, Jan H. Vercoulen, 
Martijn A. Spruit. 
Informal caregivers of patients with COPD: Home Sweet Home?  
Eur Respir Rev, 2015. 24: 498–504. 
 
Reproduced with permission of the European Respiratory Society ©. 
European Respiratory Review Sep 2015, 24 (137) 498-504; DOI: 
10.1183/16000617.00010114 
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GENERAL INTRODUCTION 
Chronic obstructive pulmonary disease  
Chronic obstructive pulmonary disease (COPD) is defined by the Global initiative for 
chronic Obstructive Pulmonary Disease (GOLD) as “a common preventable and 
treatable disease, characterized by persistent airflow limitation that is usually pro-
gressive and associated with an enhanced chronic inflammatory response in the 
airways and the lungs to noxious particles or gases. Exacerbations and comorbidities 
contribute to the overall severity in individual patients.”(1) Patients with COPD expe-
rience many symptoms, of which dyspnea, fatigue and muscle weakness are the 
most severe.(2) COPD is a major cause of morbidity and mortality throughout the 
world.(3) Its prevalence is expected to increase in the coming decades,(4) due to 
the ageing population, the continued exposure to known COPD risk factors, and 
disease-specific life-enhancing treatments.(3) Therefore, the societal and economic 
burden of COPD is expected to increase.  
Exacerbations of COPD and hospitalizations are responsible for the majority of the 
COPD-related healthcare costs.(1) Not only to reduce health care costs, but also to 
maintain patient’s well-being, exacerbations of COPD and hospitalizations should be 
prevented.(1) This could be achieved by self-management programs.(5-7) However, 
patients with chronic diseases do not self-manage their condition on their own, 
since they need instrumental support, psychosocial support and relational support 
from professionals, and family and friends.(8) The role of the informal caregiver 
(like family and friends) will probably become more essential in COPD management 
in the near future. Furthermore, the patients’ capacity to self-manage their disease 
also depends on their disease-related knowledge,(9) which has proven to be insuffi-
cient in about half of the patients with COPD.(10) Additionally, the current level of 
knowledge in informal caregivers of patients with COPD remains unknown. 
Health status and comorbidities 
Almost all patients with COPD (98%) have at least one other disease alongside COPD 
(comorbidity).(11) Comorbidities are common at any severity of COPD,(12) and are 
frequently overlooked due to similarity of symptoms,(1) for instance, breathlessness 
in COPD and heart failure, or fatigue in COPD and depression. In addition, patients 
with COPD have an impaired health status, irrespective of the disease severity.(13) 
Health status can be defined as “the impact of health on a person’s ability to perform 
and derive fulfilment from the activities of daily life”. Consequently, self-reported 
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health status includes health-related quality of life and functional status.(14) Besides 
the distressing symptoms, and impaired health status, patients with COPD experi-
ence disturbances in functional status, and quality of life.(15) 
Knowledge about the generic health status and morbidities of informal caregivers 
of patients with COPD is limited. It is known that informal caregiving can be burden-
some and that they often experience symptoms of anxiety and depression,(16, 17) 
which could lead to a poor quality of life.(18) Moreover, the likelihood of becoming 
obese or becoming a smoker increases when a relative, especially a spouse, is 
obese or a smoker.(19, 20) Therefore, knowledge about the informal caregiver’s 
health status seems critical because of their role in maintaining/obtaining a healthy 
lifestyle in patients with COPD.  
Impact on activities of daily living 
Dyspnea is a cardinal symptom in patients with COPD, which, together with fatigue, 
limits patients’ domestic activities of daily living (like walking or stair climbing), 
physical activity levels and health status.(21, 22) Often, patients still experience 
symptoms despite optimal medical treatment.(2) Furthermore, 57% of patients 
with severe-to-very severe COPD have morning symptoms that limit their activities 
like washing or dressing themselves.(23) Difficulty with at least one ADL is more 
likely in patients with COPD compared to subjects without COPD.(24) COPD patients 
with ADL problems have a lower health status, more exacerbations, more hospitali-
zations and worse survival.(25) Patients with COPD may become more care de-
pendent over time, and most probably will rely to a greater extent on (informal) 
caregivers within their home environment.(26, 27)  
Definition of informal caregivers 
The terminology used to refer to the caregiver role is ambiguous.(28) The term 
‘informal caregiver’ refers to a person, often a family member or friend, who is 
providing care, but is not a health care professional.(29, 30) However, informal 
caregivers themselves, in particular spouses, do not refer to the notion of being a 
caregiver, often describing it as an extension of their loving role and commitment to 
the person requiring support.(31, 32) Additionally, the term ‘proxy’ is used in the 
current literature as well. This term is mostly used as a substitute for patient re-
sponses, when patients are unable to provide information themselves due to their 
limitations.(33) Other terms used to describe persons within the social network of 
the patient are ‘relative’, ‘spouse’, ‘family’, ‘partner’, ‘loved one’, ‘friend’, etcetera. 
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The papers included in this thesis use different terminology, depending on the fo-
cus of that specific paper. It should be noted that the terms informal caregiver, 
resident loved one, resident relative and resident proxy are defined by the Home 
Sweet Home study as “a person living together with a patient with COPD, regardless 
of whether they provide care to the patient with COPD”.(34)  
Role of informal caregivers 
Informal caregivers are of major importance for patients with COPD, as the majority 
of home care is provided by family and friends instead of health care 
professionals.(28) To date, more than 70% of the COPD patients referred for pul-
monary rehabilitation, have one or more informal caregivers. Forty percent of these 
patients had a COPD related hospital admission in the last year and 33% used long-
term oxygen therapy. These caregivers are most often close family members, like 
spouses or cohabitants that live together with the patient.(35) Informal caregivers 
provide practical help with activities like household chores, gardening and shop-
ping.(35) Other important tasks are accompanying patients to health care provid-
ers, help with personal care, providing emotional support, and the management of 
medication use and healthcare appointments.(35, 36) 
Patients who have an informal caregiver are less likely to smoke,(37) have a better 
exercise capacity and report less frequent emergency department visits than COPD 
patients who are living alone.(38) An informal caregiver may improve patient ad-
herence. For example, a positive association was found between having an informal 
caregiver and better adherence to antihypertensive and long acting β agonist medi-
cations in COPD patients.(37) Informal caregiving may also have negative conse-
quences. Patients’ self-care behaviour may decrease with higher informal caregiv-
ers’ caring behaviour.(39) Informal caregivers can be overprotective,(40) and COPD 
patients living together with an informal caregiver may be more dependent in in-
strumental activities of daily living.(38)  
COPD is associated with significant economic burden.(3) Maintenance medication 
and hospitalizations due to a COPD exacerbation are responsible for the majority of 
the costs due to COPD.(41) So, a decrease in hospitalizations can save health care 
costs. Informal caregivers may improve patient adherence (37) and they provide 
(informal) care at home.(28) Therefore, informal caregiving reduces costs for pro-
fessional care at home. Then again, informal caregiving can also have negative con-
sequences. For example, informal caregiving may lead to higher costs for paid sick 
leave of the informal caregiver,(35) or anxiety or worrying which is associated with 
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higher rates of contacts with healthcare professionals and higher use of medica-
tion.(42) Moreover, a perceived imbalance in delegated dyadic coping can decrease 
a couple’s quality of life,(43) which may increase the use of healthcare re-
sources.(44) These findings show the complex role of informal caregivers and the 
need for healthcare providers to gain insight in how informal caregivers fulfil their 
role (Figure 1.1). 
 
 
Figure 1.1. The complex process of informal caregiving 
Impact on informal caregivers 
Caregivers of patients with COPD are mostly female spouses.(35) This could be due 
to the smoking trends some decades ago. However, the historical perception that 
COPD is a predominantly disease of males is changing, because of the changing 
smoking trends during the past 50 years.(45) In addition, a study in community-
dwelling dependent elderly concluded that women had a higher rate of living alone 
and a lower rate of receiving care by a spouse.(46) Moreover, female caregivers are 
more likely to take responsibility when a caregiving situation arises and caregiving is 
still considered as a woman’s job.(47) About half of the caregivers are part of the 
work force. However, 34% of these informal caregivers took time off from work to 
help the patient.(35) 
1General introduction 
13 
Although informal caregivers emphasized the need for increased support,(31) for-
mal support for the caregivers, is lacking.(36) Indeed, caregivers reported a lack of 
information and emotional and practical support.(48, 49) Informal caregivers have 
to rely upon extended family support,(28) and they become an integral part of the 
care support system in the home.(36) This extended support included mostly adult 
children living in the home or nearby and were caring alongside the spouse.(36) 
However, perceived extended support was negatively associated with the patient’s 
disease severity.(50) Informal caregivers who perceive less support from family and 
friends are more likely to experience loneliness and depression.(51) The social envi-
ronment encompasses more than social support, including perceived criticism. 
Therefore, the social environment is complex.(52)  
Patients often reported that COPD affects their family life.(53) Shared activities and 
familiar ways of being together as a couple could change,(49) or completely disap-
pear.(54) Moreover, informal caregivers experienced similar losses as the patients 
in terms of social life, shared experiences and the expected future.(32) Informal 
caregivers may experience anxiety, helplessness, depression, worries about the 
patient, uncertainty about the future, loss of mobility, and/or growing social isola-
tion.(35, 55) Caregiver vulnerability may even occur when an imbalance exists be-
tween burden and coping capacity.(54) Informal caregivers’ quality of life, in turn, 
has an impact on the COPD patient.(56)  
The relationship of the patient and caregiver may also be affected. For example, 16 
percent of the couples declared that smoking had a negative impact on their rela-
tionship and 42% stated that smoking had a negative impact on the family budg-
et.(53) Furthermore, for some caregivers the coughing caused feelings of disgust, 
leading to difficulties in kissing their loved one.(49) This, together with the fact that 
sexual intercourse was considered too strenuous for the patient, changed the inti-
mate relationship.(49, 53, 57) Although almost all caregivers felt that the patient 
needed their support,(49) some caregivers persevered because of duty described in 
terms of marriage vows and societal expectations.(54) On the other hand, for some 
couples the relationship deepened.(49) The quality of the relationship between 
caregivers and patients is an important predictor of caregiver burden.(58) Also oth-
er characteristics of the relationship, like a history of relational stress, conflict, and 
instability increase the risk of caregiver vulnerability.(54) 
Caregivers, as well as patients, may experience a decline in psychological and physi-
cal functioning, towards the terminal stages.(59) In fact, caregivers of patients with 
advanced COPD had more symptoms of anxiety and depression, and their self-rated 
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health was significantly worse compared to caregivers of patients with early 
COPD.(16)  
Caregiver burden is also related to the occurrence of COPD exacerbations,(60) es-
pecially when accompanied by a hospital admission. A study including patients with 
COPD and their relatives after an intensive care unit (ICU) stay, showed that 72% of 
the caregivers had symptoms of anxiety and 26% symptoms of depression at dis-
charge of the ICU.(61) After 90 days, 32% of the caregivers received medication for 
anxiety or depression prescribed after the patient’s ICU stay.(61) In a general popu-
lation, symptoms of depression were more prevalent in caregivers of non-
survivors,(62) indicating that burden is higher in caregivers of deceased patients. In 
caregivers of patients with COPD, the perceived possibility of patients to have a 
painful death associated to asphyxia was the main cause of emotional distress.(60) 
For bereaved caregivers, death is often unexpected and unanticipated.(63) Be-
reaved caregivers experienced caregiver burden and a need for bereavement sup-
port.(64) Advance care planning is a process whereby a patient, in consultation with 
health care providers, family members and other loved ones, make decisions about 
their future health care.(65) Family members of elderly patients who received facili-
tated advance care planning had fewer symptoms of posttraumatic stress, depres-
sion and anxiety compared with family members of patients receiving usual 
care.(66) However, advance care planning, in which communication about end-of-
life care is an essential part, occurs infrequently in patients with COPD.(67)  
Caregivers may not only experience distress, but also positive caregiving apprais-
als.(26) Caring for a patient with COPD was considered as an opportunity for per-
sonal growth.(60) Moreover, being able to care for a loved one and help the patient 
stay at home as long as possible may be rewarding.(31) Considering the above, 
adequate communication between the patient and the informal caregiver are a 
prerequisite, and therefore may be a target for interventions.  
Informal caregiver’s perceptions of the patient’s health 
Patients and informal caregivers may have discrepant perceptions of the patients’ 
symptoms and health status.(68, 69) This can result in distress for patients, which, 
in turn, has a negative influence on the informal caregivers’ quality of life.(40)   
Informal caregivers witness the gradual deterioration in health and increasing symp-
toms over the years, and are concerned about the patient’s struggle with these con-
sequences of COPD. However, informal caregivers also reported that they felt that 
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the patient had tried to ‘get on with their life with COPD’.(28) Pinnock and col-
leagues concluded that patients as well as their informal carers accepted the debili-
tating symptoms of a lifelong condition.(63) However, uncertainty about the trajec-
tory of the disease caused stress to the patient and the informal caregiver.(28)  
Subjective burden is the person’s appraisals of the caregiving situation. This subjec-
tive burden is considered as an important predictor of informal caregivers’ psycho-
logical health, like symptoms of anxiety and depression.(70) Researchers concluded 
in a study about perceived breathlessness, that spouses who perceived breathless-
ness of the patient as more severe were more likely to experience a higher level of 
psychological distress.(71) Moreover, there may be an important discrepancy be-
tween the patient’s and informal caregiver’s experience of the patients’ symptoms. 
For example, informal caregivers reported a higher number of symptoms than pa-
tients. The severity of symptoms like fatigue, coughing and anxiety were rated 
higher by informal caregivers than by the patients.(68) Additionally, disagreement is 
also shown between the physician and patient in the perception of symptoms. Only 
a low concordance was found between the patient with COPD and the physician in 
the impact of the symptoms on the patient’s life. When the disease became more 
severe, this concordance increased.(72) Patients and informal caregivers may also 
disagree in how satisfied they are with the medical treatment. However, results 
about the direction of the disagreement are conflicting.(68, 73) Therefore, more 
knowledge is needed about the informal caregiver’s perception of the patient’s 
health status.  
Perspectives 
To date, the importance of informal caregiving seems underrated in the English-
language literature,(3) and many clinically relevant questions remain unanswered. 
Indeed, living together with a patient with COPD can be demanding and may cause 
health problems in informal caregivers.(56) To date, it remains unknown whether 
and to what extent informal caregivers of patients with COPD have adapted the 
family system to the limitations and needs of their chronically ill loved one. Pilot 
data (n=4 couples) suggest that a common sense of companionship between part-
ners assists with reshaping their relationship and adapting it to the new life rhythm 
required by living with COPD.(74)   
The possible influence of informal caregivers’ lifestyle on (non-)adherence to medi-
cal regimens and healthy lifestyle of the patient with COPD, like regular daily physi-
cal activity, smoking cessation, and healthy nutrition also warrants further studies. 
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For example, indoor smoking by the resident loved one negatively influences air 
quality, which is associated with worse health status of the patient with COPD.(75) 
Finally, informal caregivers, like spouses and adult children, are uniquely positioned 
to witness the limitations that COPD patients experience during activities of daily 
life. This will provide healthcare providers with new insights, and may result in new, 
personalized interventions.  
To conclude, patients with COPD and their informal caregivers are confronted daily 
with multiple limitations due to COPD. Therefore, COPD management should not 
only focus on the optimal drug therapy, but also on its home management 
throughout the whole disease trajectory. Informal caregivers play an important 
role, but the process of informal caregiving is complex. Therefore, exploring the 
interaction between patients and informal caregivers and paying attention to the 
needs of informal caregivers should be part of research,(34) and in turn, of regular 
clinical care for patients with COPD. This could improve quality of life of both the 
patients and their informal caregivers and save health care costs.(44) A more in-
depth insight in the role of the home environment is needed to optimize home 
management programs. 
AIMS OF THIS THESIS 
The general introduction described the complex role of informal caregivers of pa-
tients with COPD. In addition, it also described the knowledge gaps within the cur-
rent understanding of the home situation of patients with COPD. In order to gain 
knowledge about the role of these informal caregivers, and thus the home situation 
of patients with COPD, an observational, longitudinal study was designed.  
This thesis aimed to answer the following research questions:  
- Whether and to what extent do caregiver burden and positive aspects of 
caregiving change during 1-year follow-up in patients with advanced COPD, 
chronic heart failure (CHF) and chronic renal failure (CRF), and what are the 
determinants of a change? 
- What are the differences between health status, morbidities, care depend-
ency, and mobility between patients with COPD and their resident rela-
tives? 
- Whether and to what extent are proxies able to correctly estimate the 
COPD patient’s problematic ADLS, and to what extent do differences exist 
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between patient-reported and proxy-reported performance and satisfac-
tions scores of equally reported problematic ADLs? 
- What causes of perceptual differences could be distinguished between pa-
tients and proxies about the patients’ problematic ADLs?  
- How is the health-related and COPD-related knowledge in patients with 
COPD and their proxies?  
- Do differences exist between male and female partners of patients with 
COPD regarding their own health status, symptoms of anxiety and depres-
sion, social support, caregiver burden and coping styles, or regarding their 
perceptions of the patients’ care dependency, symptoms of anxiety and 
depression and health status?  
OUTLINE OF THIS THESIS 
Following this introduction about the home situation of patients with COPD, Chap-
ter 2 describes the changes, and its determinants, in caregiver burden and positive 
aspects of caregiving during 1-year follow up in patients with advanced chronic 
organ failure. This chapter is based on a previous longitudinal observational study in 
patients with chronic organ failure, which gave direction to the Home Sweet Home 
study. The research protocol of the study conducted for this thesis, the Home Sweet 
Home study, is described in detail in Chapter 3. To gain insight in the home envi-
ronment of patients with COPD, resident relatives (like partners or resident family 
members) should not be ignored. Therefore, Chapter 4 describes the health status 
and morbidities of both patients with COPD as well as their resident relatives. Pa-
tients with COPD experience problems with activities of daily living (ADLs), mostly 
due to perceived symptoms. Chapter 5 describes perception differences between 
patients and proxies (i.e. resident relatives) about patients’ problematic ADLs. Chap-
ter 6 focuses on the causes of these perception differences. Knowledge about a 
disease, and health in general, is an important aspect when supporting patients 
with managing their disease. Thus, Chapter 7 shows the knowledge about general 
health and COPD in both patients and their proxies. Future efforts to involve part-
ners’ of patients with COPD in regular care and disease management may benefit 
from an understanding about gender differences in partners. Therefore, these gen-
der differences are described in Chapter 8. The general discussion in Chapter 9, 
discusses all chapters in a broader context, including the clinical implications and 
directions for future research.   
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ABSTRACT 
Background: Family caregivers already have a paramount role in daily care for pa-
tients with chronic obstructive pulmonary disease (COPD), chronic heart failure 
(CHF), or chronic renal failure (CRF). To date, it remains unknown whether and to 
what extent the experience of caregiving changes over time. 
Objectives: To examine changes in caregiver burden and positive aspects of caregiv-
ing during 1-year follow-up in patients with advanced COPD, CHF or CRF and to study 
determinants of changes in caregiver burden and positive aspects of caregiving. 
Methods: In this longitudinal observational study, patients and their family caregiv-
ers who had complete data at baseline and 12 months (n = 104) and family caregiv-
ers of patients who died during 1-year follow-up (n = 15) were included. Caregiver 
burden and positive aspects of caregiving were assessed using the Family Appraisal 
of Caregiving Questionnaire for Palliative Care (FACQ-PC). Domain scores were clas-
sified into three categories, and baseline characteristics were compared between 
these categories. 
Results: A majority of the individuals showed 1-year changes in FACQ-PC domain 
scores. These individual changes were not explained by demographic or clinical 
patient characteristics at baseline or changes in patient characteristics during 1-
year follow-up. Furthermore, caregiver burden was higher for caregivers of patients 
who died during 1-year follow-up compared to caregivers whose relative completed 
1-year follow-up. 
Conclusion: This study showed that caregiver burden and positive aspects of care-
giving can change over time, and these changes are highly individual. Therefore, 
healthcare providers should regularly pay attention to family caregivers, regardless 
the patients’ characteristics.  
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INTRODUCTION 
The societal and economic burden of chronic obstructive pulmonary disease 
(COPD), chronic heart failure (CHF) and chronic renal failure (CRF) will increase in 
the coming years.(1-3) The prevalence of these diseases will increase, while nurse 
and physician workforce shortages rise. Therefore, a shift from hospital care to 
home care for patients with advanced chronic organ failure is anticipated.(4) 
To date, family caregivers already have a paramount role in daily care for patients 
with advanced chronic organ failure, like COPD, CHF or CRF.(5-7) Family caregiving 
is unpaid caregiving often provided by family or friends.(8) Therefore, the term 
‘family caregiver’ refers to a person who is providing care, but is not a healthcare 
professional.(9, 10) Referring to the developments above, the role of the family 
caregivers is expected to increase.(11) Caring for a loved one with advanced disease 
may have important consequences for family caregivers. Family caregivers often 
change their own daily schedule, adjust their daily activities and may experience a 
change of their original family role into lifestyle coach and home helper.(7, 12, 13) 
Therefore, caring for chronically ill patients may negatively affect the well-being of 
the caregivers, but can also be a positive experience.(13-15) To be able to comfort 
the patient and to help the patient to stay at home as long as possible are experi-
enced as positive sides of family caregiving.(16) Having a family caregiver is not only 
positive for the caregiver, but also for the patient. For example, the availability of a 
family caregiver may reduce the length of hospitalization.(17) 
To date, it remains unknown whether and to what extent caregiver burden and 
positive aspects of caregiving change during the course of the disease. Cross-
sectional studies have shown an association between caregiver burden and the 
patient–caregiver relationship, patient’s psychological symptoms and comorbidi-
ties.(15, 18, 19) Furthermore, caregivers who experienced the highest level of dis-
tress associated this with increasing illness demands.(6) However, there is a lack of 
knowledge about which patient and caregiver characteristics are associated with a 
1-year change in burden and positive aspects of caregiving in advanced disease. 
It is reasonable to assume that caregiver distress increases at the end of life of the 
patient.(20) However, findings about caregiver burden in terminally ill patients with 
cancer were contradictory.(21, 22) In patients with advanced chronic organ failure, 
it remains unknown whether and to what extent caregiver burden is changing to-
wards the end of life. 
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Aims of the present longitudinal observational study were to examine changes in 
caregiver burden and positive aspects of caregiving during 1-year follow-up in pa-
tients with advanced COPD, CHF or CRF and to study determinants of changes in 
caregiver burden and positive aspects of caregiving. A priori, we hypothesised that 
caregiver burden and positive aspects of caregiving change during 1-year follow-up. 
We also hypothesised that an increase in symptoms of anxiety and depression, care 
dependency and comorbidities during 1-year follow-up is associated with increase 
in caregiver burden. Finally, we hypothesised that caregiver burden will increase 
and positive aspects of caregiving will decrease towards the end of life. 
METHODS 
Design 
This is a secondary analysis of a longitudinal observational study concerning self-
perceived symptoms and care needs in patients with advanced COPD, CHF or CRF 
and the consequences for their closest relatives.(23) This study was approved by 
the Medical Ethical Committee of the Maastricht University Medical Centre (MEC 
07-3-054) and was registered at the Dutch Trial Register (NTR 1552). All participat-
ing patients and family caregivers have given written informed consent. Data on 
health status, symptom burden, care dependency, advance care planning and 
cross-sectional data on family caregiving have been published.(15, 23-26) Longitu-
dinal data on family caregiving have not been published before. 
Study population 
Patients with advanced COPD, CHF or CRF were recruited by their physician special-
ist at the outpatient clinic of seven hospitals in the Netherlands in 2008 and 2009. 
Patients were included if they had a diagnosis of severe to very severe COPD (Glob-
al initiative for chronic obstructive lung disease (GOLD) grade III or IV,(27) or pa-
tients using long-term oxygen therapy (LTOT), independent from GOLD grade), 
advanced CHF (New York Heart Association (NYHA) class III or IV) or advanced CRF 
(requiring dialysis). Patients were asked to identify the person who spent the most 
time with them and/or provided most of their care, assistance and support.(28) 
Only family caregivers that had complete Family Appraisal of Caregiving Question-
naire for Palliative Care (FACQ-PC) data on baseline and 12 months and family care-
givers of patients who died during 1-year follow-up were included. 
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Instruments 
Patients and their closest relatives (person who spent most time with the patient 
and/or provided most of the care, assistance and support) were visited in their 
home environment at baseline, 4, 8 and 12 months after baseline. During these 
visits, demographic and clinical patient characteristics (such as smoking status, cur-
rent self-reported comorbidities (Charlson comorbidity index,(29)) and the use of 
LTOT) were recorded. Patients’ generic health status was assessed using the self-
administered questionnaire EuroQol-5 Dimensions (EQ-5D), providing an index 
score which ranges from -0.59 (worst) to 1.0 (best).(30) Patients rated their current 
health status using a visual analogue scale (VAS). This scale ranges from 0 (worst 
possible health) to 100 (best possible health). Generic health status of the patients 
was also assessed using the Assessment of Quality of Life [AQoL, total scores ranges 
from -0.04 (worst) to 1.00 (best)].(31, 32) Symptoms of anxiety and depression 
were assessed using the Hospital Anxiety and Depression Scale (HADS). This scale is 
divided into an anxiety subscale (HADS-A) and a depression subscale (HADS-D).(33) 
For each subscale, the total scores range from 0 (optimal) to 21 points (worst). Care 
dependency was assessed using the Care Dependency Scale (CDS).(34) The score 
ranges from 15 (worst) to 75 points (best).(35)  
General characteristics from the family caregivers (sex, age and relationship with 
the patient) were also recorded. Caregiver burden and positive aspects of caregiv-
ing were assessed using the FACQ-PC.(36) The FACQ-PC consists of 25 items in four 
domains: caregiver strain (role overload and role captivity), positive caregiving ap-
praisals (representing gains or positive affective returns from caregiving), caregiver 
distress (negative emotional responses and feelings of guilt) and family well-being 
(quality of family functioning). The item scores range from 1 (strongly disagree) to 5 
points (strongly agree). Therefore, a higher score means a greater amount of the 
variable being measured. The midpoint of the scale, 3 points, indicates a neutral 
position. The FACQ-PC has good initial psychometric properties.(36) 
Statistics 
Data are presented as mean and standard deviation (SD); median and interquartile 
range (IQR); or frequencies, as appropriate. Baseline characteristics, stratified for 
patients and caregivers who completed 1-year follow-up, patients who died during 
1-year follow-up, and patients and caregivers who withdrew from the study for 
other reasons were compared using one-way analysis of variances (ANOVA) with 
LSD as post hoc test, Kruskal–Wallis test followed by Mann–Whitney U-tests or chi-
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square tests, as appropriate. To compare patient characteristics between baseline 
and 12 months, paired sample t-tests or Wilcoxon signed rank tests were used as 
appropriate. Paired sample t-tests were performed to compare the baseline scores 
of the FACQ-PC domain scores with the follow-up scores at 4, 8 and 12 months. The 
12-month changes of the FACQ-PC domain scores were classified into three catego-
ries: decrease [change < 0 - (1.96 x SE of mean change)], increase [change > 0 + 
(1.96 x SE of mean change)] or no change. Baseline characteristics of patients and 
family caregivers were compared between these three groups using a one-way 
analysis of variances (ANOVA) with LSD as post hoc test, Kruskal–Wallis test fol-
lowed by Mann–Whitney U-tests or chi-square tests as appropriate. Furthermore, 
using the same statistical analysis, the changes in patient characteristics during 1-
year follow-up were compared between these strata. Baseline FACQ-PC scores and 
last FACQ-PC scores in the study were compared between family caregivers of pa-
tients who survived 1-year follow-up and family caregivers of patients who died 
during 1-year follow-up using independent samples t-tests. The level of significance 
was set at p ≤ 0.05.(37) All statistics were performed using SPSS version 20.0 (IBM 
Corp., Armonk, New York, United States). 
RESULTS 
Characteristics of patients and family caregivers 
In total, 159 patients identified a family caregiver (60.0% of the original sample). Of 
these, 104 patients and their family caregivers (65.4%) completed 1-year follow-up 
(Figure 2.1). 
The majority of patients were men living with a partner. Most family caregivers 
were female partners. Patients who died during 1-year follow-up were more care 
dependent than patients who completed the 12-month measurements or those 
who withdrew from the study for other reasons (p < 0.01). Furthermore, patients 
who died had a lower health status as assessed with the AQoL than patients who 
completed the study (p < 0.01). Other baseline characteristics of the patients were 
similar between these three subgroups. No differences in baseline characteristics 
were found between the family caregivers of these three subgroups (Table 2.1). 
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Figure 2.1. Flow-chart  
FACQ-PC, Family Appraisal of Caregiving Questionnaire for Palliative Care. 
The level of care dependency deteriorated from 67.3 (8.6) points at baseline to 64.8 
(11.8) points after 1-year follow-up (p < 0.01) and patient’s quality of life deterio-
rated during 1-year follow-up measured with both the AQoL [0.49 (0.27) vs. 0.44 
(0.27) points (p = 0.02)] and the EQ-5D [0.57 (0.30) vs. 0.50 (0.34) points (p = 0.01)]. 
Symptoms of anxiety and depression, as assessed with the HADS, remained stable 
during 1-year follow-up (mean change -0.6 (3.6) and -0.1 (3.9) points, respectively; 
p > 0.05). 
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Table 2.1. Baseline characteristics of patients and their family caregivers 
 Completed one-year follow-up Patient died  Withdrawna 
 n=104 n=15 n=40 
Patients   
Disease    
COPD 44 (42.3%) 7 (46.6%) 22 (55.0%) 
CHF 33 (31.7%) 4 (26.7%) 8 (20.0%) 
CRF 27 (26.0%) 4 (26.7%) 10 (25.0%) 
Male  70 (67.3%) 8 (53.3%) 29 (72.5%) 
Age (years)b 67.1 (11.1) 74.0 (8.5) 67.5 (13.2) 
Married/living with partner 89 (85.6%) 12 (80.0%) 33 (82.5%) 
Current smokers 19 (18.3%) 3 (20.0%) 8 (20.0%) 
Charlson comorbidity index (points) 3.6 (2.1) 3.3 (1.7) 3.3 (2.1) 
Patients with ≥1 comorbidity 87 (83.7%) 13 (86.7%) 30 (75.0%) 
Long-term oxygen therapy 33 (31.7%) 3 (20.0%) 12 (30.0%) 
Care dependency score (points)b 67.3 (8.6)c 55.3 (13.2)d 65.8 (8.0) 
EQ-5D score (points) 0.57 (0.30) 0.43 (0.32) 0.53 (0.37) 
EQ-5D VAS-score (points) 63.1 (14.7) 61.0 (15.9) 65.0 (14.6) 
AQoL score (points) 0.49 (0.27)c 0.29 (0.26) 0.40 (0.29) 
HADS-A score (points) 5.2 (3.5) 5.1 (4.9) 5.9 (4.3) 
HADS-D score (points) 5.6 (3.8) 6.6 (3.8) 5.8 (3.8) 
Family caregivers    
Relationship to patient    
Spouse 87 (83.6%) 12 (80.0%) 33 (82.5%) 
Child 11 (10.6%) 3 (20.0%) 5 (12,5%) 
Othere 6 (5.8%) 0 (0%) 2 (5.0%) 
Male 29 (27.9%) 6 (40.0%) 8 (20%) 
Age (years) 63.0 (12.6) 65.8 (11.1) 62.5 (14.3) 
COPD, chronic obstructive pulmonary disease; CHF, chronic heart failure; CRF, chronic renal failure; EQ-5D, 
EuroQol-5 Dimensions; AQoL, Assessment of Quality of Life; HADS-A, Hospital Anxiety and Depression Scale, 
anxiety subscale; HADS-D, Hospital Anxiety and Depression Scale, depression subscale. Values reported as 
mean (SD) or number of participants (%).  
a Excluded due to patient dropout and caregivers who did not complete 1-year follow-up. b Nonparametric 
statistical tests have been used because of skewed data. c p < 0.01 vs. patients who died during follow-up. d p 
< 0.01 vs. dropouts. e Other = brother, sister, parent, daughter-in-law, son-in-law, professional. n = 159. 
FACQ-PC domain scores at baseline and 4, 8 and 12 months 
At baseline, the caregiver strain and caregiver distress scores were rated low, while 
the domains positive caregiving appraisals and family well-being were scored high 
(Table 2.2). On average, more than three quarters of the caregivers showed an 
increase or decrease in FACQ-PC scores during 1-year follow-up. In fact, in the do-
main family well-being, only 11.5% showed no change during 1-year follow-up (Ta-
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ble 2.3). The mean scores of all FACQ-PC domains remained stable (p > 0.05, Table 
2.2). However, almost equal proportions of participants had an increase or de-
crease in FACQ-PC scores (Table 2.3). 
 
Table 2.2. Domain scores of the Family Appraisal of Caregiving Questionnaire for Palliative Care (FACQ-PC) 
during 1-year follow-up 
    
Baseline 
n=104 
4 months 
n=101a 
8 months 
n=97b 
12 months 
n=104 
Caregiver strain 2.0 (1.0) 1.9 (0.9) 2.0 (1.0) 1.9 (0.9) 
Positive caregiving appraisals 3.8 (1.1) 3.9 (0.9) 3.8 (0.9) 3.9 (0.9) 
Caregiver distress 2.3 (1.0) 2.2 (1.0) 2.2 (1.0) 2.2 (1.0) 
Family well-being 3.7 (0.8) 3.7 (0.9) 3.7 (0.8) 3.7 (0.7) 
Values reported as mean (SD). p > 0.05 baseline vs. 4, 8 and 12 months for all domains. a n = 3 did not com-
plete the 4-month visit. b n = 7 did not complete the 8-month visit. 
Determinants of changes in FACQ-PC 
Univariate analyses showed no difference in baseline characteristics of patients for 
caregivers reporting a 1-year increase, decrease or no change in FACQ-PC domains. 
Significant differences were observed in the change in patients’ HADS depression 
scores between caregivers reporting a decrease or no change in positive caregiving 
appraisals (Table 2.3). All other changes in patient characteristics during 1-year 
were comparable for caregivers reporting a 1-year increase, decrease or no change 
in FACQ-PC domains. 
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Relationship of FACQ-PC domain scores and survival state 
Fifteen patients died during 1-year follow-up. Median time in the study was 232 
(IQR: 125–266) days. The median (IQR) number of days between the last FACQ-PC 
assessment and death of the patient was 113 (35–125). Baseline caregiver distress 
was significantly higher in caregivers of patients who died during 1-year follow-up 
compared to the scores of family caregivers of patients who survived 1-year follow-
up. In addition, during the last interview in the study, mean caregiver strain score of 
caregivers of patients who died during 1-year follow-up was higher than the score 
of caregivers of patients who survived 1-year follow-up, p < 0.05 (Table 2.4). 
 
Table 2.4. Baseline and last FACQ-PC scores in the study for caregivers who completed 1-year follow-up and 
caregivers of patients who died within 1-year follow-up 
Baseline FACQ-PC scores  Last FACQ-PC scores in the study 
Caregivers who 
completed one-year 
follow-up  
Caregivers of 
patients who died 
within one-year 
Caregivers who 
completed one-year 
follow-up 
Caregivers of 
patients who died 
within one-year 
  n=104 n=15 n=104 n=15 
Caregiver strain 2.0 (1.0) 2.2 (0.9) 1.9 (0.9)a 2.5 (0.9) 
Positive caregiving  
   appraisals 3.8 (1.1) 4.1 (0.7) 3.9 (0.9) 4.0 (0.8) 
Caregiver distress 2.3 (1.0)a 2.9 (1.2) 2.2 (1.0) 2.6 (1.0) 
Family well-being 3.7 (0.8) 3.6 (0.9) 3.7 (0.7) 3.6 (0.6) 
FACQ-PC, Family Appraisal of Caregiving Questionnaire for Palliative Care. Values reported as mean (SD). a p < 
0.05. 
DISCUSSION 
Key findings 
The current study has three key findings: (1) a majority of the caregivers experi-
enced 1-year changes in FACQPC domain scores; (2) baseline or 1-year changes in 
patient characteristics did not explain the individual changes in caregivers’ FACQ-PC 
domain scores; and (3) caregiver burden was higher for caregivers of patients who 
died during 1-year follow-up compared to caregivers of patients who completed 1-
year follow-up. 
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Caregiving during 1-year follow-up and patient characteristics  
Mean scores on the four domains of caregiving remained stable during 1-year fol-
low-up. This could be due to the almost equal proportions of participants with an 
increase or decrease in FACQ-PC scores, which might explain stable mean scores of 
all FACQ-PC domains. Garlo et al.(38) and Sautter et al.(13) had similar findings in a 
sample of patients with cancer, heart failure or COPD. In the present study, mean 
scores for caregiver burden remained relatively low, while mean scores of positive 
aspects of caregiving remained relatively positive. A possible explanation for this 
relatively positive experience of caregiving can be explained by the fact that pa-
tients and their caregivers perceive a chronic disease such as COPD as a way of life 
and get used to their situation.(39) Exacerbations are seen as interruptions of ‘nor-
mal’ life.(39) The gained confidence in the caregiver role,(40) realizing their own 
capabilities,(41) the caregiver’s good relationship with the care recipient,(42) the 
life lessons they learned through their caregiving experience,(43) or knowing they 
did everything possible to make the patient’s end-of-life comfortable,(41) may also 
contribute to the relatively positive experience of caregiving. 
The present study demonstrates that individual caregivers’ scores for FACQ-PC 
domains can change over a 1-year period. In contrast to our hypothesis, these indi-
vidual changes were not explained by the available patient characteristics. Only in 
the domain positive caregiving appraisals, changes in symptoms of depression dur-
ing 1-year follow-up were significantly different between caregivers experiencing a 
decrease in positive caregiving appraisals and no change in this domain. No differ-
ences in all other changes in patient characteristics during 1-year follow-up were 
found between strata. Therefore, a higher level of care dependency or an increased 
level of psychological symptoms does not automatically result in more caregiver 
burden. This is in line with the previous findings of Burton et al.(44) and Garlo et 
al.(38) who found that caregiver burden was not associated with patient’s diagno-
sis, symptoms and functional status. However, other studies in caregivers of pa-
tients with COPD and cancer concluded that a decline in the patients’ health caused 
feelings of depression or deteriorating psychological well-being in the 
caregivers.(16, 21) Nevertheless, all studies used different methods for measuring 
caregiver burden or caregivers’ symptoms of depression. These studies also con-
cluded that a higher caregiver burden was associated with the caregiver’s report of 
need for increased support from both friends and family, and the healthcare sys-
tem.(16, 21, 38, 44) Moreover, a significantly higher burden was found in caregivers 
who desired more communication about the patient’s illness compared to those 
who did not.(38, 45) 
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Caregiving aspects of deceased patients 
A previous study of Garlo et al.(38) found that the burden in caregivers of patients 
with advanced illness (advanced cancer, heart failure or COPD), who died or be-
came too sick to complete the follow-up period, was higher at baseline and in-
creased towards the end of life. Moreover, Sautter et al.(13) found that almost 40% 
of the caregivers experienced an increased burden, from unburdened during the 
phase of chronic illness to burdened during the patient’s last year of life. The pre-
sent study confirmed these findings. Indeed, caregiver distress and caregiver strain 
scores were significantly higher for caregivers of patients who died within 1-year. In 
fact, worrying about the patient and uncertainty about the future are the most 
demanding parts for family caregivers.(46, 47) 
Methodological considerations 
Some limitations of this study should be considered in interpreting the results. First, 
only 60% of the patients identified a family caregiver, mostly because patients were 
afraid of an increased burden for the family caregiver. Some family caregivers re-
fused participation. It may be reasonable to assume that caregivers experiencing 
the highest level of burden refused participation. This could imply that the observed 
burden in this study was lower than the burden in all caregivers of patients with 
advanced chronic organ failure. However, without data, this could not be substanti-
ated. Second, most family caregivers were female partners. Although previous stud-
ies did not show an association between the caregiver’s gender and experience of 
caregiving,(19, 38) it could be possible that female spouses react differently on 
their caregiving role than male caregivers. Therefore, this should be considered 
when interpreting these results in a population with mostly male caregivers. Third, 
patients and their caregivers are followed for only 1-year during this study. There-
fore, conclusions about the total course of the disease could not be made. Fourth, 
in the present study, the FACQ-PC is used to measure change during 1-year follow-
up. Although the FACQ-PC could be a potential outcome measure for evaluating the 
effectiveness of interventions,(36) the responsiveness to change of the FACQ-PC is 
currently unknown. Therefore, this might decrease the internal validity of the cur-
rent findings. Fifth, generalisability may be compromised by the small sample size 
and international differences in healthcare systems. Sixth, other factors that may 
influence the experience of caregiving could be the duration of care provided,(48) 
the relationship of the caregiver with the patient, the quality of the 
relationship,(49) and how caregivers cope with their caring demands.(50) However, 
data concerning these characteristics were not available. Receiving more help from 
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their social environment and successful coping styles could be positive for the care-
givers’ quality of life.(44, 51) Lopez-Hartmann et al.(52) concluded in a systematic 
review about informal caregivers of frail elderly that integrated support packages, 
tailored to the individual caregivers’ physical, psychological and social needs should 
be preferred when supporting informal caregivers. Limpawattana et al.(48) con-
cluded in a study about the informal caregivers of community-dwelling older adults 
that caregiver dependent factors were more strongly associated with high burden 
than patient characteristics. Furthermore, Pinto et al.(19) concluded that the care-
giver’s mental component summary score of a questionnaire regarding quality of 
life was one of the most important predictors of caregiver burden. Therefore, fu-
ture studies should focus on the caregiver characteristics and the response of the 
caregiver on their caregiving role instead of the patient characteristics in relation to 
caregiver burden. 
CONCLUSION 
In line with our hypothesis, this study concluded that most individual caregivers 
experienced an increase or decrease in caregiver burden and positive aspects of 
caregiving during 1-year follow-up. Furthermore, no significant differences in base-
line patient characteristics, like psychological symptoms or care dependency, were 
found between family caregivers who experienced an increased caregiver burden 
compared to those who had a decrease in caregiver burden during 1-year follow-
up. 1-year changes in patient’s symptoms of depression may be related with posi-
tive caregiving appraisals. Caregiver burden did increase when patients died during 
1-year follow-up, but positive caregiving appraisals did not change. All together, this 
study showed that changes in caregiver burden and positive aspects of caregiving 
were not due to patient characteristics at baseline and changes in patient charac-
teristics during 1-year follow-up. Therefore, it could be possible that not patient 
characteristics, but characteristics of the caregivers itself were the cause of these 
changes. In the present study, knowing only a few basic caregiver characteristics, 
this could not be assessed. Therefore, a longitudinal follow-up study is warranted to 
further reveal a broader variety of family caregivers’ characteristics. Healthcare 
providers should regularly pay attention to the family caregivers during the total 
course of the patients’ disease.  
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ABSTRACT 
Introduction: Chronic obstructive pulmonary disease (COPD) represents an im-
portant public health challenge. Patients are confronted with limitations during 
activities of daily living (ADLs). Resident loved ones of patients with COPD may be 
uniquely positioned to witness these limitations. COPD may have an impact on not 
only the patients’ life, but also on the lives of the resident loved ones. Furthermore, 
COPD exacerbation-related hospital admissions often occur in patients with COPD. 
However, whether and to what extent these admissions influence resident loved 
ones’ burden and health status remains currently unknown. Therefore, the primary 
objectives of this study are to investigate the differences between patients with 
COPD and resident loved ones’ perceptions of patients’ health status and problem-
atic ADLs and to study prospectively the effects of a COPD exacerbation on resident 
loved ones’ perceptions of patients’ health status and problematic ADLs. 
Methods and analysis: An observational, longitudinal study will be performed in 192 
patients with COPD and their 192 resident loved ones. Primary outcomes are daily 
functioning, ADL, disease-specific health status, generic health status and dyspnoea. 
These will be assessed during home visits at baseline and after 12 months. Addi-
tional home visits will be performed when a COPD exacerbation-related hospital 
admission occurs during the 12-month follow-up period. 
Ethics and dissemination: This protocol was approved by the Medical Ethics Com-
mittee of the Catharina Hospital Eindhoven, the Netherlands (NL42721.060.12/ 
M12-1280) and is registered in the Dutch Trial Register (NTR3941). 
3The research protocol of the Home Sweet Home study 
43 
INTRODUCTION 
Chronic obstructive pulmonary disease (COPD) is the fourth cause of death in the 
world,(1) and represents an important public health challenge.(2) Owing to contin-
ued exposure to COPD risk factors and aging of the population, the burden of COPD 
will increase in the upcoming decades.(2) This, combined with the shortage in 
healthcare staffing,(3) most probably causes a shift towards home care. 
Commonly, patients with COPD suffer from multiple symptoms, like dyspnoea, 
coughing, sputum production, fatigue, anxiety and/or depression.(4) Therefore, it is 
not very surprising that patients with COPD experience symptoms during activities 
of daily living (ADLs).(5, 6) Resident loved ones may be uniquely positioned to wit-
ness the limitations that patients with COPD experience during (physical and in-
strumental) ADLs. 
The terminology used to refer to the caregiver role is ambiguous.(7) The terms 
‘family caregiver’ or ‘informal caregiver’ refer to a person, often a family member or 
friend, who is providing care, but is not a healthcare professional.(8, 9) However, 
informal caregivers themselves, in particular spouses, do not refer to the notion of 
being a caregiver, often describing it as an extension of their loving role and com-
mitment to the person requiring support.(10, 11) Therefore, in this study, the term 
resident loved one will be used. We adopt the following definition: a person living 
together with a patient with COPD, regardless of whether they provide care to the 
patient with COPD. 
Caring for a loved one with advanced COPD is described as a full-time role that is 
akin to that of caring for people with severe disability.(12) General day-to-day 
commitments of resident loved ones are planned around the care of the patient 
with COPD.(13) Therefore, caregiver burden is common in family caregivers of pa-
tients with COPD.(13, 14) However, caregiver burden is not associated with objec-
tive measures of the patient’s need for assistance.(13) In fact, caregiver burden 
seems more associated with the loved ones’ report of need for greater help,(13) 
and symptoms of depression of the patient.(14) It is known that discrepancies exist 
in spouses’ perceptions of patients’ symptoms and health status and those of the 
patients themselves.(15, 16) How resident loved ones interact with patients with 
COPD probably depends on many determinants, such as their perceptions of pa-
tients’ limitations in ADLs, the quality of the relationship, as well as the patients’ 
health status and mood status.(14, 17) On the other hand, spouses' anxiousness is a 
predictor for the health status of patients with COPD.(18) 
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Family caregiving is most probably a dynamic process, in which an escalation in 
loved ones’ anxiety, depression and psychological distress may occur as the pa-
tient’s functional status declines over time or during a hospitalisation due to a 
COPD exacerbation.(17, 19, 20) In fact, caregivers of patients with heart failure who 
had fewer emergency department visits felt more positive about caregiving than 
other caregivers.(21) Whether and to what extent COPD exacerbation-related hos-
pital admissions influence resident loved ones’ burden and health status remains 
currently unknown. 
Objectives of the study 
The primary objective of this study in patients with COPD is twofold: 
1.1 To investigate the differences between patients with COPD and resident
loved ones’ perceptions of patients’ health status and problematic ADLs. 
1.2 To study prospectively the effects of a COPD exacerbation on resident loved
ones’ perceptions of patients’ health status and problematic ADLs. 
Furthermore, the following secondary objectives will be addressed: 
2.1 To investigate the differences between patients with COPD and resident 
loved ones’ perceptions of patients’ mood status, care dependency and daily
symptoms. 
2.2 To investigate the general well-being of patients when discrepancies exist
between the patients’ and resident loved ones’ perceptions of patients’ care 
dependency. 
2.3 To investigate if general well-being of patients and loved ones is influenced 
by the health or mood status of the significant other. 
2.4 To study the relationship between lifestyle factors (like physical activity,
smoking habit and fat free mass) in patients with COPD and their resident
loved ones. 
2.5 To investigate resident loved ones’ burden due to patients care dependency. 
2.6 To investigate resident loved ones’ knowledge about COPD and the relation-
ship with anxiety and social support. 
3.1 To study prospectively the effects of a COPD exacerbation on resident loved
ones’ perceptions of patients’ mood status, care dependency and daily symp-
toms. 
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3.2 To investigate whether and to what extent loved ones’ burden and resident 
loved ones’ health and mood status are influenced by exacerbation-related 
hospital admissions. 
4.1 To capture differences at baseline and 12 months later between patients’ 
and resident loved ones’ perceptions of patients’ health status, problematic 
ADLs, mood status, care dependency and daily symptoms. 
The objective of this article is to show the rationale and methods of this observa-
tional, longitudinal study in patients with COPD and their resident loved ones. Fur-
thermore, this detailed description of the research protocol of the Home Sweet 
Home study will serve as reference for the method section of future publications of 
this study. Finally, the current manuscript provides an outline of the possible 
strengths, weaknesses and clinical consequences. 
METHODS AND ANALYSIS 
Study design 
An observational, longitudinal study on the home environment of people with 
COPD has been designed. All data will be collected during home visits at baseline 
and after 12 months. Additional home visits will be performed when an exacerba-
tion-related hospital admission occurs during the 12-month follow-up period. The 
resident loved one will be visited extra at home <7 days after admission of the pa-
tient with COPD to the hospital. Finally, 2 weeks after discharge, the patient and 
loved one will be visited once more at home. Figure 3.1 gives a complete overview 
of the study design. Data collection will take place from July 2013 until April 2016. 
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Figure 3.1. Timing of the home visits  
Home visits will take place in all patients and their loved ones at baseline and after 1-year follow-up. Addition-
al home visits will be planned when a chronic obstructive pulmonary disease exacerbation-related hospital 
admission occurs. 
Eligibility criteria 
Eligible patients are those who satisfy all of the following criteria: 
1. Patients with moderate to very severe COPD as main diagnosis (Global initia-
tive for chronic Obstructive Lung Disease (GOLD) grade II, III or IV);(2) 
2. No exacerbation of COPD (defined as ‘an acute event characterised by a wors-
ening of the patient’s respiratory symptoms ie, beyond the normal day-to-day 
variations and leads to a change in medication’)(22) or hospitalization <4 
weeks preceding enrolment; 
3. Provided written informed consent; 
4. One resident loved one (defined as a person living together with a patient with 
COPD, regardless of whether they provide care to the patient with COPD) also 
provided written informed consent to participate. 
Patients will be excluded if: 
1. Patient and/or resident loved one is unable to complete the study question-
naires because of cognitive impairment (defined as Short Blessed Test score 
≥10 point);(23, 24) 
2. Patient and/or resident loved one is unable to speak or understand Dutch. 
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Patients will be equally divided based on gender and GOLD grade. Furthermore, 
about two-third of the participating patients should be frequent exacerbators (de-
fined as two or more COPD exacerbations,(25) or one or more COPD exacerbation-
related hospital admission in the year before baseline measurements).(26) 
From eligible non-participating patients, some data like disease severity (GOLD 
grade), gender, and age will be collected to compare characteristics of participating 
and non-participating patients. 
Outcomes 
The following primary outcomes will be assessed at the patients’ home environ-
ment: Daily functioning (Canadian Occupational Performance Measure (COPM)(27) 
and the Instrumental Activities of Daily Living Scale (IADLS));(28) disease-specific 
health status (COPD Assessment Test (CAT));(29) generic health status (12-Item 
Short Form Health Survey (SF-12),(30) and the EuroQol 5-Dimensions (EQ-5D));(31) 
Dyspnoea (modified Medical Research Council (mMRC) dyspnoea scale).(32) 
In addition, the following secondary outcomes will be assessed: Symptoms of fatigue 
(Subjective Fatigue subscale of the Checklist Individual Strength (CIS));(33) exercise 
self-efficacy (self-efficacy for home walking questionnaire); symptoms of anxiety and 
depression (Hospital Anxiety and Depression scale (HADS));(34) general well-being 
(Assessment of Quality of Life with 8 dimensions (AQoL-8D));(35) mobility (Timed-
Up-and-Go test);(36) daily symptoms using visual analogue scales (VAS);(4) COPD-
specific knowledge (CIROPD knowledge questionnaire); coping (Utrecht Coping List 
(UCL));(37) care dependency (Care Dependency Scale (CDS),(38) and informal and 
professional care <6 months);(4) physical activity and motivation (validated accel-
erometer,(39) the Behavioural Regulation in Exercise Questionnaire (BREQ-2),(40) 
and the social-individual focus); smoking status (self-developed questionnaire, and 
the Fagerström test for nicotine dependence);(41) social support (Medical Outcome 
Study Social Support Survey (MOSSSS));(42) quality of the relationship (Dutch rela-
tionship questionnaire (NRV));(43) cognitive functioning (Short Blessed Test 
(SBT));(23) caregiver burden and positive aspects of caregiving (Family Appraisal of 
Caregiving Questionnaire for Palliative Care (FACQ-PC)(44) (only for resident loved 
ones)); clinical characteristics (fat-free mass (using body impedance assessment 
(BIA)),(45) body weight and height, post-bronchodilator spirometry, resting blood 
pressure, resting heart rate and resting transcutaneous oxygen saturation). 
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Additionally, demographics (such as age, gender, marital status and working status), 
medical history, (Charlson comorbidity index),(46) current medication and home 
adaptations and aids (4) will be recorded. 
The resident loved one will be asked to contact the study team when an exacerba-
tion-related hospital admission occurs during the 12-month follow-up period. Fur-
thermore, COPD exacerbation-related hospital admissions of participants will be 
checked weekly in the participating hospitals by the study team. 
Besides questionnaires that will be administered about the patient or the resident 
loved one themselves, residents loved ones will be asked to complete question-
naires regarding their perception of the health status or situation of the patient. 
Table 3.1 provides an overview of the measurements per time point. 
Questionnaires that were not available in Dutch have been translated into Dutch by 
the procedure of forward-backward translation. 
Sample size 
Since no preliminary data are available concerning differences in perception in 
health status and ADLs, the sample size for the primary objective 1.1 is estimated 
using G power. A total of 171 patients and 171 resident loved ones are needed to 
detect an effect size of 0.25 with a significance of 5% and power of 90%. Since we 
expect about 10% dropout, 10% additional couples will be included. Furthermore, 
patients will be equally divided based on gender and GOLD grade. Therefore, the 
study population consists of 192 patients and their resident loved ones. 
For objective 1.2, 38 patients with an exacerbation-related hospital admission dur-
ing follow-up are needed to detect a medium effect size of 0.5 (significance 5% and 
power 85%). In this study sample, we expect about 46 hospital admissions.(47) 
Therefore, a sample size of 192 patients and 192 loved ones will also be sufficient 
to answer objective 1.2. 
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Table 3.1. Overview of measurements per home visit 
  Baseline  
Hospital 
admission  Hospital discharge  One-year follow-up 
  P LO's 
perc. 
LO P LO's 
perc. 
LO P LO's 
perc. 
LO P LO's 
perc. 
LO 
Fat free mass / height / 
weight x  x    x  x x  x 
Physical activity monitor x x x x x x x 
Post-bronchodilator 
spirometry x  x    x   x  x 
Blood pressure / heart 
rate / saturation x  x   x x  x x  x 
Timed-up-and-go test x x x x x x x 
Cognitive test (Short 
Blessed Test) x  x    x   x  x 
Problematic activities of 
daily living, Canadian 
Occupational 
Performance Measure 
(COPM) 
x x     x x  x x  
Background information x x x x 
Smoking history and 
habits x  x    x  x x  x 
Fagerström test for 
nicotine dependence x  x    x  x x  x 
COPD Assessement Test 
(CAT)  x x   x  x x  x x  
mMRC dyspnoea scale x x x x x x x 
Hospital Anxiety 
Depression Scale (HADS) x x x  x x x x x x x x 
12-Item Short Form 
Health Survey (SF-12) x x   x  x x  x x  
Informal and professional 
medical care < 6 months x  x   x x  x x  x 
Checklist home 
adaptations and aids x         x   
Care Dependency Scale 
(CDS)  x x x  x x x x x x x x 
Instrumental Activities of 
Daily Living scale (IADLS) x x     x x  x x  
Daily symptom checklist x x x x x x x 
EuroQol 5D (EQ-5D) x x x x x x x x x x x 
Medical Outcomes Study 
Social Support Survey 
(MOSSSS) 
x  x   x x  x x  x 
Charlson Co-morbidity 
index x  x    x  x x  x 
Subjective fatigue scale 
(CIS) x  x   x x  x x  x 
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  Baseline  
Hospital 
admission  Hospital discharge  One-year follow-up 
  P LO's 
perc. 
LO P LO's 
perc. 
LO P LO's 
perc. 
LO P LO's 
perc. 
LO 
COPD knowledge 
questionnaire (CIROPD) x  x    x  x x  x 
Coping style (UCL) x x 
Self-efficacy for home 
walking x x     x x  x x  
Dutch relationship 
questionnaire (NRV) x  x          
Behavioural Regulation in 
Exercise Questionnaire 
(BREQ-2) 
x  x    x  x x  x 
Social-individual focus x x x x x x 
Assessment of Quality of 
Life with 8 dimensions 
(AQOL-8D) 
x x x  x x x x x x x x 
Family Appraisal of 
Caregiving Questionnaire 
for Palliative Care (FACQ-
PC) 
  x   x   x   x 
Abbreviations: P= patient; LO’s perc.= loved one’s perception of the person with COPD; LO= loved one. 
Recruitment 
Patients, both with and without COPD exacerbations in the past year, will be re-
cruited by their chest physician or a respiratory nurse during hospital admission or 
at the outpatient clinic in four hospitals throughout the southern-eastern part of 
the Netherlands. In addition, patients participating in the study ‘Correlates of CAT’ 
(NTR3416) who meet the inclusion criteria of the Home Sweet Home study and 
were willing to participate in further research will be asked to participate in the 
current study. If patients and their loved ones agree, an appointment for a first 
home visit will be made. Informed consent will be obtained at the start of this visit. 
Data management and statistical analysis 
Missing data will be minimised because all questionnaires will be completed in the 
presence of a researcher or research assistant. Handling of missing data will be 
carried out according to the guidelines of the different questionnaires. For data-
analysis SPSS V.20.0 will be used. 
Descriptive statistics, including means, SDs, frequencies and medians and IQRs, will 
be used, as appropriate. Mean scores of continuous variables will be compared 
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between patients and their loved ones using paired sample t tests or Wilcoxon 
signed rank tests, depending on the variable distribution. Moreover, we will calcu-
late intraclass correlation coefficients to study agreement between patients and 
loved ones in mean scores and visualise agreement using Bland and Altman 
plots.(48) Cohen’s κ will be used to determine agreement in categorical variables. 
These analyses will be performed for the COPM, CAT, mMRC, SF-12, IADLS and EQ-
5D. Furthermore, a mixed effect model will be used to estimate longitudinal chang-
es. Covariates such as age and smoking status can be included as fixed effects, 
whereas time and exacerbation-related hospital admissions can be entered as ran-
dom effects. A priori, a two-sided level of significance will be set at p≤0.05. 
Ethics and dissemination 
This project will be conducted in accordance with the declaration of Helsinki,(49) 
and the principles of the Dutch Medical Research Involving Human Subjects Act 
(‘WMO’).(50) 
DISCUSSION 
This study will focus on gaining knowledge about resident loved ones, including 
their role in the disease management and the interaction between the patient and 
the resident loved one in their lifestyles. This information is necessary to involve 
resident loved ones in the disease management of patients with COPD. The study 
has several strengths and limitations, which will be described below. 
Strengths 
The approach of this study differs from other studies on loved ones of patients with 
COPD, especially because of the use of unique measurements and concepts. A major 
strength of this study is the use of an individualised, client-centred outcome to de-
tect problems in ADLs (COPM).(27) A previous study included outcomes only based 
on physical activity.(51) The current study detects problems in ADLs according to the 
patient and the loved one using a semistructured interview method. Additionally an 
accelerometer is used for both the patient as well as for the loved one. Moreover, 
these problematic ADLs are not only determined during baseline and follow-up 
measurements, but also 2 weeks after a COPD exacerbation-related hospital admis-
sion. The changes in these ADL problems over time and after a hospital admission 
are a unique point of view in this population. Furthermore, in previous studies, char-
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acteristics of the family or loved ones of the patients themselves were 
determined.(17, 52, 53) In this study, not only characteristics of the patients, and 
resident loved ones are assessed, but also the resident loved ones’ perception of the 
patients’ characteristics (such as health status, daily functioning and symptoms of 
anxiety and depression). Further, capabilities of loved ones (like coping styles and 
social support) will be investigated. In addition, these measurements are not only 
performed once, but will be repeated after a COPD exacerbation-related hospital 
admission of the patient. Moreover, the quality of the relationship between the 
patient and resident loved one will be assessed. The quality of the relationship could 
be one of the determinants of the interaction between the resident loved one and 
the patient. Therefore, this study provides a complete overview of the patient, the 
resident loved one, and the resident loved ones’ perceptions of the patient. 
Other strengths of this study are related to the inclusion of the participants. Many 
studies focus on male patients with their female partners.(14, 18, 52) In this study 
an equal number of male and female participants will be recruited and therefore 
the current study will also provide knowledge concerning female patients and their 
male resident loved ones. Furthermore, patients will also be equally divided based 
on GOLD grading. Therefore, this study includes the same number of patients with 
moderate, severe and very severe COPD, which improves the external validity of 
this study. 
Moreover, the present study is a longitudinal study, which makes it possible to ana-
lyse changes over time. Finally, the tests and questionnaires will all be performed at 
the patients’ home. So participant’s burden is minimised and all data will be collect-
ed in their own trusted environment. 
Limitations 
This study has some limitations. First, it may be possible that patients and/or loved 
ones are not willing to participate. Although the burden of this study is minimised, a 
possible reason for refusing participation could be the time investment. To minimise 
the burden of this study, all measurements are performed in the patients’ homes and 
on a day and time of their preference. Furthermore, the home visit can be spread 
over 2 days. Nevertheless, it may be possible that most burdened patients and loved 
ones are not willing to participate in (additional) home visits. This could result in an 
underestimation of the burden, health status and well-being of this population. 
Therefore, some characteristics of the non-participating patients, like gender, age and 
GOLD grade, will be collected. Furthermore, it may be possible that participating resi-
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dent loved ones are more aware of the situation of the patient compared to the non-
participating loved ones. This should be taken into account in interpreting the results. 
Second, it might be challenging to include the same number of male and female pa-
tients with COPD. However, collaboration with four hospitals and recruitment of pa-
tients admitted to the hospital as well as patients who attend the outpatient clinic, 
will facilitate recruitment. Third, some loved ones of admitted patients may be unwill-
ing to participate in additional home visits shortly after the patients’ admission to the 
hospital. This could lead to missing data or even drop-outs. However, the time in-
vestment and impact of this visit is minimal. Fourth, the follow-up period is limited to 
1 year. This follow-up period could be too short to draw conclusions about long-term 
changes in patients’ health status and problems during ADLs and the perception of 
the resident loved ones about these changes. Finally, it may be possible that partici-
pation in this study works as a stimulus for patients to talk about COPD with their 
loved ones. This could result in more understanding and agreement during the meas-
urements after 12 months. However, if participants communicate more about the 
disease and the problems during daily activities, the expectation is that this will be 
performed shortly after the first home visit. 
Clinical consequences 
The present study will gain more knowledge about the resident loved ones of pa-
tients with COPD and about their perceptions of the patients’ health status and 
problematic ADLs. With this information, a more systemic approach in the treat-
ment of patients with COPD could be developed. Healthcare providers should not 
only focus on the patient, but should see the patient, his/her loved ones and their 
interaction as a whole. Only by gaining more information about the loved ones 
themselves, the quality of the relationship, and their perception of the patients’ 
health status and problematic ADLs, loved ones could be involved in the patient’s 
treatment. With the knowledge gained in this study, we will learn about how to 
carry out self-management plans in patients and loved ones, so loved ones are able 
to facilitate and encourage the self-management. Furthermore, this study investi-
gates the impact of a hospitalisation due to an acute COPD exacerbation on the 
resident loved ones. With this information it may be possible to determine whether 
and how professional caregivers should give more attention to the resident loved 
ones during an exacerbation related hospitalisation. 
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CONCLUSION 
In conclusion, COPD may have an impact on not only the patients’ life, but also on 
the lives of the resident loved ones. As a shift towards home care is anticipated, the 
Home Sweet Home study is necessary to give more insight in the home situation of 
patients with COPD. 
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ABSTRACT 
Objectives: Resident relatives of patients with chronic obstructive pulmonary dis-
ease (COPD) may play a major role in obtaining a healthy lifestyle for patients. Little 
is known about resident relatives. This study aimed to compare health status, mor-
bidities, care dependency, and mobility between patients with COPD and their resi-
dent relatives. 
Design: Cross-sectional study. 
Participants: Stable patients with moderate to very severe COPD (n ¼ 194) and their 
resident relatives (n = 194) were visited in their home environment. 
Measurements: Post-bronchodilator spirometry was assessed and generic health 
status was measured using the EuroQole5 Dimensions and the Assessment of Quali-
ty of Life with 8 dimensions. Care dependency was measured using the Care De-
pendency Scale. Mobility was measured using the Timed “Up and Go” test (TUG). 
Morbidities (COPD, hypertension, anxiety and depression, obesity, and muscle 
wasting) were determined using accepted disease cutoff points and/or receiving 
specific treatment. 
Results: Age (patients: 66.0 [8.7], resident relatives: 64.8 [9.7]) and gender (male 
patients: 53%, male resident relatives: 45%) were comparable. Patients had worse 
generic health status, higher level of care dependency, and worse mobility. 29% of 
the resident relatives had airflow limitation based on the Tiffeneau index and 19% 
based on the lower limit of normal, 33% were current smokers, and 92% had at 
least one chronic condition. Resident relatives more frequently had hypertension 
(46% versus 69%). 
Conclusion: Resident relatives of patients with COPD are often current smokers and 
often have undiagnosed morbidities. Although their health status is better com-
pared with patients, their disease management and health behavior should also be 
considered when advising patients in obtaining a healthier lifestyle and also when 
involving them as informal caregivers. 
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INTRODUCTION 
Many patients with chronic obstructive pulmonary disease (COPD) suffer from fa-
tigue, have at least 1 comorbidity, and experience problems with multiple activities 
of daily living (ADLs).(1-3) Limitations in ADLs frequently result in care dependency 
and the degree of care dependency can increase over time.(4) Due to an aging 
population, the demand for health care professionals is expected to increase.(5) 
Therefore, patients will most probably have to rely to a greater extent on their resi-
dent relatives at some point in time for their care.  
To date, knowledge about the mobility and generic health status of resident rela-
tives of patients with COPD is limited. This, however, seems critical information, as 
the role of relatives in patients’ COPD management and in maintaining/obtaining a 
healthy lifestyle will become more essential in the near future. Indeed, inpatients 
after a stroke, relatives are important for patients to achieve a behavioral 
change.(6) In fact, the likelihood of becoming obese or becoming a smoker increas-
es when a relative, especially a spouse, is obese or a smoker.(7, 8)  
It is known that informal caregiving can be burdensome.(9) Indeed, relatives of 
patients with COPD generally prioritize the patient’s health above their own 
health.(10) This may partially explain the high prevalence of symptoms of anxiety 
and depression in relatives of patients with COPD.(11) In turn, this could result in a 
poor quality of life.(12) In a cancer population, being an ongoing caregiver was as-
sociated with increasing rates of arthritis and heart diseases.(13) Additionally, 
spouses of patients with heart failure had a lower physical quality of life compared 
with a normative sample.(14) This may be due to their own medical problems, like 
cardiovascular health problems, diabetes mellitus, arthritis, and stress-related 
symptoms.(15) However, whether and to what extent relatives of patients with 
COPD have common morbidities, such as obesity, hypertension, and chronic airflow 
limitation remains currently unknown. This, however, may affect their symptoms 
like fatigue, mobility and health status.  
This study aimed to compare mobility, health status and prevalence of morbidities 
between patients with COPD and their resident relatives. A priori, we hypothesized 
that patients with COPD report worse mobility and health status than their resident 
relatives; and that morbidities are more prevalent in patients with COPD compared 
with their resident relatives. Furthermore, we hypothesized that resident relatives 
with airflow limitation report worse mobility and health status and more additional 
morbidities than resident relatives without airflow limitation. 
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METHODS 
Study Design 
The current cross-sectional data are part of the Home Sweet Home study, a longi-
tudinal study on the home environment of patients with COPD.(16) Ethics approval 
has been obtained from the Medical Research Ethics Committees United (MEC-U), 
the Netherlands (NL42721.060.12/M12-1280). The study is registered in the Dutch 
Trial Register (NTR3941). 
Study Population 
Patients with COPD were recruited by their chest physician or a respiratory nurse 
specialist during hospital admission or at the outpatient respiratory clinic in 4 hospi-
tals throughout the southerneastern part of the Netherlands. In addition, patients 
who participated in the “Chance study” (NTR3416),(17) met the inclusion criteria of 
the Home Sweet Home study, and were willing to participate in future research 
were also asked to participate in the current study. Patients were included between 
July 2013 and December 2014. 
Patients were eligible if they had moderate to very severe COPD (Global initiative 
for chronic Obstructive Lung Disease (GOLD) grade II to IV),(18) no exacerbation of 
COPD or hospitalization less than 4 weeks preceding enrolment, and if they could 
appoint 1 resident relative (defined as a person living together with a patient with 
COPD, regardless whether or not he or she provides informal care to the patient) 
who was willing to participate. Patients and/or relatives were excluded if they were 
unable to complete the study questionnaires because of cognitive impairment (de-
fined as Short Blessed Test score ≥10 points)(19) or if they were unable to under-
stand Dutch. All participants gave written informed consent. 
Measurements 
All variables were assessed during home visits in patients and resident relatives. 
Measurements were performed by 3 researchers with knowledge and expertise 
regarding patients with COPD and all questionnaires and tests, including the post-
bronchodilator spirometry. Home visits lasted approximately 4 hours and included 
demographics, smoking history and current smoking habits, self-reported comor-
bidities (Charlson comorbidity index),(20) current medication,(21) and contacts with 
health care professionals and informal caregivers in the previous 6 months. Nico-
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tine dependence was assessed using the Fagerström test.(22) Score ranges from 0 
(very low dependence) to 10 points (very high dependence). Care dependency was 
assessed using the Care Dependency Scale (CDS). Score ranges from 15 (worst) to 
75 points (best).(23) Mobility was assessed using the Timed Up and Go test. This 
test measures in seconds the time needed to stand up from a chair, walk 3 meters, 
turn and walk back to the chair and sit down again. The fastest performance of 2 
tests was included for analysis.(24) 
Participants’ fatigue was assessed using the subjective fatigue subscale of the 
Checklist Individual Strength. The fatigue subscale score ranges from 8 (normal 
fatigue) to 56 points (most severe fatigue).(25) Scores ≤26 indicate normal fatigue, 
scores 27 to 35 indicate moderate fatigue, scores ≥36 indicate severe fatigue.(3) 
Participants’ generic health status was assessed using 2 self-administered question-
naires: EuroQol-5 Dimensions (EQ-5D) and Assessment of Quality of Life with 8 
dimensions (AQoL-8D). The EQ-5D measures 5 dimensions of health-related quality 
of life, and its index score (Dutch version) ranges from -0.33 (worst) to 1.0 
(best).(26) In addition, patients and relatives rated their current health using a Visu-
al Analogue Scale (VAS), which ranges from 0 (worst possible health) to 100 (best 
possible health). The AQoL-8D is somewhat more extensive with 8 dimensions of 
health-related quality of life, which can be combined into 2 mental and physical 
health dimensions and a utility score. The AQoL-8D scales range from 0.00 (death) 
to 1.00 (best health).(27) Both questionnaires reflect different dimensions of gener-
ic health status. The EQ-5D is more focused on assessing pain and physical function, 
whereas the AQoL-8D has a greater psychosocial content.(28) 
Post-bronchodilator spirometry was performed in patients and resident relatives 
according to guidelines.(18) Forced expiratory volume in the first second (FEV1) and 
Tiffeneau index were calculated from the flow-volume curve measured by a 
handheld pulmonary spirometer during the home visit. Resting transcutaneous 
oxygen saturation, body mass index (BMI, weight/height2), fat-free mass index 
(FFMI, using body impedance assessment),(29) resting blood pressure, and resting 
heart rate were also assessed during the home visit.  
Symptoms of anxiety and depression were studied using the Hospital Anxiety and 
Depression Scale (HADS).(30) The HADS is divided into an anxiety and a depression 
subscale. Total scores for each subscale range from 0 (optimal) to 21 points (worst). 
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Assessed Morbidities 
The prevalence of assessed morbidities was determined using the following cutoff 
points: (1) persistent airflow limitation was defined as a post-bronchodilator Tiff-
eneau index <70%, according to the current guidelines.(18) In resident relatives, the 
cutoff based on the lower limit of normal values for FEV1/FVC was also checked to 
prevent over diagnosis in the asymptomatic elderly,(18) (2) underweight was de-
fined as BMI <21 kg/m2,(2) (3) obesity was defined as BMI ≥30.0 kg/m2,(2) (4) ab-
normal low fat-free mass index (FFMI) was defined as an FFMI (kg/m2) below the 
fifth percentile according to the reference values of Franssen et al,(31) (5) systemic 
hypertension was defined as resting systolic blood pressure above 140 mm Hg 
and/or resting diastolic pressure above 90 mm Hg,(32) (6) clinically relevant symp-
toms of anxiety and depression were defined as HADS subscale score ≥11 
points.(33)  
Assessed morbidities were present if a morbidity was measured during the home 
visit and/or if the participant received treatment for that morbidity. Treatment for 
airflow limitation was considered if participants currently used one or more of the 
following medications: short-acting β2-agonists (SABA), short-acting muscarinic 
antagonists (SAMA), long-acting β2-agonists (LABA), long-acting muscarinic antago-
nists (LAMA), inhaled corticosteroids (ICS), or theophyllines (Supplementary Table 
4.1). Treatment for hypertension was considered if participants currently used 1 or 
more of the following medications: angiotensinconverting enzyme (ACE) inhibitors 
or angiotensin receptor blockers (ARB), beta blockers, calcium blockers, or diuret-
ics. Treatment for anxiety was considered if participants currently used benzodiaz-
epines (sleep medication excluded) or selective serotonin reuptake inhibitors (SSRI), 
or if they received treatment by a psychologist and/or social worker in the past 6 
months. Treatment for depression was considered if participants currently used 
SSRIs, serotonin-norepinephrine reuptake inhibitors (SNRI) or tricyclic antidepres-
sants (TCA), or if they received treatment by a psychologist and/or social worker in 
the past 6 months. 
Statistics 
Categorical variables are described as frequencies, whereas continuous variables 
were tested for normality and are presented as mean and SD. Continuous variables 
were compared between patients with COPD and their resident relatives using 
independent sample t-tests or Mann-Whitney U tests, as appropriate. Categorical 
variables were compared between patients with COPD and their resident relatives 
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using χ2 tests. Because of multiple comparisons, the level of significance was set at 
P ≤ .01. All statistics were performed using SPSS version 20.0 (IBM SPSS Statistics, 
IBM Corporation, Chicago, IL). 
RESULTS 
General Characteristics 
In total, 569 patients with COPD were screened for eligibility; 196 of the 449 (re-
sponse rate 43%) eligible patients and their resident relatives were willing to partic-
ipate and were included in this study (Supplementary Figure 4.1). The home visit 
was completed by 194 patients with COPD and their resident relatives. Age, gender 
distribution, and GOLD grade were comparable between participants and eligible 
patients refusing participation. 
Mean age and gender distribution were comparable between patients and resident 
relatives (Table 4.1). Patients had almost twice as many pack-years compared with 
their resident relatives, but a higher proportion of resident relatives were current 
smokers. Moreover, patients used a significantly higher number of medications 
(median [interquartile range (IQR)]: 7 [5-11]). Still, resident relatives reported the 
use of 3 (1-5) different medications (Supplementary Table 4.1).  
Care Dependency and Mobility 
Patients had higher levels of care dependency and received more informal care (P < 
.001) (Table 4.1). Furthermore, patients needed more time to complete the Timed 
Up and Go test compared with the resident relatives (P < .001). 
Fatigue and Generic Health Status 
Patients had worse symptoms of fatigue, and more than half of the patients experi-
enced severe fatigue. Patients reported worse generic health status as measured 
with the EQ-5D and AQoL-8D utility score. All AQoL-8D domain scores were signifi-
cantly lower among patients than among relatives, except for the domains “pain” 
and “senses” (Table 4.2). 
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Table 4.1. General characteristics of patients with COPD and their resident relatives 
 Patients  
with COPD 
(n = 194) 
Resident  
relatives 
(n=194) 
p-value 
Male, n (%) 102 (52.6%) 87 (44.8%) 0.128 
Age (years), mean (SD) a 66.0 (8.7) 64.8 (9.7) 0.329 
Married, n (%) 177 (91.2%) 177 (91.2%) 0.768 
Working situation, n (%)   0.006 
Paid job 17 (8.8%) 40 (20.6%)  
Retired 97 (50.0%) 78 (40.2%)  
Household work 23 (11.9%) 45 (23.2%)  
Unable to work 46 (23.7%) 18 (9.3%)  
Other (volunteer, or unemployed) 11 (5.7%) 13 (6.7%)  
Pack-years, mean (SD) a 40.3 (20.0) b 21.2 (22.0) <0.001 
Current smoker, n (%) 33 (17.0%) 63 (32.5%) <0.001 
Nicotine dependence score (points), mean (SD) 3.9 (2.2) c 3.3 (2.4) c 0.271 
Tried to quit smoking in past, n (%) 30 (90.9%)  53 (84.1%) 0.356 
Plan to quit smoking in future, n (%) 26 (78.8%)  36 (57.1%) 0.035 
Non-smoker, n (%) 161 (83.0%) 131 (67.5%) <0.001 
Nicotine dependence score (points), mean (SD) a 0.0 (0.1) c 0.0 (0.4) d 0.729 
Never smoker, n (%) 3 (1.5%) 52 (26.8%) <0.001 
Smoking residents, n (%) 71 (36.6%) 42 (21.6%) 0.001 
Number of used medications, median (IQR) 7 (5-11) 3 (1-5) <0.001 
Care dependency scale (pts), mean (SD) a 67.8 (8.9) c  73.7 (5.2) c  <0.001 
Receiving informal care from relatives, n (%) 32 (16.5%) 3 (1.5%) <0.001 
Timed ‘Up and Go’ test (sec), mean (SD) a 10.9 (3.7) b 9.4 (2.9) e <0.001 
Values expressed as mean (SD), median (IQR) or number of patients (%). Abbreviations: COPD= Chronic Ob-
structive Pulmonary Disease. a non-parametric statistical tests have been used because of skewed data; b 2 
missing; c 1 missing; d 8 missing; e 4 missing. 
Self-reported Morbidities 
Patients with COPD had a higher Charlson comorbidity index score than their resi-
dent relatives (median [IQR]: 2 [1-3] and 1 [0-2] points respectively, P < .001), but 
this difference diminished after excluding chronic pulmonary disease (Supplemen-
tary Table 4.2). The prevalence of specific self-reported comorbidities did not differ 
between both groups, except for chronic pulmonary disease and ulcer disease, 
which were both significantly more common in patients. 
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Table 4.2. Fatigue and generic health status  
 Patients  
with COPD 
(n = 194) 
Resident  
relatives 
(n = 194) 
p-value 
Fatigue    
Checklist individual strength (points) 35.0 (10.3) 24.4 (11.3) b <0.001 
Normal fatigue 35 (18.0%) 119 (61.3%) <0.001 
Moderate fatigue 57 (29.4%) 45 (23.2%) 0.185 
Severe fatigue 102 (52.6%) 28 (14.4%) <0.001 
EQ-5D    
Index score a 0.72 (0.25) 0.88 (0.15) c <0.001 
VAS a 62.4 (18.8) 82.4 (14.7) c <0.001 
AQoL-8D    
Independent living 0.62 (0.16) 0.87 (0.14) c <0.001 
Happiness 0.75 (0.15) 0.81 (0.11) c <0.001 
Mental health 0.62 (0.15) 0.66 (0.12) c 0.007 
Coping 0.73 (0.14) 0.84 (0.11) c <0.001 
Relationships 0.65 (0.14) 0.77 (0.13) c <0.001 
Self worth  0.79 (0.16) 0.89 (0.10) c <0.001 
Pain 0.71 (0.25) 0.77 (0.24) c 0.028 
Senses a  0.84 (0.13) 0.88 (0.10) c 0.026 
Mental Value  0.35 (0.18) 0.47 (0.16) c <0.001 
Physical Value  0.54 (0.18) 0.71 (0.20) c <0.001 
Utility score 0.63 (0.19) 0.78 (0.14) c <0.001 
Values expressed as mean (SD) or number of participants (%). Abbreviations: AQoL-8D= Assessment of Quality 
of Life instrument with 8 dimensions; COPD= Chronic Obstructive Pulmonary Disease; EQ-5D= EuroQol-5 
Dimensions; VAS= Visual Analogue Scale. a non-parametric statistical tests have been used because of skewed 
data; b n=192; c n=193. 
Assessed Morbidities Based on Measurements and Specific Treatment 
One or more additional morbidities were objectified in 94% of the patients and in 
92% of the resident relatives (P = .318). Furthermore, when taking airflow limitation 
into account, 54.7% of the patients and 24.8% of the resident relatives had 3 or 
more morbidities (Figure 4.1).  
Airflow limitation and hypertension were the most frequent morbidities in both 
patients with COPD and their resident relatives (Figure 4.2). Indeed, post-
bronchodilator airflow limitation was found in 28.9% of the resident relatives, and 
71.4% of these relatives were not treated (Table 4.3). When using the cutoff based 
on the lower limit of normal, 18.6% of the relatives had airflow limitation; 61.1% of 
these relatives were not treated with medication for this condition. The proportion 
of individuals with obesity was comparable between groups, whereas the propor-
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tion of individuals with underweight and/or abnormal low FFMI was higher in pa-
tients. Hypertension was highly prevalent in both patients and resident relatives; 
however, untreated hypertension was more common in resident relatives. Fur-
thermore, an equal proportion of patients and resident relatives had clinically rele-
vant symptoms of anxiety. More than a third of the patients with clinically relevant 
symptoms of anxiety were not treated with medication or by a psychologist/social 
worker. In resident relatives, treatment was even less common (5 of 30 relatives). 
More patients had clinically relevant symptoms of depression compared with their 
resident relatives. In both groups, symptoms of depression were rarely treated. 
 
 
Figure 4.1. Number of assessed morbidities per participant 
Total number of morbidities (airflow limitation, underweight, obesity, abnormal low fat-free mass index, 
hypertension, anxiety and depression) per patient and resident relative. * p<0.01. 
 
 
Figure 4.2. Prevalence of assessed morbidities 
Proportion of patients with COPD and their resident relatives with morbidities. Abbreviations: FFMI= fat-free 
mass index. * p<0.01. 
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Table 4.3. Morbidities in patients with COPD and their resident relatives 
 Patients  
with COPD 
(n = 194) 
Resident  
relatives 
(n=194) 
p-value 
Spirometry     
Tiffeneau index, mean (SD) 40.2 (12.7) 71.7 (10.7) f <0.001 
FEV1 (% predicted), mean (SD) a 47.2 (17.8) 104.1 (25.6) f  <0.001 
COPD GOLD I, n (%) 0 (0%) 37 (66.1%) <0.001 
COPD GOLD II, n (%) 93 (47.9%) 16 (28.6%) 0.010 
COPD GOLD III, n (%) 62 (32.0%) 3 (5.3%) <0.001 
COPD GOLD IV, n (%) 39 (20.1%) 0 (0%) <0.001 
Tiffeneau index < 70% and/or treatment for airflow limitation, n (%) 194 (100%) 61 (31.4%) f <0.001 
No airflow limitation with treatment 0 (0%) 5 (8.2%) <0.001 
Assessed airflow limitation 194 (100%) 56 (28.9%) <0.001 
Airflow limitation with treatment 190 (97.9%) 16 (28.6%) <0.001 
Airflow limitation without treatment 4 (2.1%) 40 (71.4%) <0.001 
Transcutaneous Oxygen saturation (%), mean (SD) a 93.8 (3.7) 96.9 (1.9) f <0.001 
Body composition    
BMI (kg/m2), mean (SD) a 26.3 (5.3) 28.0 (5.0) b 0.001 
<21 kg/m2, n (%) 32 (16.5%) 8 (4.1%) <0.001 
21-29.9 kg/m2, n (%) 120 (61.9%) 133 (68.6%) 0.125 
≥30.0 kg/m2, n (%) 42 (21.6%) 51 (26.3%) 0.259 
FFMI (kg/m2), mean (SD) a 18.4 (2.0) c 19.2 (1.8) d <0.001 
Abnormal low FFMI, n (%)  23 (11.9%) c 7 (3.6%) d 0.001 
Cardiovascular health    
Resting heart rate (bpm), mean (SD) 74.7 (12.8) 66.7 (10.3) <0.001 
Resting systolic pressure (mm Hg), mean (SD) 139.5 (24.1) 150.4 (23.0) e <0.001 
Resting diastolic pressure (mm Hg), mean (SD) 75.5 (12.1) 80.6 (10.4) e <0.001 
Hypertension (systolic >140 and/or diastolic >90 mm Hg and/or treatment 
for hypertension), n (%) 
150 (77.3%) 157 (81.3%) e 0.382 
Normal blood pressure with treatment 60 (30.9%) 24 (12.4%) e <0.001 
Assessed hypertension 90 (46.4%) 133 (68.6%) <0.001 
Hypertension with treatment 52 (26.8%) 75 (38.7%) e 0.012 
Hypertension without treatment 38 (19.6%) 58 (29.9%) e 0.017 
Anxiety    
HADS-Anxiety, mean (SD) 5.8 (3.7) 5.8 (3.9) 0.925 
Assessed clinically relevant symptoms of anxiety, n (%) 22 (11.3%) 30 (15.5%) 0.233 
Symptoms of anxiety and/or treatment for anxiety, n (%) 48 (24.7%) 46 (23.7%) 0.813 
No symptoms of anxiety with treatment 26 (13.4%) 16 (8.2%) 0.102 
Symptoms of anxiety with treatment 14 (7.2%) 5 (2.6%) 0.034 
Symptoms of anxiety without treatment 8 (4.1%) 25 (12.9%) 0.002 
Depression    
HADS-Depression, mean (SD) a 5.7 (3.7) 4.1 (2.9) <0.001 
Assessed clinically relevant symptoms of depression, n (%) 21 (10.8%) 5 (2.6%) 0.001 
Symptoms of depression and/or treatment for depression, n (%) 48 (24.7%) 29 (14.9%) 0.016 
No symptoms of depression with treatment 27 (13.9%) 24 (12.4%) 0.652 
Symptoms of depression with treatment 8 (4.1%) 1 (0.5%) 0.018 
Symptoms of depression without treatment 13 (6.7%) 4 (2.1%) 0.026 
Values expressed as mean (SD) or number of patients (%). Abbreviations: BMI= Body Mass Index; COPD= 
Chronic Obstructive Pulmonary Disease; FEV1= Forced Expiratory Volume in the first second; FFMI= fat-free 
mass index; HADS= Hospital Anxiety and Depression Scale. a non-parametric statistical tests have been used 
because of skewed data; b n=192; c n=168; d n=178; e n=193; f n=190. 
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Table 4.4. Comparison between resident relatives with or without airflow limitation 
 Resident relatives 
with airflow 
limitation  
(n = 56) 
Resident relatives 
without airflow 
limitation  
(n = 134) 
p-value 
General characteristics    
Male, n (%) 29 (51.8%) 57 (42.5%) 0.243 
Age (years), mean (SD) a 68.0 (7.9) 63.5 (10.2) 0.004 
Pack-years, mean (SD) a 31.1 (22.8) 16.9 (20.5) <0.001 
Current smoker, n (%) 24 (42.9%) 35 (26.1%) 0.023 
Charlson comorbidity index (points), median (IQR) a 1 (0-2) 1 (0-2) 0.104 
Chronic pulmonary disease, n (%) 19 (33.9%) 2 (1.5%) <0.001 
Care dependency scale (points), mean (SD) a 74.4 (1.0) b  73.3 (6.1) 0.825 
Timed ‘Up and Go’ test (sec), mean (SD) a 9.5 (2.3) 9.3 (3.1) c 0.165 
Spirometry    
Tiffeneau index, mean (SD) 58.9 (10.2) 77.0 (4.7) <0.001 
FEV1 (% predicted), mean (SD) a 86.9 (22.8) 111.3 (23.3) <0.001 
Transcutaneous Oxygen saturation (%), mean (SD)a 96.5 (1.9) b 97.0 (1.9) c 0.021 
Body composition    
BMI (kg/m2), mean (SD) a 28.3 (5.8) 27.9 (4.7) 0.801 
<21 kg/m2, n (%) 2 (3.6%) 6 (4.5%) 0.777 
21-29.9 kg/m2, n (%) 42 (75.0%) 89 (66.4%) 0.244 
≥30.0 kg/m2, n (%) 12 (21.4%) 39 (29.1%) 0.276 
FFMI (kg/m2), mean (SD) a 19.3 (2.0) e 19.2 (1.7) d 0.761 
Abnormal low FFMI, n (%)  4 (7.1%) e 3 (2.2%) d 0.109 
Cardiovascular health    
Resting heart rate (bpm), mean (SD) 68.1 (10.9) 65.9 (10.0) 0.169 
Resting systolic pressure (mm Hg), mean (SD) 151.4 (19.9) 149.9 (24.4) 0.695 
Resting diastolic pressure (mm Hg), mean (SD) 80.9 (8.6) 80.6 (11.2) 0.843 
Hypertension (systolic >140 and/or diastolic >90 mm Hg 
and/or treatment for hypertension), n (%) 
49 (87.5%) 105 (78.4%) 0.143 
Anxiety    
HADS-Anxiety, mean (SD) 5.1 (3.5) 6.2 (4.0) 0.095 
Clinically relevant symptoms of anxiety, n (%) 5 (8.9%) 25 (18.7%) 0.094 
Symptoms of anxiety without treatment, n (%) 4 (7.1%) 21 (15.7%) 0.113 
Depression    
HADS-Depression, mean (SD) a 3.8 (2.6) 4.2 (3.0) 0.638 
Clinically relevant symptoms of depression, n (%) 1 (1.8%) 4 (3.0%) 0.429 
Symptoms of depression without treatment, n (%) 1 (1.8%) 3 (2.2%) 0.843 
Values expressed as mean (SD) or number of patients (%). Abbreviations: COPD= Chronic Obstructive Pulmo-
nary Disease; FEV1= Forced Expiratory Volume in the first second; FFMI= fat-free mass index; HADS= Hospital 
Anxiety and Depression Scale. a non-parametric statistical tests have been used because of skewed data; b 
n=55; c n=132; d n=124; e n=53. 
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Resident Relatives With or Without Airflow Limitation 
A posteriori, a comparison was done between resident relatives with and without 
airflow limitation. Resident relatives with airflow limitation were significantly older 
and had more pack-years than resident relatives without airflow limitation (Table 
4.4). The prevalence of morbidities, mobility, and health status were comparable 
between both groups (Table 4.5). 
 
Table 4.5. Generic health status of resident relatives with or without airflow limitation 
 Resident relatives with 
airflow limitation  
(n = 56) 
Resident relatives 
without airflow 
limitation  
(n = 134) 
p-value 
Fatigue    
Checklist individual strength (points) 25.3 (10.5) b  24.0 (11.6) 0.480 
Normal fatigue 30 (53.6%) 87 (64.9%) 0.182 
Moderate fatigue 17 (30.4%) 28 (20.9%) 0.142 
Severe fatigue 8 (14.3%) 19 (14.2%) 0.948 
EQ-5D    
Index score a 0.88 (0.13) 0.88 (0.16) c 0.705 
VAS a 79.8 (16.5) 83.5 (13.8) c 0.139 
AQoL-8D    
Independent living 0.86 (0.12) b 0.88 (0.15) 0.388 
Happiness 0.84 (0.09) b 0.80 (0.12) 0.022 
Mental health 0.68 (0.10) b 0.65 (0.12) 0.157 
Coping 0.85 (0.09) b 0.84 (0.11) 0.753 
Relationships 0.79 (0.13) b 0.76 (0.13) 0.245 
Self worth  0.91 (0.08) b 0.88 (0.10) 0.073 
Pain 0.76 (0.22) b 0.77 (0.24) 0.879 
Senses a  0.89 (0.09) b 0.87 (0.11) 0.277 
Mental Value  0.50 (0.13) b 0.46 (0.16) 0.124 
Physical Value  0.70 (0.17) b 0.71 (0.21) 0.616 
Utility score 0.81 (0.11) b 0.77 (0.16) 0.074 
Values expressed as mean (SD). Abbreviations: AQoL-8D= Assessment of Quality of Life instrument with 8 
dimensions; COPD= Chronic Obstructive Pulmonary Disease; EQ-5D= EuroQol-5 Dimensions; VAS= Visual 
Analogue Scale. a non-parametric statistical tests have been used because of skewed data; b n=55; c n=133. 
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DISCUSSION 
Key Findings 
The present study found that resident relatives of patients with COPD were often 
current smokers and often suffered from multiple morbidities, including undiag-
nosed COPD and hypertension. Obesity, symptoms of anxiety, and severe fatigue 
were also frequently found in relatives. However, mobility and health status of pa-
tients with COPD was worse compared with resident relatives. The presence of 
airflow limitation in resident relatives did not determine their comorbidities, mobili-
ty, or health status. 
Care Dependency, Mobility, Fatigue, and Generic Health Status 
Patients with COPD were more care dependent, scored worse on the Timed Up and 
Go test, had more symptoms of fatigue, and a lower generic health status com-
pared with their resident relatives. The difference between the Timed Up and Go 
test of the patients and resident relatives reached statistical significance, but was 
lower than the standard error of measurement (SEM) (1.76 seconds) calculated by 
Mesquita et al.(24) However, the differences found in patients’ and relatives’ symp-
toms of fatigue and EQ-5D VAS were higher than the SEM of 10 points and mini-
mum clinically important difference of 8 points, respectively.(3, 34) These results 
are in line with studies comparing people with and without COPD,(35) and with a 
study comparing patients with heart failure and their spouses.(14) Resident rela-
tives’ scores for their generic health status were contradictory compared with the 
general population (EQ-5D index score was comparable, 0.88 versus 0.89;(36) EQ-
5D VAS score was better in relatives compared with the general population, 82.4 
versus 78.0;(36) and AQoL-8D utility score was worse in relatives, 0.78 versus 
0.84).(27) However, the difference in EQ-5D VAS score between relatives and the 
general population did not reach the MCID of 8 points. The small differences did 
most likely occur due to the different dimensions of generic health, which are re-
flected by the questionnaires. In 56 caregivers living with older people with cogni-
tive impairment, an EQ-5D index score of 0.73 was found, indicating a worse gener-
ic health status compared with relatives of patients with COPD.(37) Moreover, the 
study at hand concluded that the presence of airflow limitation in resident relatives 
did not influence their health status. On the contrary, people with chronic diseases 
had an impaired physical health status and quality of life compared with patients 
without a chronic condition.(38) However, that relatives’ health status is not influ-
enced by the presence of airflow limitation could be because only 34% of the rela-
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tives knew about their airflow limitation. Furthermore, only a mild airflow limitation 
(FEV1 = 87% predicted) was seen in these relatives. Indeed, underdiagnosis is relat-
ed to less severe airflow limitation.(39)  
Assessed Morbidities 
This study identified multimorbidity in patients with COPD as well as their resident 
relatives during a home visit, and showed that these conditions were often not 
treated. Indeed, 94% of the patients had 1 or more comorbidity, which is in line 
with the findings of Vanfleteren et al.(2) The current study showed that 61% of the 
relatives had 2 or more morbidities, which is comparable with the prevalence of 
multimorbidity in an aged population.(40) However, in this aged population, a total 
of 13 morbidities were included and these were all self-reported. Although we as-
sessed “only” 7 morbidities, other conditions like diabetes mellitus and gastrointes-
tinal disease were not included. Therefore, multimorbidity is most probably under-
estimated in this population of patients with COPD and their resident relatives.  
The present study found that, based on the Tiffeneau index, 29% of the resident 
relatives had airflow limitation, which is comparable to the prevalence of COPD in 
the Dutch population.(41) However, the prevalence of airflow limitation decreased 
to 19% when using the cutoff based on the lower limit of normal. Using the Tiff-
eneau index could result in more frequent diagnosis of airflow limitation in the 
elderly,(42) especially of mild disease. This explains the 10% difference in preva-
lence. Either way, our study confirmed that COPD is frequently undiagnosed.(39) 
Early detection of COPD can positively influence the natural history of the disease, 
for instance by providing help with smoking cessation.(18) Moreover, we found that 
one-third of the resident relatives were current smokers and only approximately a 
quarter never smoked. This prevalence of current smokers and ex-smokers is higher 
than in the general Dutch population,(41) so resident relatives share risk factors 
with patients, which emphasizes the need for early detection of COPD in relatives 
as well as the need to involve them in behavior change programs, including smoking 
cessation. However, having a relative with a life-limiting, smoking-related disease 
did not serve as an effective motivation for close family members to quit or reduce 
smoking.(43) Moreover, family members’ psychological distress could be changed 
positively when they were involved in psychosocial support and education sessions 
during patients’ pulmonary rehabilitation.(44) 
The prevalence of hypertension, measured during 1 home visit, was comparable 
between patients and resident relatives in this study. Miller et al.(45) found an 
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equal prevalence of hypertension in patients with COPD and smoking and nonsmok-
ing controls after adjusting for age and gender. Hypertension was more prevalent in 
resident relatives compared with patients, and a higher proportion of resident rela-
tives did not receive treatment for their hypertension. Indeed, hypertension is an 
underdiagnosed and undertreated condition in the general population.(46) As hy-
pertension is the leading cause of cardiovascular disease globally, it should be ac-
tively looked for and treated in both patients and relatives. 
Clinical Relevance of Current Findings 
Multimorbidity was shown in both patients and resident relatives. Resident rela-
tives play a key role in patients’ self-management, because patients do not self-
manage their disease.(47) Furthermore, relatives are also important to achieve a 
behavioral change in patients.(6) This change is necessary for smoking cessation 
and to obtain an active lifestyle. However, the relatives’ smoking status must be 
addressed first, before they are able to engage in the behavioral change of patients. 
Indeed, relatives are exposed to the same risk factors as patients with COPD. There-
fore, resident relatives should be actively involved in disease management pro-
grams, in which also their own lifestyle and health status should be addressed. 
Methodological Considerations 
Some limitations of this study should be considered in interpreting the results. First, 
the response rate of this study was 43%. Although age, sex, and GOLD grade were 
comparable between participants and eligible people refusing participation, un-
known differences between both groups may have been present. Furthermore, all 
included patients with COPD lived at home, which means they must be self-
sufficient or be able to live at home while receiving support. Both could result in an 
overestimation of the health status of the participants. Second, blood pressure was 
assessed only during 1 home visit. A diagnosis of hypertension should be based on 
at least 2 visits.(32) Third, clinically relevant symptoms of anxiety and depression 
were assessed using a validated, reliable questionnaire widely used to screen for 
these symptoms,(33) but we did not use an instrument to diagnose an anxiety dis-
order or depressive disorder according to the Diagnostic and Statistical Manual of 
Mental Disorders, Fifth Edition (DSM-5).(48) Fourth, the Charlson comorbidity index 
was used to quantify participants’ self-reported morbidities; however, this index is 
limited in the number of morbidities. Furthermore, this article analyzed 7 morbidi-
ties assessed in patients with COPD and their relatives; however, more morbidities 
could be present without being noticed. Therefore morbidities such as gas-
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troesophageal reflux disease and diabetes mellitus were not included. Fifth, we did 
not include a control group: age-matched people without a relative with COPD. 
Therefore, comparing resident relatives with the general elderly population could 
be done only by using the prevalence of morbidities in population-based studies. 
Sixth, SEM, minimal clinically important difference, or minimal detectable change 
remain unknown for the CDS, AQoL-8D, or 3-level EQ-5D index score in patients 
with COPD.(49) Therefore, it remains unknown if the observed differences between 
patients and resident relatives are clinically relevant. Last, known morbidities and 
medication were self-reported and not verified by chart review. 
CONCLUSION 
Patients with COPD and their resident relatives had multiple morbidities, which were 
often not treated. Although the mobility and health status of resident relatives is 
better compared with patients, their health should also be considered when advising 
patients in obtaining a healthier lifestyle. Also, the International Classification of 
Functioning, Disability and Health stated that environmental factors play a major role 
in patients’ health and performances, like activities and participation.(50) These 
factors can influence the patient positively or negatively.(51) An example of a posi-
tive influence is a relative who is able to motivate and join a patient during physical 
activity. An example of a negative influence is a smoking relative. In conclusion, pa-
tients most probably will rely on their relatives at some point in time. Therefore, 
clinicians should not only routinely assess the morbidities and health status of pa-
tients with COPD, but also of their resident relatives. 
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SUPPLEMENTARY MATERIAL 
Supplementary Table 4.1. Used medications by patients and resident relatives 
 Patients with 
COPD 
(n = 194) 
Resident  
relatives 
(n=194) 
1: SABA: Short acting β2-agonists 88 6 
2: SAMA: Short-acting muscarinic antagonists (or SAAC: short-acting anticholinergics) 17 0 
3: SABA + SAMA: Short-acting combinations (COMBI) 57 2 
4: LABA: Long-acting β2-agonists 59 6 
5: LAMA: Long-acting muscarinic antagonists (or LAAC: long-acting anticholinergics) 122 10 
6: ICS: Inhaled corticosteroids  47 7 
7: ICS + LABA: Inhaled corticosteroids in combination with LABA 120 11 
8: Theohyllines 6 0 
9: Oral prednisone (Oral corticosteroids)  39 2 
10: Anti-leukotrienes 4 0 
11: Antihistaminic 14 4 
12: Nasal corticosteroids 8 2 
13: Angiotensin converting enzyme (ACE) inhibitors or angiotensin receptor blockers 
(ARB)  
69 68 
14: Beta blockers 51 50 
15: Calcium blockers 26 26 
16: Anti-arrhythmic 12 5 
17: Nitrates 26 10 
18: Diuretics 59 39 
19: Antilipemics 78 76 
20: Antiaggregates (antiplatelet drug) 63 48 
21: Coumarins 23 8 
22: Oral antidiabetic / insulin 20 28 
23: Calcium suppletion and/or vitamin D 43 13 
24: Bisfosfonates 30 11 
25a: Antidepressives 21 19 
25b: Antipsychotics 1 0 
26a: Anxiolytics 24 12 
26b: Sleep medication 15 4 
27a: Paracetamol 19 6 
27b: NSAIDs 11 14 
27c: Morphine 17 10 
27d: Codeine 5 1 
27e: Other painkillers 0 0 
28: PPI (proton pump inhibitors/antacids) 94 41 
29: Antibiotics 30 1 
30: Acetylcystein 25 1 
31: H1N1 vaccination (Influvac, Pneumovax) 0 0 
33: Anti-IgE antibodies 1 0 
34: Other 88 61 
Chapter 4 
80 
Supplementary Table 4.2. Self-reported comorbidities  
 Patients with COPD 
(n = 194) 
Resident relatives 
(n = 194) 
p-value 
Charlson comorbidity index (pts) a 2 (1-3) 1 (0-2) <0.001 
Charlson comorbidity index without chronic pulmonary 
disease (pts) a 
1 (0-2) 1 (0-2) 0.028 
Myocardial infarction 33 (17.0%) 24 (12.4%) 0.197 
Chronic heart failure 12 (6.2%) 6 (3.1%) 0.148 
Peripheral vascular disease 17 (8.8%) 15 (7.7%) 0.712 
Cerebrovascular disease 22 (11.3%) 16 (8.2%) 0.305 
Dementia 0 (0%) 0 (0%) - 
Chronic pulmonary disease 194 (100%) 21 (10.8%) <0.001 
Connective tissue disease 30 (15.5%) 31 (16.0%) 0.889 
Ulcer disease 29 (14.9%) 10 (5.2%) 0.001 
Mild liver disease 1 (0.5%) 0 (0%) 0.317 
Moderate or severe liver disease 0 (0%) 1 (0.5%) 0.317 
Diabetes 21 (10.8%) 31 (16.0%) 0.136 
Diabetes with end organ damage 2 (1.0%) 0 (0%) 0.156 
Hemiplegia 9 (4.6%) 5 (2.6%) 0.276 
Moderate or severe renal disease 2 (1.0%) 1 (0.5%) 0.562 
Any tumor, leukemia or lymphoma 26 (13.4%) 22 (11.3%) 0.537 
Metastatic solid tumor 2 (1.0%) 4 (2.1%) 0.411 
AIDS 0 (0%) 0 (0%) - 
Values expressed as median (IQR) or number of participants (%). Abbreviations: COPD= Chronic Obstructive 
Pulmonary Disease. a non-parametric statistical tests have been used because of skewed data. 
 
 
Supplementary Figure 4.1. Flow-chart 
Abbreviations: COPD= chronic obstructive pulmonary disease; GOLD= Global initiative for chronic Obstructive 
Lung Disease 
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ABSTRACT 
Background and objectives: Loved ones (proxies) of patients with chronic obstruc-
tive pulmonary disease (COPD) are confronted with the patients’ limitations in ac-
tivities of daily living (ADLs). However, it remains unknown whether proxies are able 
to correctly estimate the problematic ADLs of the patient. Therefore, we aimed to 
investigate the level of agreement between patient-reported and proxy-reported 
problematic ADLs of the patient. 
Methods: Stable outpatients with moderate to very severe COPD (n=194) and their 
resident proxies (n=194) were included in this cross-sectional study. Patients’ prob-
lematic ADLs were assessed in the domains ‘self-care’, ‘mobility’, ‘productivity’ and 
‘leisure’ using the Canadian Occupational Performance Measure (COPM) in both 
patients and resident proxies. Furthermore, the perceived performance and satis-
faction for important problematic ADLs were rated on a 10-point scale. 
Results: In total, 830 problematic ADLs were reported by patients, and 735 by prox-
ies. Agreement in reporting problematic ADLs within a domain was poor (productiv-
ity and leisure; Kappa 0.20 and 0.16, respectively) to fair (self-care and mobility; 
Kappa 0.32 and 0.22, respectively). Similar performance and satisfaction scores, for 
equally reported problematic ADLs, were given by 24.0% and 17.6% of the pairs, 
respectively. 
Conclusions: Proxies were often not able to identify the patients’ most important 
problematic ADLs. Moreover, when patient and proxy agreed about the presence of 
a specific problematic ADL, the perception of the performance and the satisfaction 
with that performance differed within most pairs. This emphasizes the importance 
of involving proxies, besides patients alone, in identifying patients’ problematic 
ADLs. 
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INTRODUCTION 
Despite optimal medical treatment, patients with chronic obstructive pulmonary 
disease (COPD) still experience many symptoms,(1) which limit their performance 
of activities of daily life (ADLs), like walking, and washing.(2) Difficulty with at least 
one ADL is more likely in patients with COPD compared to subjects without 
COPD.(3) COPD patients with ADL problems have a lower health status, more exac-
erbations, more hospitalizations and worse survival.(4)  
Problematic ADLs lead to dependency in self-care activities.(5) Resident partners or 
family members (proxies) are also confronted with the patients’ limitations. Indeed, 
patients need to rely on their proxies for practical support and caring obligations,(6) 
so both need to adapt their daily routines.(7) Proxies who perceive a high severity 
of the patient’s symptoms, experience a higher level of psychological distress them-
selves.(8) Therefore, also the proxies’ perception may play a role in the way proxies 
cope with the situation. However, it remains unknown whether and to what extent 
proxies are able to correctly estimate the COPD patient’s problematic ADLs. In fact, 
discrepancies between patient-proxy perceptions exist regarding the patients’ daily 
symptoms and quality of life.(9, 10) Moreover, frustrations within a pair can occur 
due to a lack of mutual understanding.(10) 
Problematic ADLs can be measured with standardized questionnaires, but self-
nomination is mostly missing.(11) The Canadian Occupational Performance Meas-
ure (COPM) is an individualized outcome measure, which allows patients to self-
nominate specific problematic ADLs most relevant to the individual patient.(11, 12) 
The COPM could be used to gather information from proxies on behalf of 
patients,(13) is reliable in patients with COPD, and responsive to pulmonary rehabil-
itation.(14) 
We aimed to investigate the level of agreement between patient-reported and 
proxy-reported problematic ADLs of the patient, and to investigate possible differ-
ences between patient-reported and proxy-reported performance and satisfaction 
scores of equally reported problematic ADLs. A priori, we hypothesized that proxies 
are unable to identify the patients’ most important problematic ADLs, and that 
perception differences exist regarding the performance and satisfaction of equally 
reported problematic ADLs.   
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METHODS 
Design 
This cross-sectional study is part of a longitudinal study on the home environment 
of patients with COPD, the Home Sweet Home study. This study was approved by 
the Medical Research Ethics Committees United (MEC-U), the Netherlands 
(NL42721.060.12/M12-1280), registered in the Dutch Trial Register (NTR 3941), and 
conducted in accordance with the amended Declaration of Helsinki.(15) The study 
protocol and health status data were published before.(16, 17) 
Study population 
Patients with COPD were recruited by their chest physician or a respiratory nurse 
specialist during hospital admission or at the outpatient clinic in four Dutch hospi-
tals. In addition, patients participating in the ‘Chance study’ (NTR3416)(18) who 
met the inclusion criteria were asked to participate. Patients were included be-
tween July 2013 and December 2014. Inclusion occurred during the first home visit, 
which was planned once patients were clinically stable.  
Patients were eligible if they had moderate to very severe COPD (Global initiative 
for chronic Obstructive Lung Disease (GOLD) grade II, III or IV);(19) no exacerbation 
of COPD(20) or hospitalization <4 weeks preceding enrolment; and if they could 
identify a proxy (defined as a person living together with the patient with COPD, 
regardless of whether or not he/she provides care to the patient). Patients and/or 
proxies were excluded if they were unable to complete the study questionnaires 
because of cognitive impairment (defined as Short Blessed Test score ≥10 
point);(21) or if they were unable to understand Dutch. All participating patients 
and proxies have given written informed consent.  
Instruments 
During home visits, demographics, self-reported comorbidities (Charlson comorbid-
ity index),(22) and symptoms of anxiety and depression using the Hospital Anxiety 
and Depression Scale (HADS),(23) of patients and proxies were assessed. Disease-
specific health status using the COPD Assessment Test (CAT)(24) was only assessed 
in patients. Patients and proxies participated in the administration of the validated 
Dutch version of the COPM,(25, 26) which is a semi-structured interview to assess 
problematic ADLs in the domains ‘self-care’, ‘productivity’ and ‘leisure’.(12) The 
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area ‘mobility’ is part of the domain ‘self-care’. As mobility-related problems are 
highly prevalent in patients with COPD this area was analysed separately as a do-
main.(2) After identifying all problematic activities by the patient, the importance of 
each activity was rated and the five most important activities were selected by the 
patient. Then, the patient rated the perceived performance and satisfaction for 
each of these five important activities on a 10-point scale, ranging from 1 (not at all 
able/satisfied) to 10 (able to perform extremely well / extremely satisfied).(12) A 
difference of 2 points in performance and satisfaction scores represents a clinically 
important change.(12) The COPM was first administered in patients, out of proxies’ 
hearing. Thereafter, administration of the COPM for the proxies’ perception of the 
problematic ADLs of the patient took place, out of hearing of the patient.(13) So, all 
steps described above were conducted again, including identifying all problematic 
activities of the patient by the proxy. After the administration of both COPMs by 
one researcher, the researcher determined whether the five important problematic 
ADLs were in agreement within patient-proxy pairs.  
Statistics 
Categorical variables are described as frequencies, while continuous variables were 
tested for normality and are presented as mean and standard deviation (SD). Com-
parisons of continuous variables among patients and proxies were done using inde-
pendent samples t-tests or Mann-Whitney U tests, as appropriate. Categorical varia-
bles were compared among patients and proxies using Chi-square tests. All prob-
lematic ADLs were combined into four domains (self-care, mobility, productivity and 
leisure) and 25 categories. This was done for every single problematic ADL separately 
(both for equally as well as non-equally reported ADLs), by one researcher (N.N.). 
Interobserver agreement (patient versus proxy) in reporting patient’s problematic 
ADLs in any of the four domains and in any of the 25 categories were determined 
using Cohen’s kappa. In brief, kappa is a measure of the difference between the 
observed agreement and the expected agreement. It is calculated by taking the ob-
served agreement minus the expected agreement, divided by 1 minus the expected 
agreement.(27) A value for kappa between 0.81 and 0.99 was defined as almost 
perfect agreement, 0.61-0.80 as substantial agreement, 0.41-0.60 as moderate 
agreement, 0.21-0.40 as fair agreement, and ≤0.20 as poor agreement.(27) Scatter-
plots were used to graphically represent the relationship between patients’ and 
proxies’ perceptions of patients’ performance and satisfaction on equally reported 
problematic ADLs. The level of significance was set at p≤0.05. All statistics were per-
formed using SPSS version 20.0 (IBM SPSS Statistics, IBM Corp, Version 20.0, Ar-
monk, NY, USA).  
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RESULTS 
General characteristics  
In total, 194 patient-proxy pairs (response rate 43%)(17) completed the baseline 
visit and were included in the analysis (Figure 5.1). Mean age and gender distribu-
tion were comparable between patients and proxies (Table 5.1). Patients had mod-
erate to very severe COPD (48% GOLD grade II, 32% grade III and 20% grade IV, 
respectively),(17) and median (IQR) number of years since diagnosis (patient-
reported) was 7 (4-12). 
 
 
Figure 5.1. Flow-chart. 
Problematic ADLs 
In total, 830 problematic ADLs were reported by patients and 735 by proxies. 187 
patients (96%) and 164 proxies (85%) reported two or more problematic ADLs. 
Agreement in reporting problematic ADLs within a domain was poor (productivity 
and leisure) to fair (self-care and mobility) (Table 5.2).  
The three problematic ADLs which were mostly reported by both patients and prox-
ies were walking, household activities and stair climbing (Table 5.3). Patients scored 
the performance of dressing/undressing the highest and were most satisfied with 
their self-care and dressing/undressing. Proxies scored highest on performance and 
satisfaction for eating and drinking.   
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Table 5.1. General characteristics of patients with COPD and their proxies 
 Patients  
with COPD 
(n = 194) 
Proxies 
(n=194) 
P-value 
Male, n (%) 102 (52.6%) 87 (44.8%) 0.128 
Age (years), mean (SD) a 66.0 (8.7) 64.8 (9.7) 0.329 
Patient-proxy relationship    
Married or partners, n (%) 191 (98.5%)   
Parent/child, n (%) 3 (1,5%)   
Years living together, mean (SD) 37 (14) 37 (14) 0.877 
Level of education, n (%)   0.671 
Intermediate vocational education or lower 166 (85.6%) 163 (84.0%)  
Secondary general education or higher 28 (14.4%) 31 (16.0%)  
Working situation, n (%)   0.006 
Paid job 17 (8.8%) 40 (20.6%)  
Retired 97 (50.0%) 78 (40.2%)  
Household work 23 (11.9%) 45 (23.2%)  
Unable to work 46 (23.7%) 18 (9.3%)  
Other (volunteer, or unemployed) 11 (5.7%) 13 (6.7%)  
Participated in a rehabilitation program, n (%)   <0.001 
Pulmonary rehabilitation 84 (43.3%) 7 (3.6%)  
Other rehabilitation program 24 (12.4%) 23 (11.9%)  
Number of exacerbations, median (IQR)    
Without hospitalization in previous year 1 (0-3) b   
With hospitalization in previous year 0 (0-1)   
Charlson comorbidity index (points), median (IQR) a 2 (1-3) 1 (0-2) <0.001 
HADS-Anxiety, mean (SD) 5.8 (3.7) 5,8 (3.9) 0.925 
HADS-Depression, mean (SD)  5.7 (3.7) 4.1 (2.9) <0.001 
COPD Assessment Test (CAT), mean (SD) 21.2 (7.1) b   
Values expressed as mean (SD), median (IQR) or number of participants (%). Abbreviations: COPD= Chronic 
Obstructive Pulmonary Disease. a non-parametric statistical tests have been used because of skewed data; b 
n=193. 
 
Agreement about presence of specific categories of problematic ADLs was moder-
ate for cycling, showering and bathing, and gardening (kappa 0.41-0.54, Table 5.3). 
For twelve ADLs (walking, household activities, stair climbing, dressing and undress-
ing, uphill walking, ‘do-it-yourself’, performing hobbies, sports, social activities, 
activities with (grand)children, cooking, and performing a job) agreement was fair 
(kappa 0.21-0.39). Finally, agreement was poor for the remaining ten ADLs (kappa 
≤0.20).  
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Table 5.2. Patient-reported and proxy-reported COPM domains of COPD patients’ problematic ADLs  
 Patients  
with COPD 
(n = 194) 
Proxies 
(n=194) 
Cohen’s kappa 
Mobility 89% 83% 0.22 
Productivity 68% 55% 0.20 
Leisure 46% 43% 0.16 
Self-care 37% 33% 0.32 
Values expressed as percentage of participants. Abbreviations: COPD= Chronic Obstructive Pulmonary Dis-
ease.  
Scores for equally reported problematic ADLs 
In total, 262 problematic ADLs were equally perceived by patients and proxies, both 
in type as well as the approximate duration of the problematic ADL. More than half 
of these equally reported problematic ADLs were in the COPM domain ‘mobility’ 
(52.7%), and less frequently in self-care 11.1%, productivity 22.5% and leisure 
13.7%.  
Mean performance scores (4.4 (2.3) vs 4.4 (2.3), p=1.00) and mean satisfaction 
scores (4.4 (2.3) vs 4.2 (2.4), p=0.31) for these equally reported problematic ADLs 
were similar between patients and proxies. Nevertheless, at the level of individual 
‘patient-proxy pairs’, large discrepancies were found for performance and satisfac-
tion scores (Figures 5.2 and 5.3, respectively). Indeed, frequently the equally re-
ported problematic ADLs had a difference in performance (48.5%) and satisfaction 
scores (57.6%) of at least 2 points between patient and proxy. Exactly the same 
performance and satisfaction scores were given by 24.0% and 17.6% of the pairs, 
respectively. 
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Figure 5.2. Patient-reported and proxy-reported performance scores on equally reported problematic ADLs 
n=147 pairs; n=262 problematic ADLs. 
 
 
Figure 5.3. Patient-reported and proxy-reported satisfaction scores on equally reported problematic ADLs  
n=147 pairs; n=262 problematic ADLs. 
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DISCUSSION 
Key findings 
Consistent with our hypothesis, proxies were often not able to identify the patients’ 
most important problematic ADLs. Indeed, low agreement was shown between 
patients and proxies in reporting the patients’ problematic ADLs. When patient and 
proxy agreed about a specific problematic ADL, the perception of the performance 
and the satisfaction with that performance differed within most pairs.  
Problematic ADLs in patients with COPD 
It is well known that patients with COPD walk less and at a lower intensity com-
pared to healthy subjects.(28) Moreover, self-reported mobility-related problematic 
ADLs are well-known in symptomatic patients with COPD referred for pulmonary 
rehabilitation.(2) The current study corroborates these findings in an independent 
sample of clinically stable outpatients with moderate to very severe COPD. Limited 
mobility can give patients with COPD feelings of being housebound, loneliness, and 
an inability to actively participate in life.(29) Indeed, patients scored below 5 points 
on performance and satisfaction for mobility-related problematic ADLs. To prevent 
further deterioration and social isolation, mobility-related problems should be iden-
tified early and, if possible, treated. Non-pharmacological interventions (i.e. provid-
ing a walking aid and/or pulmonary rehabilitation) should be considered to improve 
patients’ mobility.(30)  
Perception differences between patients and their proxies 
Proxies seem to experience the mobility-related problematic ADLs of the patients, 
as 83% reported mobility-related problematic ADLs. Indeed, most of the by patients 
and proxies equally reported problematic ADLs were in the COPM domain ‘mobili-
ty’. Then again, the interobserver agreement is only fair (Kappa: 0.22). However, a 
measure of Kappa is influenced by the prevalence of the problematic ADL under 
consideration.(27) Mobility problems are very common and therefore prevalent in 
patients with COPD, which is why we should recognize this limitation of Kappa. 
Indeed, the observed agreement for mobility problems between patients and prox-
ies is high (0.81). Because mobility problems are very prevalent, the expected 
agreement is also high (0.76). As a result, the interobserver agreement is only fair 
(Kappa: 0.22). Nevertheless, the patient-proxy agreement for all COPM domains 
was only poor to fair. The reason could be that it is easier for proxies to answer 
Chapter 5 
92 
questions about the presence or absence of a specific problematic activity, rather 
than to rate the performance or satisfaction of a problematic activity,(31) let alone 
to report ‘any’ problematic activity. 
To the best of the authors’ knowledge, no other studies reported perception differ-
ences of the patients’ problematic ADLs between patients with COPD and their 
proxies. In injured older adults, authors concluded that proxy reports could be used 
to assess older adults’ physical function.(32) Moreover, studies among community-
dwelling elderly concluded that proxies are able to accurately report on physical 
and instrumental ADL tasks, but not on health status,(33) and that proxies tended 
to report more functional limitations compared with patients.(34) The present 
study shows that proxies of patients with COPD are unable to identify the patients’ 
problematic ADLs. Therefore, when patients with COPD are admitted to the hospital 
or due to any other reason unable to self-report their problematic ADLs, healthcare 
professionals should take into account that proxy-reported problematic ADLs could 
be incorrect or incomplete.  
Knowledge is lacking regarding the causes of perception differences. For instance, 
proxies’ perceptions may be influenced by their own needs and problems,(35) the 
perceived burden of caregiving,(36) living together with the patient,(33) or being 
the patient’s partner.(37) A qualitative study in patient-proxy pairs with disagree-
ment about the COPD patients’ problematic ADLs should be conducted to explore 
the causes of perception differences.  
Implications 
Perception differences in problematic ADLs may have important consequences. 
Overestimating the patients’ problematic ADLs can result in overprotective behav-
iour by their proxies, while an underestimation can result in a lack of understand-
ing. Both could lead to frustrations within a pair,(10) which, in turn, could result in 
patients’ distress, a lower quality of the relationship, and a lower quality of life.(38, 
39) The assumption that it is important for patient-proxy pairs that proxies are able 
to identify and understand the patients’ problematic ADLs is therefore plausible. 
The level of understanding could be increased by promoting the communication 
within a pair.(40)  
The present study clearly shows that discrepancies exist in identifying patients’ 
problematic ADLs within patient-proxy pairs. So, proxy-reported problematic ADLs 
can only be considered supplementary by healthcare professionals, because identi-
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fication by patients only may be incomplete. Obviously, discrepancies need to be 
discussed within patient-proxy pairs.  This is in line with a comprehensive assess-
ment and management of COPD, which should include the patient’s home envi-
ronment and social situation,(41) and therefore it should include information pro-
vided by proxies as well. Involving proxies during the identification of the patients’ 
problematic ADLs can also result in feelings of shared responsibility.(42) This is es-
pecially important regarding the patients’ inactive lifestyle,(43) since proxies can 
positively affect this. In fact, behavioural change is effective when social support 
(like proxies’ support) is included.(44, 45) Shared insight in problematic ADLs is 
therefore necessary and an important step in behavioural change.  
Methodological considerations 
A major strength of this study is the use of the COPM, an instrument that allows 
participants to identify the patients’ most important problematic ADLs. Then again, 
as the reported problematic ADLs are very personal and specific, it was needed to 
combine all problematic ADLs into domains/categories for further analyses. For prox-
ies, it is more difficult to identify ‘any’ kind of problematic ADL for the patient, in-
stead of answering a closed-ended question like ‘does the patient experience limita-
tions in showering’.(31) Furthermore, proxies might not have enough information on 
private, unobservable, or complex questions.(34) This could explain the finding that 
proxies are able to report many problematic ADLs in the domain ‘mobility’, like 
‘walking’, because these are concrete, not private and mostly observable.(33, 46) 
Problematic ADLs are not personal and specific anymore when using a question-
naire. This, however, could result in a higher patient-proxy agreement, thus in a 
higher Kappa. In addition, patient-reported and proxy-reported problematic ADLs 
were compared, without objectively assessing them. Yet, an objective test could be 
more valid, but measures different aspects of functioning compared to self-
reports.(46) Some eligible pairs (n=253) refused participation due to various 
reasons.(17) Patients and their proxies were informed about the aims of this study, 
which might be a reason to refuse participation.  
CONCLUSION 
In conclusion, proxies are frequently unable to identify and rate the patients’ most 
important problematic ADLs. Communication within a pair, by involving proxies 
when identifying patients’ problematic ADLs, could be the key to increase the level 
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of understanding. Subsequently, existing discrepancies should be discussed with 
patient and proxy together.  
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ABSTRACT  
Objectives: The aim of this qualitative study was to explore causes of perceptual 
differences between patients and proxies about the problematic activities of daily 
living (ADLs) of the patient. 
Methods: We conducted ten interviews with an open structure in the presence of 
both the patient and proxy. Patients’ five most important problematic ADLs identi-
fied by the couple were compared and discussed. Transcribed interviews were ana-
lysed following Strauss and Corbin’s grounded theory methods. 
Results: Ten main causes were identified: (1) differences in the level of satisfaction; 
(2) differences in the level of acceptance; (3) estimation of own capabilities; (4) 
problematic ADL goes unnoticed; (5) proxy is not present during problematic ADL; 
(6) problematic ADL is not performed (often or anymore); (7) problematic ADL is 
not (longer) talked about; (8) masked by another problematic ADL; (9) value judge-
ment; (10) solution for problematic ADL.  
Conclusions: Ten causes of perceptual differences between patients and proxies 
about patients’ problematic ADLs were identified, which were related to both the 
patient’s and the proxy’s perception. 
Practice implications: Involving proxies when patients need to identify their prob-
lematic ADLs may be a way to encourage communication within a couple and to 
make sure that all important problematic ADLs are identified.  
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INTRODUCTION 
Patients with chronic obstructive pulmonary disease (COPD) experience various 
limitations in activities of daily living (ADL), like walking, stair climbing and self-care 
activities.(1) These limitations in ADLs are caused by perceived symptoms, like 
breathlessness and fatigue.(2) Resident loved ones, family members or friends 
(proxies) are also confronted with patients’ limitations in ADLs. Discrepancies be-
tween patient-proxy perceptions can occur due to a lack of understanding which 
could lead to frustrations within a couple.(3) Previous research investigated the 
agreement between patient-reported and proxy-reported problematic ADLs of the 
patients, and concluded that proxies are often unable to identify the patients’ most 
important problematic ADLs.(4) 
The underlying causes for the perceptual differences between patients with COPD 
and their proxies remain currently unknown. These causes could be influenced by 
several factors, like proxies’ own needs and problems,(5) perceived informal care-
giver burden,(6) and the patient-proxy relationship.(7, 8) In addition, several sce-
narios for disagreement are possible: 1) over report the patient’s abilities by the 
patient, for instance to minimize their illness and to avoid pity; 2) under report the 
patient’s abilities by the patient, for instance to get more help; 3) over report the 
patient’s abilities by the proxy, for instance when proxy is only present when help is 
needed; 4) under report the patient’s abilities by the proxy, for instance when proxy 
experiences caregiver burden and is unable to care for the patient.(9)  
Insight in why patients and proxies disagree about the patient’s problematic ADLs 
could be important to involve proxies (in an appropriate way) in patients’ care, to 
help proxies cope with patients’ limitations and to improve the ability to interpret 
and use proxy information.(10) Moreover, exploring the causes of disagreement is 
important because it influences the close relationship and may also improve both 
the patients’ and proxies’ well-being.(11)  
The aim of this qualitative study was to explore causes of perceptual differences 
between patients and proxies about the problematic ADLs of the patient. By unrav-
elling the causes of perceptual differences between patients and proxies, 
knowledge may be gained about why proxies interact with the patient the way they 
do. Furthermore, communication within a couple about the patient’s illness and 
problematic ADLs could be encouraged, when the cause of the perceptual differ-
ences is known. This may also provide better directions to help proxies cope with 
patients’ limitations in daily life.  
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METHODS 
Study design 
This qualitative study is part of the Home Sweet Home study,(12) registered in the 
Dutch Trial Register (NTR 3941). Patients with moderate to very severe COPD were 
recruited by their chest physician or respiratory nurse specialist in four hospitals in 
the Netherlands. Participants of the Home Sweet Home study underwent a home 
visit at baseline and after one-year follow-up, to investigate the differences be-
tween patients’ and proxies’ perceptions of patients’ health status and problematic 
ADLs. Participants of this qualitative study were also interviewed during a home 
visit. Ethics approval has been obtained from the Medical Research Ethics Commit-
tees United (MEC-U), the Netherlands (NL42721.060.12/M12-1280).  
Participants 
Stable patients with COPD GOLD grade II, III or IV with a resident proxy (defined as a 
person living together with the patient, regardless of whether they provide care to 
the patient) were eligible for inclusion in the Home Sweet Home study. Only couples 
who completed the baseline visit as well as the one-year follow-up visit of the Home 
Sweet Home study, and who (together) reported at least six different important 
problematic ADLs on the Canadian Occupational Performance Measure (COPM) 
during the follow-up visit were eligible to participate in this qualitative study. The 
latter because we expected that causes for disagreements could be diverse. There-
fore, we tried to minimize the number of couples needed by including only couples 
with six or more disagreements. Purposed sampling was used to include patients 
and proxies until data saturation occurred. Finally, ten couples were included be-
tween May 26th 2015 and August 8th 2015. All participants provided additional writ-
ten informed consent for this qualitative part of the Home Sweet Home study. 
Data collection of the Home Sweet Home study 
Demographics and clinical characteristics (including post-bronchodilator spirome-
try) were assessed in patients and their resident proxies during the home visit of 
the original Home Sweet Home study. Demographics included the relationship be-
tween the patient and proxy, the current smoking status of both and their working 
situation. Moreover, post-bronchodilator spirometry was performed in patients and 
proxies according to guidelines.(13) Forced expiratory volume in the first second 
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(FEV1) was calculated from the flow–volume curve measured by a handheld pulmo-
nary spirometer during the home visit.  
Problematic ADLs of the patient with COPD were identified using the COPM.(14) 
The COPM is a semi-structured interview to identify and discuss patients’ specific 
problematic ADLs. Problematic ADLs are activities, which the patient still performs 
but with symptoms like fatigue or breathlessness, or activities which are no longer 
performed by the patient because of the experienced symptoms. This interview is 
administered in patients and in proxies about the patient’s problematic ADLs, out of 
hearing of the significant other. The five most important problematic ADLs, accord-
ing to the patient and proxy separately, are recorded. The researcher determined, 
directly after the interviews, whether these five identified problematic ADLs were 
an agreement between the patient and proxy. An agreement was defined as the 
same activity with an almost equal duration (or distance). The remaining problem-
atic ADLs were considered as a patient-proxy disagreement.  
Data collection of the present qualitative study 
The COPM, assessed during the one-year follow-up home visit of the original Home 
Sweet Home study, was used as the basis for the qualitative study. The interviews 
for the qualitative study were planned preferably within one month after the one-
year follow-up visit of the Home Sweet Home study, in order to minimize the risk 
that problematic ADLs changed over time. The interviews had an open structure 
and were performed in the presence of both the patient and proxy. During the 
interviews, the five most important problematic ADLs during the last home visit of 
the Home Sweet Home study identified by each person of the couple were com-
pared and discussed. All interviews were conducted by one researcher (N.N.) using 
an interview guide (Table 6.1). The interview guide includes six main questions. 
Participants’ responses on the questions were explored in depth. The duration of 
the interview was approximately one hour. Interviews were recorded by audiotap-
ing using two recorders (to prevent missing data by failure of recording equipment). 
 
Table 6.1. Interview guide 
Present the COPM form of the patient’s and proxies’ perception about the patient to the couple. Name the five most 
important problematic activities of daily living (ADLs), mentioned by both during the follow-up visit of the Home 
Sweet Home study.  
Do you recognize the problematic ADLs that were indicated by the other?  
How do you experience the problematic ADL which is indicated by the other? 
Can you explain why you think there is a difference in the chosen problematic ADL? 
What consequences does this have for how you deal with this problematic ADL? 
What would you like to see differently? 
What do you need to see this differently? 
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Data analysis 
To describe the characteristics of the couples, data of the Home Sweet Home study 
were used. Categorical variables are described as frequencies, and continuous vari-
ables are presented as mean and standard deviation (SD).  
The interviews were transcribed verbatim. Data analysis took place at the same 
time with the data generating process. Data analysis was done by two researchers 
(N.N. and E.v.d.B.) following Strauss and Corbin’s grounded theory methods where-
by open coding, axial coding and selective coding were conducted.(15) Open coding 
is identifying and categorizing phenomena found in the text, axial coding is the 
process of relating codes or categories to each other and selective coding includes 
choosing a category as core category and relating all other categories to it. Re-
searchers coded independently and discussed results until they reached consensus. 
Quantitative data were analysed using SPSS version 20.0 and qualitative data analy-
sis was done using NVivo version 10. 
RESULTS 
General characteristics of the study population 
Ten patients with COPD GOLD II, III or IV (n= 3, 4 and 3, respectively), and their resi-
dent proxies were included. Half of the patients and proxies were male and patients 
were slightly older than their proxies (Table 6.2). Most proxies were retired.  
 
Table 6.2. Characteristics of patients with COPD and their resident proxies.  
 Patients with COPD 
(n = 10) 
Resident proxies 
(n = 10) 
Male, n (%) 5 (50%) 5 (50%) 
Age (years), mean (SD) 64.6 (5.5) 59.4 (15.2) 
FEV1 (% predicted), mean (SD) 36.6 (16.5) a 101.2 (25.7) a 
Current smoker, n (%) 1 (10%) 2 (20%) 
Relationship, n (%)   
Spouse/partner 9 (90%) 9 (90%) 
Parent/child 1 (10%) 1 (10%) 
Working situation, n (%)   
Paid job 0 1 (10%) 
Retired 4 (40%) 6 (60%) 
Household work 0 1 (10%) 
Unable to work 6 (60%) 1 (10%) 
Student 0 1 (10%) 
Values expressed as mean (SD), or number of participants (%). Abbreviations: COPD= Chronic Obstructive 
Pulmonary Disease; FEV1= Forced Expiratory Volume in the first second. a 1 missing. 
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Findings 
In total, these ten couples disagreed about 73 problematic ADLs, which were fur-
ther elaborated in depth during the open interview. 121 explanations for disagree-
ment were identified between the patients and proxies. These were categorized 
into ten main causes: (1) differences in the level of satisfaction; (2) differences in 
the level of acceptance; (3) different estimation of capabilities; (4) problematic ADL 
goes unnoticed; (5) proxy is not present during problematic ADL; (6) problematic 
ADL is not performed (often or anymore); (7) problematic ADL is not (longer) talked 
about; (8) masked by another problematic ADL; (9) different value judgement; (10) 
solution for problematic ADL.  
Differences in the level of satisfaction  
Some discrepancies exist because the patient or proxy was satisfied with the pa-
tient’s performance of a problematic ADL, while the significant other was not. 
Therefore, these problematic ADLs were only identified by one person of the cou-
ple. For instance, Patient5 mentioned dressing as an important problematic ADL. He 
explained that he was able to do it himself, but that he was really tired afterwards, 
already at the start of the day. So, he identified this activity as problematic. Howev-
er, his proxy thought otherwise. 
“I do not have to help him, let me put it that way. He can do it himself. So 
therefore I think it is not a problem. That he needs about an hour, that’s 
something else.” [Proxy5] 
Another example is Patient2 who organized a birthday party for his grandson. The 
proxy recognized this as a problematic ADL, but the patient did not. 
“They loved it. I experience a lot of satisfaction of such a day. I am broken, 
afterwards. I realise that I am sleeping on the couch in the evening. But that 
does not matter.” [Patient2] 
Differences in the level of acceptance 
Disagreement in identifying problematic ADLs existed because patients and proxies 
had another level of acceptance. Patients or proxies accepted a problematic ADL, 
like not being able to shower independently, as a normal way of life.  
“Because for me it is self-evident, that they come to help me. Now.” [Patient6] 
“That is a crime anyway. But in the meantime I accepted that, that I need 
help.” [Patient6] 
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“Yes, I just know that he has difficulties with dressing. But I think that’s al-
ready in the background.” [Proxy5] 
For some patients, it was difficult to accept and face the truth about not being able 
to do activities, like household activities, that they used to do independently and 
without any symptoms. 
“So I can, I cannot yet face the truth completely.” [Patient1] 
Different estimation of capabilities 
Another cause of disagreement between patients and proxies was the estimation of 
capabilities. Sometimes patients overestimated their own abilities.  
“Yes, I have the feeling that I’m still able to do a lot of things. But in reality, it 
is simply not true.” [Patient1] 
Sometimes proxies estimated the patients’ abilities differently compared to the 
patients themselves.  
“Fifteen minutes is exaggerated. She does not admit, apparently not… After 
three, four minutes she already has problems. … Fifteen minutes of shop-
ping, but then you stop, you walk from window to window. But that’s not 
walking, walking is for instance to walk around the block, on flat ground, and 
you are not able to succeed.” [Proxy9] 
Problematic ADL goes unnoticed  
Although the patient and proxy did an activity together, some problematic ADLs 
were not or barely noticed by one of them. Proxy1 explained his experience that 
driving a mobility scooter was difficult for his wife, resulting in unsafe situations. 
However, his wife did not notice this herself: 
“I did not realize that I did something wrong. No, I did not notice that at all.” 
[Patient1] 
Another example is eating, which was a problematic ADL for Patient2. Even though 
the patient and wife always ate together, she did not notice his difficulties. In fact, 
she also did not recognize this problematic ADL after showing the problematic ADLs 
identified by her husband. 
Proxy2: “We eat less than before. That also makes a difference that we eat 
less. We do not have any problem with that.” Interviewer: “Do you have the 
idea that eating is difficult for (name patient)?” Proxy2: “No, not at all.” 
[Proxy2] 
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Proxy is not present during problematic ADL 
Many proxies did not identify a problematic ADL because he or she was not present 
during the performance of that ADL. The reason was that the patient did it by 
him/herself (for instance a hobby), because the proxy was at work or because their 
social lives were separate. The latter applied to the patient and her son:  
“Our social lives are a little bit separated from each other. She is sitting here, 
I sit in my room, so we almost don’t cross each other. Sometimes I do hear 
things like: ‘I have talked with him and her’, but that’s not directly applicable 
for me and not something I come in contact with.” [Proxy6] 
Problematic ADL is not performed (often or anymore) 
Many problematic ADLs were not identified by one person from a couple, because 
that problematic ADL was rarely or not performed. Various reasons could be distin-
guished: the activity itself had changed, the problematic activity is not performed 
by the patient (at the moment, for instance due to the season or because the pa-
tient is not able to perform that activity anymore), or the problematic ADL does not 
occur often. For instance, Patient8 did not identify playing with her grandchildren 
as problematic, because they don’t see them a lot. However, she did recognize this 
as an important problematic ADL during the interview. 
“If they live nearby, yes, then I would see them more often, and then it 
would be a major item. Then you want to go there and do something with 
them. We don’t have that. Because they live so far away, therefore we don’t 
see the grandchildren a lot.” [Patient8] 
Problematic ADL is not (longer) talked about 
Some problematic ADLs were not identified by the proxy because it is not some-
thing that they talked about. An example was the symptoms Patient2 experienced 
during showering:   
“There was never any talk about that actually.” [Proxy2] 
Moreover, sometimes they talked about a problematic ADL in the past, but not 
anymore, so it was faded into the background. This was the case when male 
Proxy10 talked about a problematic ADL identified by his wife, namely to rub oint-
ment on the skin (also on intimate places): 
“We talked about it in the past. When she was admitted to the hospital, and I 
said that everything became too much. I could not do it any longer. But in 
fact, after the hospital admission in (place hospital), it’s no longer discussed. 
So that faded into the background, for me.” [Proxy10] 
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Masked by another problematic ADL 
Some couples mentioned that another problematic ADL masked the problematic 
ADL mentioned by the significant other. This was mostly caused by the feeling that 
when a person is not able to perform a specific activity like walking indoors, this 
person is also not able to perform a more difficult activity, like walking outdoors. 
“I explain it like this, if you are not able to walk 10 metres, than you are also 
not able to play golf.” [Proxy5] 
Different value judgement 
Couples associated a problematic ADL with a specific value judgement. Either they 
recognized the activity as problematic, but did not identify it as such because it is of 
major importance for the patient.  
“Like doing the dishes. Well, I do not enjoy that, but it does have value for 
me. Because when I’m doing the dishes, they (proxy and daughter) can do 
something else. So that is the value to me, that I still mean something.” [Pa-
tient1] 
Or they did admit it as a problematic activity, but other activities were far more 
important for this person. For instance, (female) Patient10 who cooked daily (her 
role within the household), but never did it for fun.  
“No, that’s not one of the things I miss. No, I cooked dinner, and what I 
cooked, I cooked properly, I put hundred percent effort in it. But I never said: 
‘wow, I really enjoy cooking’. I mean, he is an amateur chef, he really enjoys 
cooking. But, no, I don’t have that.” [Patient10] 
Solution for problematic ADL 
A frequent cause of discrepancies between patients and proxies is the fact that one 
of them found a solution for that problematic ADL, making it no longer a problem. 
Different kinds of solutions were mentioned by these couples: the use of helping 
aids, using another method, or the activity is taken over by another person (for 
example the proxy). However, the fact remains that the significant other still no-
ticed this activity as problematic. Problematic ADLs with a solution were for exam-
ple: walking (mobility scooter), climbing the stairs (working downstairs) or dry your-
self after a shower (receiving help from proxy). 
“Yes, then I’ll have a problem. But I don’t take that very seriously, because I 
have my mobility scooter.” [Patient2] 
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“(Name patient) talked about a stair lift, and then I think well, I’d rather 
spend my money on something else. He can also work downstairs.” [Proxy5] 
“When she is finished I say: ‘Come on, I’ll help you to dry your back, feet and 
legs.’ So I thought this was more or less solved.” [Proxy10] 
DISCUSSION 
The causes of perceptual differences between patients and proxies are diverse, just 
like the problematic ADLs themselves. In addition, the perceptual differences could 
be caused by both the patient’s and the proxy’s perception. Disagreements could 
be caused due to the process of acceptation, because the patient is on a different 
level of acceptance than the proxy thinks the patient is. Different stages of the 
grieving process in COPD could be distinguished: denial, resistance, sorrow and 
acceptance.(16) A perfect example is the patient who has difficulties with facing the 
truth about doing household activities, and thought she was able to do all these 
things herself (stage: denial), while her proxy did identify this as a problematic ADL. 
Other examples are the patients, or proxies who accepted a problematic ADL (like 
showering or dressing) as a normal way of life (stage: acceptance), while the signifi-
cant other thinks differently (stage: resistance or sorrow).  
Moreover, reasons for disagreement in identifying problematic ADLs due to the 
proxies were also mentioned, like when the proxy is not present during the ADL, did 
not notice it as problematic, or they did not talk about the problematic ADL. Alt-
hough 90% of patients and caregivers find it important to talk to each other about 
the patient’s illness,(17) it still appears to be a reason for disagreement. A previous 
study already revealed that encouragement to communicate with each other is 
necessary because proxies felt that the capacity to communicate or the opportunity 
to keep conversations going, was affected by the patient’s breathlessness.(18) 
Carswell and colleagues,(19) concluded in their review that the COPM could be 
used to collect information from proxy respondents on behalf of patients who were 
not able to report their own occupational performance, like caregivers of persons 
with Alzheimer disease or minor children. However, findings of a previous study in 
patients with COPD showed that proxy responses should be used with caution, 
because of the many discrepancies between patients and their proxies when identi-
fying patient’s problematic ADLs.(4) Furthermore, the current study shows many 
different causes of these perceptual differences. This makes it reasonable to believe 
that discussing the patient’s problematic ADLs as part of goal setting, for instance at 
the start of a pulmonary rehabilitation program, should be done in the presence of 
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the proxy. Indeed, a qualitative analysis showed that patients entering pulmonary 
rehabilitation identified only abstract and immeasurable goals.(20) Often, they had 
an unrealistic perception, for instance because they overestimate or underestimate 
themselves. Proxies living together with the patients have a different view on the 
patients’ performances than the patients themselves.(4)  Discussing problematic 
ADLs within a couple, instead of with the patient alone, is therefore important to 
make sure that rehabilitation goals are realistic and not missed. In addition, involv-
ing proxies when discussing the patients’ problematic ADLs could result in feelings 
of shared responsibility,(21) and maintains the quality of a close relationship.(22)  
More advantages of involving proxies in the assessment and treatment of patients 
with COPD could be mentioned. A study in patients with chronic organ failure also 
concluded that caregiver burden could change over time, but that these changes 
were not explained by patient characteristics.(23)  Furthermore, two studies found 
that the level of caregiver burden was more related to caregiver’s perception and 
attitude than to patient characteristics.(24, 25) Therefore, paying attention to the 
perception of these proxies seems important, because this perception seems to 
have an impact on the proxy. In a study by Marques and colleagues,(26) patients 
and family members were asked about their expectations of a family-based pulmo-
nary rehabilitation program. Both patients and family members hoped to improve 
their social relationship, indicating the importance of, and the impact on this rela-
tionship. In fact, patients and proxies considered that COPD had an impact on their 
marital relationship, affecting the couple’s communication.(27) For instance, be-
cause patients were embarrassed when asking for help with ADLs, or when patients 
felt not being understood by their partner. This indicates once more the lack of 
transparent communication within a couple.  
Some limitations need to be addressed. First, a cause of disagreement could exist 
when the patient did not identify an ADL as problematic (anymore), for instance 
because he/she attached no value to it.(28) Some causes of disagreement could be 
diminished when more concrete questions were asked (for instance in question-
naires) instead of the broad questions in the COPM.(29) However, we have con-
sciously chosen the COPM because of its major strength, namely the rating of any 
problematic ADL, which makes the open dialogue very individual.(28) Second, this 
qualitative study had a cross-sectional design. The interviews of this qualitative 
study were based on the problematic ADLs identified with the COPM during the 
follow-up visit of the original longitudinal study. Therefore, the problematic ADLs 
are reported on only one specific moment in time. This could have biased the prob-
lematic ADLs identified during this COPM. Although this should be taken into ac-
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count when interpreting the results, it should also be noted that a cross-sectional 
design is appropriate for the aim of this study. Lastly, this qualitative study included 
ten patients with COPD and their proxies. Although sample size was limited, we 
interviewed to the point of data saturation.  
CONCLUSION AND PRACTICE IMPLICATIONS 
This qualitative analysis identified many causes of perception differences between 
patients and proxies about patients’ problematic ADLs. Involving proxies when pa-
tients need to identify their problematic ADLs may be a way to encourage commu-
nication within a couple and to make sure that all important problematic ADLs are 
identified.  
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ABSTRACT 
Although proxies of patients with chronic obstructive pulmonary disease (COPD) 
need health-related knowledge to support patients in managing their disease, their 
current level of knowledge remains unknown. We aimed to compare health-related 
knowledge (generic and COPD-related knowledge) between patients with COPD and 
their resident proxies.  
In this cross-sectional study, we included stable patients with moderate to very 
severe COPD and their resident proxies (n=194 couples). Thirty-four statements 
about generic health and COPD-related topics were assessed in patients and proxies 
separately. Statements could be answered by ‘true’, ‘false’, or ‘do not know’. This 
study is approved by the Medical Research Ethics Committees United (MEC-U), the 
Netherlands (NL42721.060.12/M12-1280).  
Patients answered on average 37% of the statements incorrect or with ‘do not 
know’. For proxies this was similar (38%). Patients who attended pulmonary rehabil-
itation previously answered more statements correct (about three) compared to 
patients who did not attend pulmonary rehabilitation. More correct answers were 
reported by: younger patients, patients with a higher level of education, patients 
who previously participated in pulmonary rehabilitation, patients with better cogni-
tive functioning, and patients with a COPD diagnosis longer ago.  
In conclusion, proxies of patients with COPD as well as patients themselves have 
insufficient knowledge about COPD. Therefore, education about general health and 
COPD should be offered to all subgroups of patients with COPD and their proxies.  
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INTRODUCTION 
Worldwide, 65 million people have moderate to very severe chronic obstructive 
pulmonary disease (COPD).(1) COPD is associated with high burden on society, both 
in terms of wellbeing of patients and their family as well as economic. Exacerba-
tions of COPD and hospitalizations are responsible for the majority of the COPD-
related healthcare costs.(2) Not only to reduce health care costs, but also to main-
tain patient’s well-being, exacerbations of COPD and hospitalizations should be 
prevented.(2) This can be achieved by self-management programs.(3-5) The pa-
tient’s capacity to self-manage the disease, at least partly, depends on the disease-
related knowledge.(6) Next to acquiring and applying skills, self-management pro-
grams should focus on increasing the patient’s knowledge to cope with the disease 
and its related exacerbations.(7) However, disease specific knowledge has proven 
to be insufficient in about half of the patients with COPD.(8) Besides this, general 
health knowledge regarding physical activity and nutrition behaviour is also limited 
in the general older population.(9)  
Proxies living together with patients with COPD could support patients in managing 
their disease.(10) Therefore, they also need health-related and COPD-specific 
knowledge. Moreover, proxies have an impaired health status themselves, as they 
are often current smokers and often have (undiagnosed) morbidities.(11) So, they 
can benefit from health-related knowledge as well. The level of knowledge could be 
increased by providing education to proxies. Indeed, in caregivers of patients with 
(severe) mental illness, education proved to increase knowledge, reduce 
anxiety,(12) and reduce subjective burden.(13) As a consequence, COPD-related 
knowledge may result in improved caring behaviour.(14) However, the current level 
of knowledge in resident proxies of patients with COPD remains unknown. 
Therefore, the current study aimed to compare health-related knowledge (including 
COPD-related knowledge) between patients with COPD and their resident proxies. 
A priori, we hypothesized that both patients and proxies have insufficient 
knowledge about COPD.  
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METHODS 
Study design 
The current study is part of the Home Sweet Home study, a longitudinal study on 
the home environment of patients with COPD.(15) This study is approved by the 
Medical Research Ethics Committees United (MEC-U), the Netherlands 
(NL42721.060.12/M12-1280), and registered in the Dutch Trial Register (NTR3941). 
The study protocol and data about health status and morbidities of patients and 
their proxies were published before.(11, 15) 
Study population 
Patients with COPD were recruited by their chest physician or a respiratory nurse 
specialist during hospital admission or at the outpatient respiratory clinic in four 
hospitals throughout the southern-eastern part of the Netherlands. In addition, 
patients who participated in the ‘Chance study’ (NTR3416),(16) met the inclusion 
criteria of the Home Sweet Home study and were willing to participate in future 
research were also asked to participate in the current study. Participants were in-
cluded between July 2013 and December 2014.  
Patients were eligible if they had moderate to very severe COPD (Global initiative 
for chronic Obstructive Lung Disease (GOLD) grade II to IV);(2) no exacerbation of 
COPD or hospitalisation <4 weeks preceding enrolment; and if they had a resident 
proxy (defined as: a person living together with a patient with COPD, regardless of 
whether they provide informal care to the patient with COPD). Patients and/or 
proxies were excluded if they were unable to complete the study questionnaires 
because of cognitive impairment (Short Blessed Test score ≥10 points)(17); or if 
they were unable to understand Dutch. All participants gave written informed con-
sent.  
Measurements 
All outcomes were assessed during home visits, including: demographics, level of 
education, post-bronchodilator spirometry,(2) smoking status, self-reported 
comorbidities (Charlson comorbidity index),(18) cognitive functioning (Short 
Blessed Test),(17) presence of (informal) care, and whether patients had followed a 
pulmonary rehabilitation program.  
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Knowledge of patients and proxies was assessed using 34 statements about generic 
health and COPD-related topics. These 34 statements were all formulated by a mul-
tidisciplinary pulmonary rehabilitation team. All statements were pre-tested in au-
thentic patients in a pulmonary rehabilitation centre to make sure participants 
would be able to understand and respond to the statements correctly. All state-
ments could be answered by ‘true’, ‘false’, or ‘do not know’.   
Statistics 
Categorical variables are described as frequencies, while continuous variables were 
tested for normality and are presented as mean and standard deviation (SD). To 
compare continuous variables between patients with COPD and their resident prox-
ies, independent samples t-tests or Mann-Whitney U tests were used, as appropri-
ate. Categorical variables, including responses on individual statements, were com-
pared between patients with COPD and their resident proxies using Chi-square 
tests. A multiple regression analysis model was developed to study predictors of 
patients’ knowledge. The number of correct statements in patients was used as 
dependent variable and the highest completed education, participation in pulmo-
nary rehabilitation, cognitive functioning (Short Blessed Test), age, and the years 
since COPD diagnosis were entered as independent variables. The level of signifi-
cance was set at p≤0.01. All statistics were performed using SPSS version 20.0. 
RESULTS 
General characteristics 
In total, 194 of the 449 eligible patients and their resident proxies were willing to 
participate and completed the home visit (response rate 43%). Age, gender distri-
bution and GOLD grade were comparable between included patients and eligible 
patients who refused to participate because of various reasons (Figure 7.1).(11)  
Almost half of the patients (48%) had COPD GOLD grade II, 32% GOLD grade III and 
20% GOLD grade IV. Patients’ self-reported time since diagnosed with COPD was 8.7 
(7.1) years. Mean age, gender distribution, cognitive functioning and level of educa-
tion were comparable between patients and their resident proxies (Table 7.1). Al-
most one third of the resident proxies had a Tiffeneau index below the cut-off value 
of 70%, which is suggestive for an obstructive airflow limitation. Patients scored 
significantly more points on the Charlson comorbidity index. Proxies were signifi-
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cantly more often current smokers. Moreover, almost half of the patients partici-
pated at least once in pulmonary rehabilitation. In this subgroup, the median time 
since their last pulmonary rehabilitation program was 24 (3-36) months. 
 
 
Figure 7.1. Flow-chart.  
Abbreviations: COPD= Chronic Obstructive Pulmonary Disease; GOLD= Global initiative for chronic Obstructive 
Lung Disease. 
COPD and health related knowledge 
Patients answered on average 22 statements (64.7%) correct and resident proxies 
21 statements (61.8%). No significant differences were found in knowledge be-
tween patients and their proxies (Table 7.2). In addition, no differences were found 
in correct answers (20.6 vs 21.0), incorrect answers (6.7 vs 6.1) and ‘do not know’ 
responses (6.2 vs 6.8) between proxies with and without a Tiffeneau Index < 70% 
(all p>0.05). Significant differences did exist in the number of correct answers and 
‘do not know’ responses between patients who attended pulmonary rehabilitation 
in the past and those patients who did not (Table 7.3). Additionally, patients with 
COPD GOLD grade IV answered significantly more statements correct and signifi-
cantly less statements with ‘do not know’ compared to patients with COPD GOLD 
grade II (Table 7.4). Moreover, less patients with COPD GOLD grade II attended 
pulmonary rehabilitation previously compared to patients with COPD GOLD grade III 
and GOLD grade IV. A multiple regression model in patients with COPD, with the 
number of correct statements as dependent variable, and participation in pulmo-
nary rehabilitation, cognitive functioning (SBT), age, the highest completed educa-
tion, and the years since COPD diagnosis  as independent variables was able to 
explain 33.0% of the variance in correct statements (Table 7.5). More correct an-
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swers were reported by: patients who previously participated in pulmonary rehabil-
itation, patients with better cognitive functioning, younger patients, patients with a 
higher level of education, and patients who were diagnosed with COPD longer ago.  
 
Table 7.1. General characteristics  
 Patients with COPD 
(n=194) 
Resident proxies 
(n=194) 
p-value 
Male, n (%) 102 (52.6%) 87 (44.8%) 0.128 
Age (years), mean (SD) a 66.0 (8.7) 64.8 (9.7) 0.329 
Relationship, n (%)   0.801 
Married or partners 191 (98.5%) 191 (98.5%)  
Parent/child 3 (1.5%) 3 (1.5%)  
Years living together, mean (SD) 37 (14) 37 (14) 0.877 
Tiffeneau Index < 70%, n (%)  194 (100%) 56 (29.5%) b <0.001 
FEV1 (% predicted), mean (SD) a 47.2 (17.8) 104.1 (25.6) b  <0.001 
Charlson comorbidity index, mean (SD) a 2.3 (1.4) 1.2 (1.6) <0.001 
Current smoker, n (%) 33 (17.0%) 63 (32.5%) <0.001 
Short Blessed Test (points), mean (SD) 1.6 (2.1) 1.3 (3.0) 0.150 
Level of education, n (%)   0.671 
Intermediate vocational education or lower 166 (85.6%) 163 (84.0%)  
Secondary general education or higher 28 (14.4%) 31 (16.0%)  
Working situation, n (%)   <0.001 
Paid job 17 (8.8%) 40 (20.6%)  
Retired 97 (50.0%) 78 (40.2%)  
Household work 23 (11.9%) 45 (23.2%)  
Unable to work 46 (23.7%) 18 (9.3%)  
Other (volunteer, or unemployed) 11 (5.7%) 13 (6.7%)  
Receiving care in past 6 months   <0.001 
Informal care, n (%) 32 (16.5%) 3 (1.5%)  
Care from professional, n (%) 40 (20.6%) 5 (2.6%)  
Participated in a rehabilitation program, n (%)   <0.001 
Pulmonary rehabilitation 84 (43.3%) 7 (3.6%)  
Other rehabilitation program 24 (12.4%) 23 (11.9%)  
Values expressed as mean (SD) or number of participants (%). Abbreviations: COPD= Chronic Obstructive 
Pulmonary Disease; GOLD= Global initiative for chronic Obstructive Lung Disease. a non-parametric statistic 
tests were used because of skewed data; b n=190. 
Regarding individual statements, two were answered significantly different be-
tween patients and proxies, namely: “The spacers of puffers should be wiped dry 
after rinsing” and “Regular exercises and the intake of milk products will reduce the 
risk for osteoporosis” (Table 7.6). The first statement regarding medication was 
answered more often correct by patients, while the second statement about gen-
eral health was answered more often correct by proxies. Nine statements were 
answered correctly by less than 50% of the patients and proxies.  
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Table 7.2. Knowledge of patients with COPD and their resident proxies 
 Patients with COPD 
(n=194) 
Resident proxies 
(n=194) 
 
p-value 
Knowledge statements    
Correct answers, mean (SD) 21.6 (4.9) 20.9 (5.4) b 0.208 
Incorrect answers, mean (SD) 5.9 (2.5) 6.3 (2.5) b 0.130 
‘Do not know’, mean (SD) a 6.5 (4.9) 6.6 (5.4) b 0.899 
Values expressed as mean (SD) or number of participants (%). Abbreviations: COPD= Chronic Obstructive 
Pulmonary Disease. a non-parametric statistic tests were used because of skewed data; b n=193. 
 
Table 7.3. Knowledge of patients who did and did not previously attend pulmonary rehabilitation  
 Patients who attended PR 
(n=84) 
Patients who did not attend PR  
(n=110) p-value 
Knowledge statements    
Correct answers, mean (SD)  23.5 (4.3) 20.0 (4.8) <0.001 
Incorrect answers, mean (SD) 5.7 (2.6) 6.1 (2.4) 0.337 
‘Do not know’, mean (SD) 4.7 (4.2) 7.9 (5.0) <0.001 
Values expressed as mean (SD). Abbreviation: PR= pulmonary rehabilitation. 
 
Table 7.4. Knowledge of patients with COPD GOLD grade II, GOLD grade III and GOLD grade IV  
 Patients with 
COPD GOLD  
grade II 
(n=93) 
Patients with 
COPD GOLD  
grade III 
(n=62) 
Patients with 
COPD GOLD 
grade IV 
(n=39) p-value 
Knowledge statements     
Correct answers, mean (SD) a 19.4 (5.5) b 20.4 (5.0) 25.2 (3.3) 0.006 
Incorrect answers, mean (SD) 6.2 (2.5) 6.8 (2.6) 5.8 (2.0) 0.767 
‘Do not know’, mean (SD) a 8.4 (6.1) b 6.3 (4.3) 3.1 (2.8) 0.006 
Pulmonary rehabilitation     
Patients who attended PR, n (%) 24 (25.8%) b,c 33 (53.2%) 27 (69.2%) <0.001 
Values expressed as mean (SD). Abbreviations: COPD= Chronic Obstructive Pulmonary Disease; PR= pulmo-
nary rehabilitation. a non-parametric statistic tests were used because of skewed data; b p<0.01 vs patients 
with COPD GOLD grade IV; c p<0.01 vs patients with COPD GOLD grade III. 
 
Table 7.5. Multiple regression model, the predictors of knowledge in patients with COPD 
Model Predictors Unstandardized Beta p-value 
Number of correct 
statements  
R2=0.330 
Attended pulmonary rehabilitation 3.101 <0.001 
Cognitive functioning (SBT), points -0.536 <0.001 
Age, years -0.123 0.001 
Level of education 0.846 <0.001 
 Years since diagnosis COPD 0.135 0.002 
Abbreviations: SBT= Short Blessed Test. n=194. 
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DISCUSSION 
Key findings 
The results in this paper endorse the hypothesis that proxies of patients with COPD 
as well as patients themselves have insufficient knowledge about COPD. Indeed, 
patients answered on average 37% of the statements incorrect or with ‘do not 
know’. For proxies this was similar (38%).  
Knowledge in patients with COPD  
This study showed that patients answered on average 37% of the statements about 
COPD and general health incorrect or with ‘do not know’. Statements answered 
often incorrect were mostly about lung function and functioning with COPD, such as 
“Exercising will improve my lung function” and “My lung function determines which 
activities I will be able to do at home”. Previous studies showed a need for infor-
mation about COPD and its consequences as well, for both patients and their prox-
ies.(19, 20) The conclusions of Seamark(19) and Wilson(20), together with the re-
sults of this study, is sufficient to conclude that education for patients with COPD is 
currently inadequate and therefore necessary. Patients who were younger, attended 
pulmonary rehabilitation, had a higher level of education, better cognitive function-
ing, and with a diagnosis of COPD longer ago had a higher knowledge-level com-
pared to other patients. This is in line with another study, which found that patients 
who attended a pulmonary rehabilitation program had better understanding about, 
for instance, the advantages of exercising, in contrast to patients who did not attend 
a rehabilitation program.(20) On the other hand, patients who attended pulmonary 
rehabilitation previously, answered only 3 more statements correct than patients 
who did not attend pulmonary rehabilitation. Considering the total number of 34 
statements presented to the patients, this is only a 9% benefit. Moreover, the num-
ber of wrong answers remained unchanged. It should be noted that patients with 
COPD GOLD grade IV answered more statements correct but also attended more 
often a pulmonary rehabilitation program compared to patients with COPD GOLD 
grade II, which might explain the results. Furthermore, patients with a very low level 
of cognitive functioning (Short Blessed Test score ≥10 points) were excluded from 
the present study. Yet, it is also well-known that patients with COPD are most often 
older and have lower levels of education compared to the general population.(21) 
Moreover, poor COPD outcomes (like hospitalization and mortality) are more likely 
to be found in patients of low socioeconomic status, compared to patients of high 
socioeconomic status.(22) Additionally, about 85% of the patients and proxies had 
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low levels of education, and the current analysis showed that these patients report-
ed less correct answers on the statements. Therefore, the knowledge gap in these 
proxies and patients with COPD could be the result of the low educational levels or 
low socioeconomic status. However, a non-COPD control group should be included 
to investigate this in depth. Indeed, Friis and colleagues,(21) found that people with 
long-term conditions reported more difficulties with understanding health infor-
mation compared with the general population.  
Another remaining question is if current education programs are sufficient in this 
group of patients.  At least, all patients with mild to very severe COPD should be 
given the opportunity to participate in an education program or be referred to a 
pulmonary rehabilitation program, in which education is an integral part.(3, 23) 
Indeed, two hours of education, without a pulmonary rehabilitation program, in a 
primary care setting increased disease specific knowledge in patients with 
COPD.(23, 24) In addition, education reduced the need for rescue medication by 
more than 50% and for visits to the general practitioner.(25) On the other hand, 
education without other components of pulmonary rehabilitation were of limited 
value for patients’ disease understanding.(26) A systematic review showed the wide 
variation in the content and method of delivery of educational interventions in 
patients with COPD.(27) In the “official American Thoracic Society/European Res-
piratory Society statement: key concepts and advances in pulmonary rehabilita-
tion”, a list of relevant educational topics is provided.(3)  
Knowledge in resident proxies of patients with COPD  
Not only patients, but also proxies answered less than two thirds of the statements 
correctly. In previous literature proxies identified five areas of learning, namely: 1) 
understanding breathlessness; 2) managing anxiety and panic; 3) helpful and safe 
levels of activity; 4) maintaining quality of life; and 5) knowing what to expect in the 
future.(28) Indeed, a perfect example of a statement which is often answered in-
correct is: ‘It is better to avoid exercise because it will strain my lungs too much’. 
Believing this statement could lead to overprotective behaviour when proxies let 
patients avoid exercising and take over activities. Except for the fact that this could 
lead to frustrations between a couple,(29) and distress in patients,(30) it could also 
lead to a less active way of living for patients.(29) Therefore, education should be 
provided to patients together with their proxies. Indeed, studies showed that edu-
cation sessions for patients and proxies together were beneficial in terms of im-
proved coping strategies,(31) strengthening the relationship and a decreased bur-
den.(32) Moreover, education is needed to arrange lifestyle changes.(24) 
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Future perspectives 
The current study shows the low levels of health related knowledge in patients with 
COPD and their resident proxies. Small differences were found in the total number 
of correct answered statements, between patients who attended a pulmonary re-
habilitation program and patients who did not, and between patients with GOLD 
grade II compared to GOLD grade IV. Thus, education should be made available in 
all subgroups of patients with COPD in primary, secondary and tertiary care. Also 
resident proxies should be able to attend education sessions about general health 
and COPD, because their level of knowledge was insufficient as well. Besides this, 
the present study showed the specific educational needs of patients and proxies, 
which together with the list of relevant educational topics from the official ATS/ERS 
statement,(3) could be used as a basis to provide education sessions.  
Cognitive functioning proved to be a predictor of patients’ knowledge about gen-
eral health and COPD. Although half of the written material for educational inter-
ventions is adapted to the patients’ level of literacy,(27) it remains unknown 
whether other education sessions are adjusted to the patients’ cognitive function-
ing. Moreover, a study in chronic pain patients suggested that an assessment of the 
patient’s learning style might lead to a better fit of the patient education.(33) Addi-
tionally, a study in the primary care setting showed that increasing knowledge alone 
provided no additional health benefit compared to usual care.(34) Therefore, more 
knowledge should be gained about the use of different learning styles, teaching 
methods and dyadic approaches in patients with COPD and their proxies, especially 
regarding the effects on their knowledge level and their capacity to self-manage 
their disease.  
Methodological considerations 
The present study has some limitations. First, the response rate was 43%. Unknown 
differences between participants and eligible patients refusing participation may be 
present. For instance, patients with little knowledge could have refused participa-
tion, so the current study overestimated the knowledge of participants. On the 
other hand, perhaps patients with a higher level of knowledge could have refused 
participation because they did not see any additional benefit in participation. Sec-
ond, we did not include a control group of couples from the general population 
who were matched for age and education. Therefore, comparisons with the non-
COPD population, regarding health related knowledge, could not be made. Lastly, 
participants’ knowledge was not assessed using a validated questionnaire. Howev-
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er, existing questionnaires focus more on specific disease-related knowledge,(35-
37) while the current statements were also general in nature. In addition, these 
statements were formulated by a multidisciplinary pulmonary rehabilitation team.  
CONCLUSION AND PRACTICE IMPLICATIONS 
The present study confirmed the low levels of knowledge in both patients and their 
proxies. Therefore, education about general health and COPD should be provided 
to clinically stable outpatients with COPD and their proxies, regardless of the pa-
tients’ disease severity. 
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ABSTRACT 
Background/Objectives: Chronic obstructive pulmonary disease (COPD) not only 
affects patients, but also their partners. Gender-related differences in patients with 
COPD are known, for instance regarding symptoms and quality of life. Yet, research 
regarding gender differences in partners of patients with COPD has been conducted 
to a lesser extent, and most research focused on female partners. We aimed to in-
vestigate differences between male and female partners of patients with COPD re-
garding their own characteristics and their perceptions of patients’ characteristics. 
Design: Cross-sectional study. 
Setting: Four hospitals in the Netherlands. 
Participants: 188 patient-partner couples were included in this cross-sectional 
study. 
Measurements: General and clinical characteristics, health status, care dependency, 
symptoms of anxiety and depression, social support, caregiver burden and coping 
styles were assessed during a home visit. 
Results: Female partners had more symptoms of anxiety and a worse health status 
than male partners. Social support and caregiver burden were comparable, but 
coping styles differed between male and female partners. Female partners thought 
that male patients were less care dependent and had more symptoms of depres-
sion, while these gender differences did not exist in patients themselves. 
Conclusion: Healthcare providers should pay attention to the needs of all partners 
of patients with COPD, but female partners in particular. Obtaining an extensive 
overview of the patient-partner couple, including coping styles, health status, symp-
toms of anxiety and caregiver burden, is necessary to be able to support the couple 
as affectively as possible.  
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INTRODUCTION 
Chronic obstructive pulmonary disease (COPD) is a preventable and treatable dis-
ease, characterized by a usually progressive, persistent airflow limitation.(1) Alt-
hough once seen as a disease of men, nowadays COPD is known to be increasingly 
prevalent among women.(2) As COPD becomes more prevalent in women, several 
studies have focused on possible gender-related differences. For instance, women 
with COPD report more symptoms like dyspnea, fatigue, chronic cough, anxiety and 
depression, but they also report a lower health related quality of life compared to 
their male peers.(3-6)  
Patients’ symptom burden can result into problems with activities of daily life, 
which, in turn can result in care dependence on family-members and in particular 
partners.(7) Yet, research regarding possible gender differences in partners of pa-
tients with COPD has been conducted to a lesser extent, and most research focused 
on female partners.(8, 9) Indeed, compared to male family caregivers, female family 
caregivers of patients with COPD reported a higher prevalence of increased symp-
toms of anxiety and depression.(10) This is in line with findings in female family 
caregivers of patients from the general population, hospice patients and patients 
with cancer.(11-13) These female caregivers, compared to male caregivers, have 
more difficulty with balancing informal caregiving with other (family and employ-
ment) responsibilities, suffer from poorer emotional health,(11) and appear to be 
more distressed.(12) Moreover, they show a more negative impact on their daily 
activities, health and family support,(13) compared to men. It seems that males’ 
distress is related to their own health condition and not to the health condition of 
their female patient partner, while this is different in women.(14) Another explana-
tion may be that female informal caregivers use different coping strategies, like 
seeking social support and wishful thinking, as was shown in caregivers of patients 
with dementia.(15) Partners’ perceptions of the patients’ health status may also 
explain differences in the experience of caregiving. Indeed, a previous study in pa-
tients with COPD, chronic heart failure or chronic renal failure showed major differ-
ences between the patients’ symptom report and their family caregivers’ percep-
tion.(16) It is reasonable to assume that gender differences do exist in partners’ 
perceptions of patients’ health status, care dependency and symptoms of anxiety 
and depression. These gender differences in partners’ perceptions may also explain 
gender differences in the experience of caregiving. To date, it remains unknown 
whether gender differences in partners’ perceptions of patients with COPD actually 
do exist.     
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Therefore, we aimed to investigate differences between male and female partners 
of patients with COPD regarding their own health status, symptoms of anxiety and 
depression, social support, caregiver burden and coping styles, but also regarding 
their perceptions of the patients’ care dependency, symptoms of anxiety and de-
pression and health status. We hypothesized that female partners have a worse 
health status, more symptoms of anxiety and depression, perceive lower levels of 
social support and higher levels of caregiver burden themselves. Moreover, we hy-
pothesized that coping styles like seeking social support and reassuring thoughts are 
more important for female than for male partners. Additionally, we hypothesized 
that female partners perceive a worse health status, more symptoms of anxiety and 
depression and more care dependency in patients compared to male partners.  
METHODS 
Design 
The baseline results of the Home Sweet Home Study were used, in which data were 
collected during home visits at baseline and after 12 months.(17) Additional home 
visits were performed when an exacerbation-related hospital admission occurred 
during the 12-month follow-up period. This study is approved by the Medical Re-
search Ethics Committees United (MEC-U), the Netherlands (NL42721.060.12/M12-
1280), and is registered in the Dutch Trial Register (NTR3941). The protocol of this 
study and data about health status and problematic activities of daily life were pub-
lished before.(17-19) 
Study population 
Patients with COPD were recruited by their chest physician or a respiratory nurse 
specialist in four hospitals throughout the southern-eastern part of the Nether-
lands. Additionally, patients participating in the ‘Chance study’ (NTR3416)(20) who 
met the inclusion criteria of the Home Sweet Home study and were willing to par-
ticipate in further research were asked to participate in the current study. Inclusion 
occurred during the first home visit, between July 2013 and December 2014.  
Patients were eligible if they had moderate to very severe COPD (Global initiative 
for chronic Obstructive Lung Disease (GOLD) grade II, III or IV);(21) no exacerbation 
of COPD (22) or hospitalization <4 weeks preceding enrolment; and if they could 
identify a loved one (defined as a person living together with the patient with 
8Gender differences 
135 
COPD, regardless of whether or not he/she provides (informal) care to the patient 
with COPD). Patients and/or partners were excluded if they were unable to com-
plete the study questionnaires because of cognitive impairment (defined as Short 
Blessed Test score ≥10 point)(23); or if they were unable to understand Dutch. Fur-
thermore, non-partner relationships and non-heterosexual patient-partner pairs 
are excluded in the current analysis. All participating patients and their participating 
partners have given written informed consent.  
Instruments 
Demographics and clinical characteristics were assessed in both patients and part-
ners, during a visit in their home environment. This included body mass index (BMI, 
weight/height2), self-reported comorbidities (Charlson comorbidity index),(24) 
smoking history and current smoking habits, and post-bronchodilator spirometry 
(to calculate the forced expiratory volume in the first second (FEV1) and Tiffeneau 
index, using a handheld spirometer according to guidelines).(1) In patients, the total 
number of COPD exacerbations with and without hospital admission in the year 
before the home visit, and receiving help with personal care from professionals or 
relatives during the last six months before the home visit were assessed.  
The Dutch relationship questionnaire (NRV) was used to assess the quality of the 
relationship between the patient and partner.(25) This self-administered question-
naire was assessed in both patients and partners separately and consists of 80 
questions in five domains (independence, emotional solidarity, identity, conflict 
handling and sexuality). Its total score ranges from 0 (very low) to 80 points (very 
high quality of the relationship). 
Care dependency was assessed using the Care Dependency Scale (CDS), which con-
sists of 15 items.(26) The total score ranges from 15 (worst) to 75 points (best), 
whereby patients with a score ≤68 points were considered as care dependent.(27) 
This questionnaire was assessed in patients, partners and partners’ perception of 
the patients. 
Coping styles, i.e. the way a person (partner) deals with problems or stressful situa-
tions, were assessed using the Utrecht Coping List (UCL).(28) It consists of 47 items 
divided into seven subscales:  
1. Active confronting: confronting problems and employing purposeful strat-
egies. Item example: “Immediately intervene if there are difficulties”.  
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2. Palliative reaction: distracting one’s attention from the problems, includes 
smoking and drinking. Item example: “Trying to relax”.  
3. Avoidance: waiting and keeping clear of the problem. Item example: “Avoid 
difficult situations”.  
4. Seeking social support: seeking comfort and help from others. Item exam-
ple: “Sharing your concerns with someone”.  
5. Passive reaction pattern: worrying and drawing back. Item example: “Iso-
late yourself from others”.  
6. Expressing emotions: showing annoyance or anger. Item example: “Release 
your tension”.  
7. Reassuring thoughts: self-encouragement and realizing that worse things 
can happen. Item example: “Tell yourself that it will turn out better than 
expected”.  
Each item has four levels: seldom or never, sometimes, often, and very often. A 
higher score indicates a greater amount of the variable being measured. 
Symptoms of anxiety and depression in patients, partners and partners’ perceptions 
of patients, were assessed using the Hospital Anxiety and Depression Scale 
(HADS).(29) This scale is divided into an anxiety subscale (HADS-A) and a depression 
subscale (HADS-D). Total scores, for both subscales, range from 0 (optimal) to 21 
points (worst). In addition, a score ≥10 points for each subscale was considered as 
clinically relevant symptoms of anxiety or depression. 
Generic health status was assessed using the EuroQol-5 Dimensions (EQ-5D) and 
the Assessment of Quality of Life with 8 Dimensions (AQoL-8D). The EQ-5D included 
five questions about health related quality of life, and provided an index score 
(Dutch version) between -0.33 (worst) and 1.0 (best). In addition, current health 
was rated on a Visual Analogue Scale (VAS), which ranges from 0 (worst possible 
health) to 100 (best possible health). The AQoL-8D is more comprehensive with 35 
questions in eight dimensions of health related quality of life. These eight dimen-
sions can also be combined into a mental and physical health dimension and a utili-
ty score. All scales range from 0.00 (death) to 1.00 (best health). The EQ-5D and 
AQoL-8D were assessed in patients and partners themselves, and in partners’ per-
ceptions of the patients. 
Social support perceived by patients and partners themselves, was assessed using 
the Medical Outcome Study Social Support Survey (MOSSSS).(30) This multidimen-
sional questionnaire contained 19 items regarding five dimensions of social sup-
port: emotional support, informational support, tangible support, positive social 
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interaction, and affectionate support. Each item has five response choices to indi-
cate how often support was available to them if they needed it, namely: (1) none of 
the time, (2) a little of the time, (3) some of the time, (4) most of the time, and (5) 
all of the time. A higher score indicates a greater amount of that specific kind of 
support. Additionally, the total number of close friends and relatives were asked. 
To assess caregiver burden in resident partners, the Family Appraisal of Caregiving 
Questionnaire for Palliative Care (FACQ-PC) was used.(31) This 25-item question-
naire includes caregiver burden and positive aspects of caregiving in four domains: 
caregiver strain, positive caregiving appraisals, caregiver distress, and family well-
being. The item scores range from 1 (strongly disagree) to 5 points (strongly agree), 
so a higher score means a greater amount of the variable being measured.  
Statistics 
Categorical variables are described as frequencies, while continuous variables were 
tested for normality and are presented as mean and standard deviation (SD). Con-
tinuous variables were compared between male and female partners using inde-
pendent samples t-tests or Mann-Whitney U tests, as appropriate. Categorical vari-
ables were compared between male and female partners using Chi-square tests. In 
a post hoc analysis, we compared coping styles in female partners with and without 
symptoms of anxiety. Moreover, we checked for differences in patients’ health 
status between patients of partners with and without symptoms of depression. 
Post hoc Pearson’s product-moment correlations or Spearman’s Rank correlations, 
depending on the variable distribution, were performed to measure the association 
between caregiver burden and partners’ social support. Strength of the correlation 
was classified as: no relationship (<0.25), fair (0.25-0.50), moderate to good (0.50-
0.75), and good to excellent (>0.75).(32) A priori, the level of significance was set at 
p≤0.01, because of multiple comparisons. All statistics were performed using SPSS 
version 20.0 or GraphPad Prism 6. 
RESULTS 
General characteristics 
In total, 569 patients were screened for eligibility, 449 patient-partner pairs met the 
inclusion criteria and 194 pairs completed the home visit. Six pairs were excluded 
for this analysis due to non-partner relationships or non-heterosexual relationships 
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(Supplementary Figure 8.1). Therefore, 188 pairs (42% of eligible patient-partner 
pairs) were included. No differences were found between participants and eligible 
patients refusing participation regarding age, gender distribution and GOLD grade 
(all p>0.05). In total, 85 partners were male (45.2%) and 103 were female (54.8%). 
On average, partners and patients had similar age (65.3 (8.7) versus 66.3 (8.6) 
years, respectively, p=0.274). Most patients had COPD GOLD II (47.9%), followed by 
COPD GOLD III (32.4%) and COPD GOLD IV (19.7%). The majority of the patients had 
a mMRC dyspnea score of 2 or higher (77.7%). Moreover, 16.5% of the patients and 
32.4% of the partners were current smokers.  
Male versus female patients 
Female patients were significantly younger than male patients, and had better EQ-
5D index scores (Table 8.1). Other general and clinical characteristics, care depend-
ency, symptoms of anxiety and depression were comparable between male and 
female patients (Table 8.1).  
Male versus female partners 
Male and female partners were comparable regarding general and clinical character-
istics, except for higher number of smoking pack years in male partners (Table 8.2). 
Six out of the total seven subscales of the questionnaire about coping showed sig-
nificantly different outcomes for male partners compared to female partners (Fig-
ure 8.1). Very low levels of active confronting, very high levels of palliative reaction, 
and high levels of avoidance were found significantly more often in female partners 
compared to male partners. Low levels of seeking social support were more often 
found in female partners, while medium levels were more common in male part-
ners. In contrast, (very) low levels of the subscales passive reaction pattern and 
reassuring thoughts were significantly more often found in male partners, while 
high levels were more common in female partners.  
Post hoc analysis showed that low levels of active confronting and high levels of 
passive reaction pattern were found significantly more often in female partners 
with symptoms of anxiety compared to female partners without these symptoms 
(Supplementary Figure 8.2). In addition, medium levels of passive reaction pattern 
were found significantly more often in female partners without anxiety symptoms 
compared to female partners with symptoms of anxiety. Moreover, female partners 
had worse mean HADS-A scores, EQ-5D index scores, AQoL-8D mental health di-
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mension scores, and AQoL-8D utility scores (Table 8.2). HADS-D scores, social sup-
port and caregiver burden were comparable between male and female partners. 
Post hoc analysis showed that patients of a partner with clinically relevant symp-
toms of depression scored significantly worse on the AQoL-8D physical and utility 
scores (Supplementary Table 8.1). Furthermore, the caregiver strain subscale 
showed a fair and significant relationship with the MOSSSS subscales ‘emotion-
al/informational support’, ‘tangible support’ and the ‘overall support index’ (Sup-
plementary Table 8.2a). No relationship was found for the caregiver distress sub-
scale (Supplementary Table 8.2b).   
 
Table 8.1. Patient characteristics, symptoms of anxiety and depression, and health status.  
 
Female patients 
(n=85) 
Male patients 
(n=103) p-value 
General and clinical characteristics    
Age (years) 63.3 (8.0) 68.7 (8.3) <0.001 
BMI (kg/m2) 25.8 (5.4) 26.8 (5.2) 0.240 
Charlson comorbidity index (pts) a 2.2 (1.3) 2.5 (1.6) 0.141 
Current smoker 19 (22.4%) 12 (11.7%) 0.049 
Packyears (years) a 36.4 (17.5) 43.3 (21.8) 0.068 
FEV1 (% predicted) 47.7 (18.0) 46.7 (17.5) 0.697 
Number of exacerbations in previous year    
Without hospital admission a 1.64 (1.73) 1.81 (2.02) b 0.718 
With hospital admission a 0.73 (1.34) 0.90 (1.30) 0.186 
Receiving care in past 6 months    0.375 
From professionals 19 (22.4%) 19 (18.4%)  
From relatives 11 (12.9%) 21 (20.4%)  
Dutch Relationship questionnaire (pts) a 62.5 (13.9) c 60.4 (13.4) d 0.115 
Care dependency scale (pts) a 68.9 (7.6) 67.1 (9.5) b 0.294 
Anxiety, depression and health status    
Anxiety subscale (HADS-A) 5.7 (3.5) 5.8 (3.6) 0.940 
Depression subscale (HADS-D) 5.2 (3.3) 6.1 (3.9) 0.072 
Symptoms of anxiety (≥10), n (%) 13 (15.3%) 15 (14.6%) 0.889 
Symptoms of depression (≥10), n (%) 11 (12.9%) 18 (17.5%) 0.392 
EQ-5D index score a 0.76 (0.22) 0.68 (0.27) 0.010 
EQ-5D VAS score  64.8 (17.2) 60.0 (19.9) 0.081 
AQoL-8D, mental 0.34 (0.16) 0.35 (0.18) 0.754 
AQoL-8D, physical  0.53 (0.18) 0.55 (0.17) 0.540 
AQoL-8D, utility score 0.63 (0.18) 0.64 (0.18) 0.821 
Values expressed as mean (SD) or number of patients (%). Abbreviations: AQoL-8D= Assessment of Quality of 
Life with 8 Dimensions; EQ-5D= EuroQol-5 Dimensions; FEV1= forced expiratory volume in the first second; 
HADS-A= Hospital Anxiety and Depression Scale, Anxiety subscale; HADS-D= Hospital Anxiety and Depression 
Scale, Depression subscale. a non-parametric statistical tests have been used because of skewed data; b n=1 
missing; c n=5 missing; d n=9 missing. 
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Table 8.2. Male versus female partners 
 Male partners 
(n=85) 
Female partners 
(n=103) 
p-value 
General and clinical characteristics    
Age (years) 65.1 (8.9) 65.4 (8.6) 0.808 
BMI (kg/m2) a 28.2 (4.6) b 27.7 (5.1) b 0.227 
Charlson comorbidity index (pts) a 1.4 (1.7) 1.1 (1.5) 0.449 
Current smoker 29 (34.1%) 32 (31.1%) 0.657 
Pack-years a 26.7 (21.7) 16.3 (18.5) <0.001 
Tiffeneau index < 70%, n (%) 29 (34.1%) b 27 (26.2%) c 0.269 
FEV1 (% predicted) a 100.4 (27.6) b 107.1 (23.7) c 0.066 
Dutch Relationship questionnaire (pts) 62.7 (11.3) d 58.8 (14.6) e 0.053 
Care dependency scale (pts) a 74.2 (2.1) 73.4 (6.4) b 0.946 
Anxiety, depression and health status    
Anxiety subscale (HADS-A) 4.5 (3.3) 6.9 (4.1) <0.001 
Depression subscale (HADS-D) a 3.7 (2.5) 4.3 (3.1) 0.261 
Symptoms of anxiety (≥10), n (%) 7 (8.2%) 31 (30.1%) <0.001 
Symptoms of depression (≥10), n (%) 3 (3.5%) 4 (3.9%) 0.898 
EQ-5D, index score a 0.93 (0.11) b 0.86 (0.17) 0.001 
EQ-5D, VAS score a 83.5 (14.4) b 81.9 (14.2) 0.414 
AQoL-8D, mental 0.52 (0.16) 0.43 (0.15) b <0.001 
AQoL-8D, physical  0.74 (0.18) 0.69 (0.21) b 0.109 
AQoL-8D, utility score a 0.82 (0.14) 0.75 (0.14) b <0.001 
Social support    
Good friends or close relatives a 11 (13) 12 (10) b 0.368 
Emotional/informational support 3.9 (0.9) 4.1 (0.9) c 0.222 
Tangible support 4.0 (0.9) 4.0 (1.0) f 0.897 
Affectionate support a 4.3 (0.8) 4.3 (0.8) c 0.521 
Positive social interaction 4.0 (0.9) b 4.2 (0.8) f 0.245 
Overall support index 4.0 (0.8) b 4.1 (0.8) d 0.387 
Caregiver burden    
Caregiver strain 1.5 (0.7) 1.6 (0.7) 0.528 
Positive caregiving appraisals 3.9 (1.2)  3.8 (1.2) 0.401 
Caregiver distress 2.0 (1.0) 2.1 (1.0) 0.724 
Family well-being a 3.9 (0.7) 3.7 (0.9) 0.452 
Values expressed as mean (SD) or number of partners (%). Abbreviations: AQoL-8D= Assessment of Quality of 
Life with 8 Dimensions; EQ-5D= EuroQol-5 Dimensions; FEV1= forced expiratory volume in the first second; 
HADS-A= Hospital Anxiety and Depression Scale, Anxiety subscale; HADS-D= Hospital Anxiety and Depression 
Scale, Depression subscale. a non-parametric statistical tests have been used because of skewed data; b n=1 
missing; c n=3 missing; d n=4 missing; e n=7 missing; f n=2 missing. 
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Figure 8.1. Categorical Utrecht Coping List scores in partners, after stratification for gender. 
Proportion of partners using a very low, low, medium, high, or very high level of a specific coping style.
*P≤0.01, compared with the same category of the same subscale for the other gender.  
Partners’ perceptions of patients’ care dependency, mood and health status 
Male partners gave female patients a significantly lower score on the care depend-
ency scale compared to female partners about male patients (Table 8.3). However, 
no differences were found between male and female partners’ perceptions of the 
proportion of care dependent patients (32.9% vs 24.3% respectively, p=0.189) 
(Supplementary Figure 8.3).  
Moreover, female partners gave their male patients a higher score on the HADS 
depression subscale. Although an equal amount of male and female patients 
(p=0.392, Table 8.1) reported symptoms of depression (shown in the two right 
quadrants in Figure 8.2), more female partners than male partners perceived clini-
cally relevant symptoms of depression in patients (p=0.007, Table 8.3) (shown in 
the two upper quadrants in Figure 8.2). In addition, a significant difference between 
male and female patients was found for the EQ-5D index score (Table 8.1). Howev-
er, male and female partners scored the patients not significantly different on the 
EQ-5D (Table 8.3). 
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Table 8.3. Partners’ perceptions of patients’ care dependency, symptoms of anxiety and depression, and 
health status. 
 Male partners 
(n=85) 
Female partners 
(n=103) 
p-value 
Care dependency    
Care dependency scale (pts) a 68.2 (9.0) 70.4 (7.9) 0.003 
Anxiety, depression and health status    
Anxiety subscale (HADS-A) 6.1 (3.7) b 6.0 (3.8) 0.915 
Depression subscale (HADS-D) 4.7 (3.0) b 6.3 (3.7) 0.001 
Symptoms of anxiety (≥10), n (%) 15 (17.6%) b 22 (21.4%) 0.550 
Symptoms of depression (≥10), n (%) 6 (7.1%) b 22 (21.4%) 0.007 
EQ-5D index score 0.74 (0.23) b 0.68 (0.29) 0.082 
EQ-5D VAS score 64.1 (17.8) b 61.1 (21.8) 0.299 
AQoL-8D, mental 0.38 (0.18) b 0.35 (0.18) 0.221 
AQoL-8D, physical  0.51 (0.18) b 0.52 (0.18) 0.784 
AQoL-8D, utility score 0.65 (0.20) b 0.62 (0.20) 0.359 
Values expressed as mean (SD) or number of partners (%). Abbreviations: AQoL-8D= Assessment of Quality of 
Life with 8 Dimensions; EQ-5D= EuroQol-5 Dimensions; HADS-A= Hospital Anxiety and Depression Scale, 
Anxiety subscale; HADS-D= Hospital Anxiety and Depression Scale, Depression subscale. a non-parametric 
statistical tests have been used because of skewed data; b n=1 missing. 
 
 
Figure 8.2. Patients’ and partners’ perceptions about patients’ symptoms of depression.  
HADS-D scores of patients with COPD (horizontal axes) and partners’ perceptions of the patients (vertical
axes). 
Abbreviations: COPD, chronic obstructive pulmonary disease; HADS-D, Hospital Anxiety and Depression Scale,
Depression subscale. 
8Gender differences 
143 
DISCUSSION 
Key findings 
Female partners had more symptoms of anxiety and a worse health status than 
male partners, but social support and caregiver burden were comparable for male 
and female partners of patients with COPD. Coping styles differed between male 
and female partners. Moreover, female partners thought that male patients were 
less care dependent and had more symptoms of depression, while these gender 
differences did not exist in patients themselves. 
Male versus female partners 
This study showed that female partners have more often clinically relevant symp-
toms of anxiety compared to male partners, which is in line with a study by Jácome 
and colleagues.(10) Factors which might contribute to the higher levels of anxiety in 
women are: women might be more emotional attentive and more likely to report 
negative emotions,(33, 34) women use more emotion-focused coping styles,(33) 
and perform more time consuming caregiving tasks and household chores.(35) In 
the current study, equal levels of depression in men and women were found. These 
findings are in line with a large population-based study providing normative data of 
the United Kingdom.(36) Depressive symptoms in caregivers of patients with chron-
ic heart failure and terminally ill cancer patients were related to patients’ disease 
burden.(37, 38) Therefore, the current authors conducted a post hoc analysis, 
which showed that patients had a worse health status when their partner had 
symptoms of depression. 
Comparable with other studies,(39, 40) we found no differences in caregiver bur-
den between male and female partners. Moreover, we did not find any difference 
in the quality of the relationship and levels of social support between male and 
female patients and partners. The equal levels of burden found in this study might 
be explained by the equal levels of social support in partners, because more care-
giver burden could be experienced when perceiving less social support.(41) By con-
ducting post hoc correlations, we confirmed that lower levels of social support were 
associated with higher levels of caregiver strain. 
This study showed differences in categorical subscales of coping between male and 
female partners, which was also found in a random sample of the Swedish popula-
tion.(42) These gender differences could be related to the higher anxiety scores in 
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female partners. In fact, female partners in the current study reported similar levels 
of coping compared to patients with symptoms of anxiety in a previous study,(43) 
namely a lower use of active confronting style and an increased use of palliative 
reaction, avoidance and passive reaction pattern. Therefore, we conducted a post 
hoc analysis in female partners of patients with COPD. The post hoc results were in 
line with the results of Stoilkova et al.(43)  
Partners’ perceptions of patients’ care dependency, symptoms of anxiety and 
depression, and health status 
Male partners thought that female patients were more care dependent than fe-
male partners did, while male and female patients’ scores were comparable. No 
differences were found between male and female partners’ perceptions regarding 
patients’ health status. However, a small difference on the EQ-5D index score did 
exist between male and female patients themselves. So it seems reasonable to 
believe that patients’ health status is not a main cause of the perception differ-
ences between male and female partners regarding patients’ care dependency. Our 
conclusion is that more knowledge regarding these perception differences is need-
ed.(44) 
Although no differences were found in symptoms of depression between male and 
female patients, female partners rated patients more often with symptoms of de-
pression compared to male partners. This could not be due to the symptoms of 
depression of partners themselves, because female partners showed an increased 
level of anxiety symptoms only. Janssen et al.(16) studied the agreement between 
patients with advanced chronic organ failure and their family caregivers regarding 
patients’ symptoms. They concluded that family caregivers reported a higher num-
ber of symptoms than patients themselves and that patients’ or family caregivers’ 
gender were not determinants for clinically relevant differences. Nevertheless, 
research in partners’ perceptions about patients’ symptoms is very rare and should 
be expanded.(44) 
The study at hand could not distinguish a difference between male and female 
partners’ perceptions of the health status of patients with COPD. Additionally, male 
patients had a worse health status compared to female patients as assessed with 
the EQ-5D index score in patients themselves. A previous study concluded that 
proxies rated the patients as having a more impaired health status than the patients 
themselves.(45) However, that study could not check for gender differences be-
cause their study population consisted solely of male patients with COPD.  
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Clinical consequences 
Recently, the definition and ultimate goals of a collaborative self-management in-
tervention in COPD patients were published.(46) One of the goals referred to the 
patients’ partner: “Establishing effective alliances with healthcare professionals, 
family, friends and community.” Therefore, all healthcare professionals who at-
tempt to achieve self-management in patients with COPD should involve the pa-
tient’s partner. Especially in case of female partners, attention should be paid to 
coping styles, symptoms of anxiety and health status. We should also be aware of 
the social expectations of the idea that women act as “natural” caregivers.(13) Be-
cause the feeling that caregiving is an assumed responsibility instead of a choice, 
could affect the reaction to caregiving.(13) For instance, when the social environ-
ment view the female caregiver as naturally better at caregiving, they might be less 
likely to perceive support as being needed, thus less likely to offer it.  
So, obtaining an extensive overview of the patient-partner couple, including coping 
styles, health status, symptoms of anxiety and caregiver burden, is necessary to be 
able to support the couple as affectively as possible. Future studies should explore 
more knowledge regarding gender-specific involvement of partners of patients with 
COPD. 
Methodological considerations 
Focus on the experience of mostly female caregivers was one of the most common 
limitations of studies included in the review by Grant and colleagues.(8) Therefore, 
a positive aspect of the current study is the fact that there is an almost equal 
amount of male and female patients and partners. 
Nevertheless, some limitations of the present study should be acknowledged. First, 
the response rate was 42%. So, unknown differences between participants and 
eligible patients or partners refusing participation may be present. Second, symp-
toms of anxiety and depression were assessed using the HADS, which is a validated 
and reliable questionnaire to screen for these symptoms.(29) However, we did not 
use an instrument to diagnose an anxiety or depressive disorder according to the 
Fifth Edition of the Diagnostic and Statistical Manual of Mental Disorders.(47) Last-
ly, we excluded non-partner and non-heterosexual relationships which may limit 
the generalizability of our findings.  
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CONCLUSIONS AND IMPLICATIONS 
Consistent with our hypothesis, we found that female partners, compared to male 
partners, have more symptoms of anxiety, used different coping styles and have a 
worse health status. In addition, perception differences between male and female 
partners did exist regarding patients’ care dependency and patients’ symptoms of 
depression. Yet, research in partners of patients with COPD is not very common and 
many research questions remain unanswered. Despite this, the current study 
showed that healthcare providers should pay attention to the needs of all partners 
of patients with COPD, but female partners in particular.   
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SUPPLEMENTARY MATERIAL 
Supplementary Table 8.1. Patients’ health status of partners with and without clinically relevant symptoms of 
depression 
 
Partners with symptoms of 
depression  
(n=7) 
Partners without symptoms 
of depression  
(n=181) p-value 
Patients’ health status    
EQ-5D index score a 0.49 (0.31) 0.73 (0.24) 0.029 
EQ-5D VAS score  56.3 (14.2) 62.4 (19.0) 0.400 
AQoL-8D, mental a 0.20 (0.16) 0.35 (0.17) 0.020 
AQoL-8D, physical  0.34 (0.13) 0.55 (0.17) 0.002 
AQoL-8D, utility score 0.41 (0.21) 0.64 (0.18) 0.001 
Values expressed as mean (SD). Abbreviations: AQoL-8D= Assessment of Quality of Life with 8 Dimensions; 
EQ-5D= EuroQol-5 Dimensions. a non-parametric statistical tests have been used because of skewed data. 
 
Supplementary Table 8.2a. Correlation between caregiver strain in partners and partners’ social support 
 Correlation coefficient p-value 
Emotional/informational support -0.348 b <0.001 
Tangible support -0.262 c <0.001 
Affectionate support a -0.211 b 0.004 
Positive social interaction -0.247 b 0.001 
Overall support index -0.307 d <0.001 
a non-parametric statistical tests have been used because of skewed data; b n=185; c n=186; d n=183. 
 
Supplementary Table 8.2b. Correlation between caregiver distress in partners and partners’ social support 
 Correlation coefficient p-value 
Emotional/informational support -0.177 b 0.016 
Tangible support -0.124 c 0.091 
Affectionate support a -0.085 b 0.248 
Positive social interaction -0.091 d 0.219 
Overall support index -0.144 d 0.051 
a non-parametric statistical tests have been used because of skewed data; b n=185; c n=186; d n=183. 
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Supplementary Figure 8.1. Flow-chart. 
Abbreviations: COPD= chronic obstructive pulmonary disease; GOLD= Global initiative for chronic Obstructive
Lung Disease. 
 
 
Supplementary Figure 8.2. Categorical Utrecht Coping List (UCL) scores in female partners, after stratification
for anxiety symptoms. 
Proportion of female partners using a very low, low, medium, high or very high level of a specific coping style.
*P≤0.01, compared with the same category of the same subscale. 
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Supplementary Figure 8.3. Patients’ and partners’ perceptions about patients’ care dependency. 
Care Dependency Scale (CDS) scores of patients with COPD (horizontal axes) and partners’ perceptions of the 
patients (vertical axes). 
Abbreviation: COPD, chronic obstructive pulmonary disease. 
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GENERAL DISCUSSION 
In recent years informal caregivers are increasingly being recognized as an im-
portant element in the disease management of patients with COPD. Informal care-
givers provide help during household chores, garden work, shopping, transporta-
tion, accompanying the patient to healthcare services, nursing, dressing and help 
with medication.(1) Moreover, informal caregivers play an important role in decid-
ing when to contact formal healthcare providers, for instance during an acute exac-
erbation of COPD.(2) During these acute exacerbations of COPD, the informal care-
givers’ role becomes more unclear, as the patients’ care needs intensified.(2) Caring 
for a patient with COPD has both negative and positive consequences.(1, 3) Indeed, 
the complete picture is a mixture of the strains of the disease and the strains and 
joys of caregiving, experienced by both the patient as well as the caregiver.(4) In-
formal caregivers feel unsupported, powerless and marginalized, and are routinely 
overlooked.(5) Positive aspects of caregiving were represented by perceived gains, 
positive affective returns from caregiving and an improved family functioning, for 
instance due to more effective communication.(3, 6) Healthcare services, however, 
are mainly patient-centred, so there is a risk that healthcare providers exclude fami-
ly caregivers.(2) The process of a COPD self-management intervention requires 
iterative interactions between patients and healthcare professionals who are com-
petent in delivering self-management interventions.(7) Indeed, these interventions 
are mainly disease specific, for instance reducing COPD specific symptoms like 
dyspnoea.(8) 
Informal caregiving can have positive and negative consequences for society as 
well. For instance, the latest version (updated 2016) of the global strategy for the 
diagnosis, management, and prevention of COPD stated that the family member 
might be forced to leave the workplace to care for the disabled relative.(9) This 
increases the indirect costs of COPD, beyond the direct medical costs like costs for 
hospital admissions. On the other hand, patients living together with an informal 
caregiver have fewer emergency visits compared to patients living alone, while the 
number of hospitalizations was equal between both groups.(10) The latter shows 
the positive impact of informal caregivers on the direct medical costs.  
This thesis underlines the importance and complex role of informal caregivers. In-
deed, the main aim of this thesis was to obtain a comprehensive understanding of 
the home situation of patients with COPD and their resident loved ones, whereby 
we intended to gain knowledge about the patient-loved one relationship and its 
consequences. The general introduction (Chapter 1) already showed gaps in the 
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literature about informal caregiving in patients with COPD. In the chapters that 
followed, we implicated the need to involve resident loved ones in the patients’ 
treatment. In this final chapter, the main findings of this thesis will be discussed in 
depth. The Home Sweet Home study, on which this thesis is based, is an observa-
tional study, and could provide a basis for further (interventional) research. There-
fore, future directions and recommendations for research will also be described in 
the current chapter. 
Are resident loved ones able to provide informal care? 
Before healthcare providers are capable to involve loved ones within the patient’s 
treatment process, they should know about the loved ones’ characteristics. For 
instance, previous literature showed that almost 38% of the caregivers younger 
than 65 years reported occupation-related problems.(11) A fifth of the resident 
loved ones in the Home Sweet Home study population reported to have a paid 
job.(12) This should be taken into account when aiming at involving loved ones 
within the patient’s treatment process, in order to prevent absence from work due 
to sick leaves,(1) or other occupation-related problems such as having problems 
with the work schedule.(11)  
More than 80% of the informal caregivers reported having social problems due to 
the informal caregiving and 36% reported health-related problems themselves.(11) 
Indeed, Chapter 4 showed that resident loved ones often suffered from multiple 
(undiagnosed) morbidities. So the question arises, are loved ones able to take care 
for the patient? At least, we cannot expect that resident loved ones provide appro-
priate informal care to patients with COPD without any support from healthcare 
providers. Indeed, a recent review also urged for an examination of strategies to 
assist caregivers to provide informal care, because they can facilitate adherence to 
COPD management behaviours.(13) On the other hand, loved ones could also cause 
an increase in patients’ symptoms of anxiety during a COPD exacerbation.(14) We 
already showed (Chapter 4) that loved ones have equal levels of anxiety compared 
to patients themselves. Therefore, it is certainly not inconceivable that anxiety 
symptoms in patients can be reinforced by symptoms of anxiety in loved ones. In 
accordance, a recent published study in informal caregivers of patients who re-
ceived mechanical ventilation in the intensive care unit (ICU) also showed that in-
formal caregivers were at risk for poor mental health outcomes.(15)  
Subsequently, Chapter 2 showed that caregiver burden did exist in the majority of 
informal caregivers and that these were not explained by patient characteristics, 
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which was confirmed in the previous mentioned study in caregivers of ICU patients, 
whereby informal caregiver outcomes were not related to patients’ clinical charac-
teristics or to patients’ changed functional and psychological outcomes over 
time.(15) Altogether, this means that the mental health status of loved ones them-
selves, including their symptoms of anxiety and experienced burden, should be 
taken into account. Treating symptoms, like anxiety, in patients with COPD should 
be part of current self-management interventions and integrated disease manage-
ment, like pulmonary rehabilitation.(16, 17) However, assessment and manage-
ment of symptoms in loved ones of patients with COPD is the next step.  
Besides symptoms of anxiety and caregiver burden, (undiagnosed) COPD (29%), 
moderate to severe fatigue (38%) and hypertension (69%) were frequently seen in 
resident loved ones themselves (Chapter 4). A quarter of the resident loved ones in 
the Home Sweet Home study had 3 or more morbidities. In fact, older adults with 
≥3 morbidities had an almost threefold increased risk of dying compared to older 
adults without multimorbidity.(18) Multimorbidity is not only associated with an 
increased risk of death, but also with an increased healthcare use and need for 
assistance with activities of daily living (ADLs).(19) This may also limit the loved 
ones’ ability to provide informal care to the patient with COPD at some point in the 
disease trajectory. On the other hand, however, COPD patients with comorbidities 
seem to have a better capacity to self-manage their disease, possibly because they 
already have more experience with healthcare and knowing how to cope with the 
disease.(20) This could indicate that loved ones with morbidities have more experi-
ence with healthcare and coping with a disease as well, which makes them more 
able to adequately collaborate on the patients’ disease management. 
Moreover, gender differences in loved ones of patients with COPD should be taken 
into account, as female sex is for instance a risk factor for caregiver burden.(21) 
Chapter 8 showed that female partners had more symptoms of anxiety and showed 
different levels of coping styles compared to male partners. So differentiating clini-
cal phenotypes in COPD, with an individualised approach as part of integrated dis-
ease management as a result,(17) should also take into consideration the patient’s 
home environment and the preferences and needs of their resident loved one(s). 
Involving the loved ones seems also important during patients’ end of life. In fact, 
preferences of patients and loved ones are highly individual regarding information, 
involvement and communication about care during the end of life,(22) and there-
fore require an individual approach.(23) The fact that loved ones experience an 
increased burden during the patients’ last year of life,(24) was collaborated in Chap-
ter 2. 
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Do resident loved ones have sufficient knowledge to provide informal care? 
Health knowledge, in general, could be defined as the knowledge about how to 
approach a health condition and the ability to know when to apply this knowledge 
in a specific context.(25) Health knowledge is important to prevent and cope with 
chronic conditions and is associated with health behaviour,(26, 27) and successful 
adherence to treatment plans and disease management.(28, 29) Low levels of 
knowledge were not only seen in patients with COPD (Chapter 7), but also in pa-
tients with other chronic conditions, such as diabetes,(30-32) chronic pain,(33) 
asthma, congestive heart failure,(31) and hypertension.(31, 32) Resident loved ones 
want to provide meaningful care to patients, but recognized their limited 
knowledge.(34) Chapter 7 showed the insufficient level of knowledge about COPD 
and general health in resident loved ones. Therefore, Bove and colleagues recom-
mended that nurses should take the responsibility for including loved ones in as-
pects of decision making that involve the common life of the patients and loved 
ones.(34) Moreover, Chapter 4 showed that 33% of the resident loved ones were 
current smokers, and we showed in Chapter 7 that 32% of the loved ones did not 
know that smoking is the most important cause of COPD. This shows the im-
portance of involving loved ones during education sessions. In fact, providing edu-
cation sessions for informal caregivers together with the patients with COPD result-
ed in better family coping.(37) In addition, informal caregivers of patients with end-
stage lung disease recognized the need for better information about the future 
course of the illness and about service availability.(35) Also in a population of in-
formal caregivers of heart failure patients, informal caregivers were important in 
the information management process because the patients relied on them.(36) 
Patients with COPD living alone were less likely to quit smoking compared to pa-
tients not living alone.(38) Shared decision making may be achieved by frequent, 
accurate and timely communication, characterized by mutual respect, shared goals 
and shared knowledge.(39) This again emphasizes the importance of knowledge 
and shared goals in patient-loved one couples. Furthermore, a dialogue between 
patients and loved ones or healthcare professionals is needed to find out what is 
important and/or possible for patients with COPD and how valued these activities 
are.(40) 
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Do resident loved ones have enough insight into the patients’ situation to provide 
informal care? 
Due to symptoms,(41) patients with COPD experience difficulties during activities of 
daily living (ADLs).(42) According to previous research, the following problematic 
ADLs were most prevalent in patients with COPD: walking, stair climbing and cy-
cling.(42) In participants of the Home Sweet Home study, walking, household activi-
ties and stair climbing were the most prevalent important problematic ADLs (Chap-
ter 5). Lindenmeyer and colleagues published an adapted meta-ethnography of 
qualitative research to understand which ADLs are valued by patients with 
COPD.(40) They arranged the themes into five linked concepts: 1. Caring for the 
body, 2. Caring for the personal environment, 3. Moving between spaces, 4. Inter-
acting with others, 5. Selfhood across time. We (partially) confirmed these results in 
Chapter 5, in which for instance, the concept ‘caring for the body’ includes washing 
and dressing (fifth prevalent problematic ADL according to patients) and the con-
cept ‘caring for the personal environment’ includes household activities (second 
prevalent problematic ADL according to patients). Organizing these concepts into 
three key aspects of personal integrity (linked to effectiveness or “being-able”, 
connectedness or “being-with” and control) resulted in a set of reasons why activi-
ties are important for patients with COPD (Figure 9.1).(40) The authors concluded 
that ADLs were mostly valued if they increased integrity. However, knowledge is 
currently lacking on how these concepts can be applied in practice.(40)   
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Figure 9.1. COPD core concepts (reproduced with permission from: Lindenmeyer et al., Qualitative Health
Research, 2016).(40) 
Problematic ADLs can result in care dependency,(43) including personal care.(1) 
This process is part of a downward spiral (Figure 9.2), because care dependency can 
result in an impaired health status.(44) In turn, a worsened health status has a 
higher likelihood of having an exacerbation, hospitalisation or dying.(45) After an 
exacerbation-related hospitalisation, patients are more inactive, (46) which again is 
associated with an increased mortality risk.(47) This indicates the importance of 
gaining knowledge about patients’ problematic ADLs. Furthermore, especially pa-
tients with advanced COPD are at risk for an increase in care dependency due to 
problematic ADLs.(43) Additionally, we showed in Chapter 2 that patients who died 
during 1-year follow-up were more care dependent compared to patients who 
completed follow-up. This was also established by the typical disease trajectory in 
patients with advanced COPD (Figure 9.3).(48) However, also patients who com-
plete a follow-up period were at risk for a 1-year increase in care dependency.(43)  
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Figure 9.2. Downward spiral regarding symptoms,(41) problematic ADLs,(42) care dependency,(43) impaired 
health status,(44) higher likelihood of exacerbations and hospitalisations,(45) lower physical activity level,(46)
and an increased mortality risk.(47) 
 
 
Figure 9.3. Typical end-of-life disease trajectory in patients with COPD (reproduced with permission from: 
Lehman, British Journal of General Practice, 2004).(48) 
Resident loved ones are also confronted with patients’ problematic ADLs, especially 
when patients get more care dependent over time. However, Chapter 5 generally 
showed low agreement between patient and proxy reported important problematic 
ADLs. Mobility-related problematic ADLs of patients were recognized by proxies 
more often than more private problematic ADLs like taking a shower, which we also 
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described in Chapter 6. This is in line with previous research which concluded that 
proxy-reported outcomes should be used with caution when it concerns physical, 
affective, cognitive, or social status and private, unobservable, or complex ques-
tions.(49) Although important, identifying problematic ADLs and estimating the 
value of these ADLs cannot always be objective, observable and easy. Regarding the 
question if loved ones have enough insight into the patients’ situation, we can con-
clude that loved ones should be integrated and involved in the patients’ treatment 
and disease management in order to obtain the required insight. 
Within the downward spiral regarding patients with COPD (Figure 9.2), conse-
quences for resident loved ones could be linked. Patients’ care dependency,(11) but 
also caregivers’ mental health status,(50) caregivers’ desire for more help from 
their family and friends,(51) and the quality of the relationship between patient and 
caregiver,(50) were associated with higher caregiver burden. Moreover, higher 
caregiver burden was associated with higher mortality rates in caregivers of pa-
tients with cardiovascular disease.(52, 53) This again emphasizes the importance of 
taken loved ones into account when predictors of caregiver burden (for instance 
patients’ care dependency)(11) do exist. Indeed, involving loved ones during a pul-
monary rehabilitation program in patients with COPD potentially prevents loved 
ones’ negative psychological outcomes.(54) Moreover, increasing the communica-
tion between patients and informal caregivers may be a modifiable determinant of 
caregiver burden.(55) 
The effects of caregiving can be bidirectional: the health of the caregiver is affected 
by that of the patient and the wellbeing of the caregiver affects the patients’ well-
being.(4) Indeed, the relation between emotional distress and quality of life is in-
teractive within a couple,(56) and levels of depression symptoms are correlated 
between patients with COPD and their caregivers.(57) This again contributes to the 
idea that the patient-loved one relationship should be taken into account when 
aiming at involving loved ones in patients’ disease management. Altogether, there 
is still work to do in order to involve loved ones adequately so they are able to con-
tribute positively to the patients’ disease management.  
Are interventions including resident loved ones effective? 
This thesis provides the rationale for a well-designed intervention study to investi-
gate the effects of involving loved ones during patients’ treatment on both patients 
and loved ones. Indeed, recognizing that a chronic disease affects the patient’s 
entire family allows us to address the total impact of the disease.(4)  
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Yet, the question remains whether interventions with loved ones are effective. A 
meta-analysis showed that interventions with caregivers are effective on different 
domains (i.e. burden, depression, and wellbeing).(58) Moreover, a recent review 
regarding physical activity interventions in family caregivers of patients with a men-
tal, physical or cognitive illness, significantly decreased caregivers’ distress and 
increased their well-being, quality of life, sleep quality, and physical activity 
levels.(59) These physical activity interventions would certainly be important in 
loved ones of patients with COPD, as patients with a physically active loved one are 
more active themselves.(60) 
Although less common in other phases of life, a family-centered view is common 
during the end-stage of life, for instance when a patient is discharged to a 
hospice.(4) Considering the family as a whole (instead of the traditional focus on 
the patient alone), can provide direct benefits to the patient and family 
members.(4) This is already incorporated in cardiac rehabilitation, in which the core 
components evolved into a holistic, patient tailored approach, including family 
members or domestic partners.(61) Education and counselling on adjustment and 
lifestyle change for example, this should be offered to individual and/or small 
groups of patients including their significant others.(62)  
When looking at treatment options for patients with COPD, pulmonary rehabilita-
tion proved to be beneficial in terms of physiological, symptom-reducing, psychoso-
cial and health economic aspects for patients.(63) Still, a clear role for informal 
caregivers of patients with COPD is not described in the document about key con-
cepts in pulmonary rehabilitation.(64)  The results of a randomized controlled trial 
by Marques and colleagues provide an indication about the advantages of involving 
loved ones, in terms of improvements in family coping and psychosocial adjustment 
to the illness.(35) These benefits were sustained by qualitative data.(54)  Moreover, 
loved ones may act as facilitator for getting out of the house and undertake physical 
activity.(65) Therefore, the focus of future healthcare should be broadened, in 
which treatment options in patients with COPD include their social environment as 
well. This full consideration of patient and family will allow us to care for all involved 
and to develop interventions and policies to support the family and the patient.(4) 
This thesis did not include cost-effectiveness effects. However, medical cost-
effectiveness analyses traditionally treat patients as isolated individuals and there-
fore neglect the effects of patients’ improved health on the health effect and wel-
fare of their loved ones.(66, 67) So, if optimizing health is the goal of healthcare 
policy, all important effects should be captured.(67) 
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How should resident loved ones be involved in the patients’ treatment and disease 
management? – Future directions for an intervention study. 
In the individual chapters of this thesis, we implicated that:  
- Healthcare providers should regularly pay attention to the burden of resi-
dent loved ones (Chapter 2); 
- Loved ones’ own lifestyle, comorbidities and health status should be ad-
dressed (including current smoking status) (Chapter 4);  
- Loved ones should engage in the patients’ behavioural change (Chapter 4); 
- Communication within a pair (during assessment of problematic ADLs) 
should be promoted to increase the level of mutual understanding (Chapter 
5 and Chapter 6);  
- Education about general health and COPD should be provided to resident 
loved ones (most preferably together with the patient) (Chapter 7); 
- An extensive overview of the patient-partner couple, including coping styles, 
health status, symptoms of anxiety and caregiver burden should be obtained 
to support the couple affectively (Chapter 8).  
Designing an intervention study could use the basis of a pulmonary rehabilitation 
(PR) program, and expand this with the active involvement of loved ones.(54) First, 
this could be done by an active participation during the patients’ assessment in 
which the loved ones’ goals for rehabilitation should be discussed together with the 
patient. This could provide benefits in terms of loved ones’ burden and sense of 
commitment.(35, 68) We should be careful, however, that patients are not over-
shadowed by the presence and contribution of their loved one. Assessing the pa-
tients’ problematic ADLs perceived by the loved ones (separate from the patients) 
could result in more specific problematic ADLs to be worked on during PR. Loved 
ones could be actively invited to attend education sessions together with the pa-
tient to increase their health-related and COPD-related knowledge.(35) Additional-
ly, education session(s) designed especially for loved ones could promote their 
active participation, and decrease their feelings of stress and frustration, during the 
patient’s disease trajectory.(34) The latter could also be the result of the supportive 
feeling of meeting others in the same situation.(68) Involving loved ones during 
psychosocial interventions, next to individual sessions, may also be beneficial in 
addressing symptoms of anxiety and depression in patients and loved ones.(35, 57) 
Lastly, loved ones should be involved when treatment is especially aimed at main-
taining a lifestyle change after the rehabilitation program, in which the loved ones’ 
lifestyle will be included.(65) Indeed, interventions with peer contact showed to be 
one of the characteristics for an effective self-management intervention in patients 
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with COPD.(69) However, research on the effectiveness in general of coaching in-
terventions that are continued after completion of a supervised program (like PR), 
of which involving loved ones could be one aspect, is necessary.(70)  
Methodological considerations 
We would like to acknowledge some strengths of this thesis. First, we used many 
questionnaires and tests to gain a complete overview of the patients’ home envi-
ronment. This did not only include characteristics of the patients, but also charac-
teristics of the resident loved ones and their perceptions about the patients. Sec-
ond, we used not only questionnaires, but also an individualized client-centred 
outcome (the Canadian Occupational Performance Measure (COPM)) to assess 
problematic ADLs in patients (Chapter 5). Its advantage is that self-nomination is 
possible, which is missing in questionnaires. Third, we aimed at increasing the 
chance for a higher degree of external validity. Therefore, we included an almost 
equal amount of male and female patients and loved ones, to gain knowledge 
about the complete population of patients with COPD and their resident loved 
ones. Fourth, this thesis did not only include quantitative data, but also qualitative 
data. We used the qualitative approach (Chapter 6) to explain the findings of the 
quantitative data (Chapter 5). The strengths of both methodologies provided a 
broader perspective about the perceptual differences in problematic ADLs between 
patients with COPD and their proxies. Lastly, although not included in this thesis, 
the Home Sweet Home study has a longitudinal design which makes it possible to 
analyse changes over time.  
Besides the strengths of this thesis, some limitations should be considered in inter-
preting the results. First, Chapter 2 of this thesis was based on a study in patients 
with advanced chronic organ failure. More than half of the population of that Chap-
ter consisted of patients with chronic heart failure and chronic renal failure. There-
fore, results are only partly based on a population of patients with COPD, which was 
the included population in the Home Sweet Home study. On the other hand, no 
significant differences were found between patients’ diseases.    
Second, Chapters 4-8 were based on the baseline data of the Home Sweet Home 
study only. This study is originally a longitudinal study, but a large amount of data 
were obtained in this study. During this project, all data (at baseline, after an exac-
erbation-related hospitalization and one-year follow-up) could be collected and 
most of the baseline data could be analysed and reported. Therefore, longitudinal 
data is still available to address the longitudinal objectives of this study (for in-
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stance: ‘to study prospectively the effects of a COPD exacerbation on resident loved 
ones’ perceptions of patients’ health status and problematic ADLs’).  
Third, the response rate of the Home Sweet Home study was slightly over 40%. 
Therefore, unknown differences between participants and eligible patients refusing 
participation may be present. This could also have biased the included study popula-
tion. For instance, patients and loved ones with lower levels knowledge about health 
and COPD or who experience higher levels of (caregiver) burden could refuse partic-
ipation. This could result in an overestimation of the participants’ knowledge or an 
underestimation of participants’ (caregiver) burden. Furthermore, patient-loved one 
couples were informed about the aims of this study, which might have worked as a 
stimulus to talk about the disease and its limitations in daily life. On the other hand, 
age, gender and COPD GOLD grades were comparable between included patients 
and patients refusing participation. Moreover, we included an almost equal amount 
of male and female patients and loved ones, in order to overcome the major limita-
tion of studies included in a review about (mostly female) caregivers.(71)  
Fourth, some limitations do exist regarding the tests and questionnaires used in the 
Home Sweet Home study. Blood pressure was assessed during 1 home visit, while a 
diagnosis of hypertension (Chapter 4) should be based on at least 2 visits.(72) Clini-
cally relevant symptoms of anxiety and depression were assessed using the validat-
ed and reliable Hospital Anxiety and Depression Scale (HADS),(73) but we did not 
use an instrument to diagnose an anxiety or depressive disorder according to the 
Diagnostic and Statistical Manual of Mental Disorders, Fifth Edition (DSM-5).(74) 
General health and COPD-related knowledge (Chapter 7) in patient and loved ones 
was not assessed using a validated questionnaire, because available questionnaires 
focus more on specific disease-related knowledge only.(75-77) Therefore, we used 
34 statements formulated by a multidisciplinary pulmonary rehabilitation team and 
all statements were tested in authentic patients with COPD. To assess patients’ 
problematic ADLs, we used the COPM. Because this instrument allows participants 
to identify any problematic ADL it was needed to combine all problematic ADLs into 
domains and categories for further analyses (Chapter 5). Nevertheless, the rating of 
any problematic ADL makes the open dialogue very individual,(78) while the ADLs 
are not personal and specific anymore when using a questionnaire.  
Lastly, we did not include a control group besides resident loved ones of patients 
with COPD. So age-matched persons without a relative with COPD, or matched cou-
ples from the general population. Therefore, comparisons with the general elderly or 
non-COPD population could be done only by using population-based studies. 
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GENERAL CONCLUSION 
Resident loved ones carry out many different and complex roles in the lives of pa-
tients with COPD. This thesis provides a starting overview of this complex, challeng-
ing but also very valuable population, certainly in the future. Moreover, it is a fact 
that resident loved ones are a key aspect of the daily life, health status and quality 
of life of patients with COPD, and should therefore not be overlooked. 
To preventively address the health status and lifestyle of these couples and in order 
to improve their quality of life, resident loved ones should be involved in the com-
prehensive treatment and disease management of patients with COPD. Pulmonary 
rehabilitation, an optimal treatment for patients with COPD, may form the basis 
which can be extended with the preventive and active involvement of loved ones, 
based on the observational results of this thesis. Future research should focus on 
the effectiveness of interventions that actively involve loved ones of patients with 
COPD during their whole disease trajectory. 
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SUMMARY 
Chronic obstructive pulmonary disease (COPD) is characterized by persistent airflow 
limitation, which causes symptoms of breathlessness and fatigue. COPD is a major 
cause of morbidity and mortality throughout the world, and its burden on society is 
increasing. Therefore, healthcare systems try to support patients with COPD in 
achieving an optimal quality of life, while limiting the costs of care. As a conse-
quence, a shift from hospital care to home care seems inevitable. Therefore, pa-
tients will have to rely to a greater extent on their loved ones (as informal caregiv-
ers) for practical help and emotional support. Due to perceived symptoms despite 
optimal medical treatment, patients with COPD experience multiple problems with 
activities of daily living (ADLs). Their resident loved ones are also facing these prob-
lematic ADLs. Therefore, COPD impacts the loved ones in terms of symptoms of 
anxiety, social limitations and caregiver burden. Moreover, discrepant perceptions 
of the patients’ health status and symptoms between patients and informal care-
givers can have a negative influence on both the patient and loved one.  
To be able to involve resident loved ones appropriately in the patients’ manage-
ment of the disease, more knowledge is necessary regarding these resident loved 
ones themselves and their perceptions of the patients. Therefore, the aim of this 
thesis is to provide a comprehensive understanding of the home environment, 
including the resident loved one of patients with COPD (Chapter 1).  
Since it remains unknown whether and to what extent the experience of caregiving 
could change over time, Chapter 2 examined possible changes during 1-year follow-
up in patients with advanced COPD, chronic heart failure (CHF) and chronic renal 
failure (CRF). Additionally the determinants of changes in caregiver burden and 
positive aspects of caregiving were studied. A majority of the individual family care-
givers showed changes in caregiver burden and positive aspects of caregiving over 1 
year, which were not explained by patient characteristics at baseline or changes 
during 1-year follow-up. Moreover, caregivers of patients who died during follow-
up showed higher levels of caregiver burden compared to caregivers whose relative 
completed follow-up. Due to the changes in, and the individual nature of the impact 
on caregivers, healthcare providers should regularly pay attention to family caregiv-
ers, regardless the patients’ characteristics. 
The Home Sweet Home study, an observational, longitudinal study in patients with 
COPD and their resident loved ones was designed with the primary aim to gain 
more knowledge about the differences between patients with COPD and their resi-
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dent loved ones’ perceptions of patients’ health status and problematic ADLs 
(Chapter 3). Patients with COPD were recruited by their chest physician or respira-
tory nurse specialist in four hospitals in the Netherlands, and only if they had a 
resident loved one. The following primary outcomes were assessed in patients and 
loved ones’ perceptions about the patients, during home visits at baseline, after a 
COPD exacerbation-related hospital admission and after 12 months: problematic 
ADLs, disease-specific health status, generic health status and dyspnoea.  
Health status, morbidities, care dependency, and mobility were compared between 
patients and resident loved ones (so called relatives) in Chapter 4. In 194 couples, 
we found that patients had worse generic health status, higher level of care de-
pendency, and worse mobility compared to relatives. However, we also found that 
29% of the resident relatives had airflow limitation, 33% were current smokers, and 
92% had at least one chronic condition. Therefore, we concluded that resident 
relatives are often current smokers and often have undiagnosed morbidities, which 
should be considered when involving them as informal caregivers and when advis-
ing patients to obtain a healthier lifestyle. 
We hypothesized that resident loved ones (or ‘proxies’) are unable to identify the 
patients’ most important problematic ADLs. Therefore, we aimed to investigate the 
level of agreement between patient-reported and proxy-reported problematic ADLs 
of the patient in Chapter 5. We included all 194 patient-proxy couples for this cross-
sectional analysis and assessed the problematic ADLs using the Canadian Occupa-
tional Performance Measure (COPM) in both patients and resident proxies sepa-
rately. We found that agreement in reporting problematic ADLs was poor to fair 
and that similar performance and satisfaction scores were given by only 24% and 
18% of the pairs, respectively. 
Thereafter, Chapter 5 constituted the basis of Chapter 6, in which we aimed to ex-
plore the causes of perceptual differences between patients and proxies about 
these problematic ADLs of the patient. We conducted a qualitative study in ten 
couples with discrepancies in patients’ problematic ADLs and used an interview 
method with an open structure in the presence of both the patient and proxy. We 
identified ten main causes of perceptual differences, which were related to both 
the patient’s and the proxy’s perception. Overall, we concluded that proxies should 
be involved in identifying patients’ problematic ADLs to make sure that all im-
portant problematic ADLs are identified, but also as a way to encourage communi-
cation within a couple. 
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Chapter 7 describes the knowledge gaps in patients with COPD and their proxies. 
For this, thirty-four statements about generic health and COPD-related topics were 
assessed in patients and proxies separately. Patients answered on average 37% and 
proxies 38% of the statements incorrect or with ‘do not know’. Younger patients, 
patients with a higher level of education, patients who previously participated in 
pulmonary rehabilitation, patients with better cognitive functioning, and patients 
who were diagnosed with COPD longer ago, reported more correct answers. There-
fore, education about general health and COPD should be offered to all subgroups 
of patients with COPD and their proxies. 
The objective of Chapter 8 was to investigate differences between male and female 
partners of patients with COPD regarding their own characteristics and their per-
ceptions of patients’ characteristics. We included 188 patient-partner couples, and 
found that female partners themselves had more symptoms of anxiety, a worse 
health status and they used different coping styles compared to male partners. 
Moreover, female partners thought that male patients were less care dependent 
and had more symptoms of depression, while these gender differences did not exist 
in patients themselves. Although many research questions remain unanswered, we 
implicated that healthcare providers should pay attention to all partners of patients 
with COPD, but female partners in particular. 
Altogether, we implicated the need, but also the remaining questions, to involve 
resident loved ones in patients’ treatment and disease management. In Chapter 9, 
the main findings of this thesis were discussed in dept. Are loved ones able, and do 
they have sufficient knowledge and insight in the patient, to provide informal care? 
We tried to answer these questions by combining our results together with the 
findings of (recent) published literature. Only by gaining knowledge about the home 
situation of the patient with COPD, so by gaining a holistic view of the patient in-
cluding their resident loved one(s), loved ones can be involved adequately in the 
patients’ disease management. Although only a few outcome measures were in-
cluded and cost-effectiveness studies are missing, recent intervention studies in 
which loved ones of patients with COPD were involved in the patients’ treatment or 
disease management seem promising.  
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SAMENVATTING 
Chronisch obstructieve longziekten (COPD) worden gekarakteriseerd door een aan-
houdende luchtwegobstructie, die symptomen van kortademigheid en vermoeid-
heid veroorzaakt. COPD is een belangrijke oorzaak van morbiditeit en mortaliteit in 
de wereld, en de belasting van deze ziekte voor de maatschappij neemt toe. In de 
zorg voor patiënten met COPD is niet alleen het bereiken van een optimale kwaliteit 
van leven van belang, maar wordt ook gestreefd naar het beperken van de zorgkos-
ten. De zorg wordt zoveel mogelijk aangeboden in de thuissituatie. Daardoor zullen 
patiënten moeten vertrouwen op hun naasten (als informele zorgverleners of man-
telzorgers) voor praktische hulp en emotionele steun. Door de merkbare sympto-
men ervaren patiënten met COPD diverse problemen bij activiteiten van het dage-
lijks leven (ADL), ondanks dat ze medisch optimaal behandeld worden. Hun naasten 
worden ook geconfronteerd met deze probleemactiviteiten. Daarom heeft COPD 
ook een impact op de naasten, bijvoorbeeld resulterend in symptomen van angst, 
sociale beperkingen en een verhoogde zorglast. Verschillen tussen patiënten en 
naasten in de perceptie van de gezondheidsstatus of de symptomen van de patiënt 
kunnen mogelijk een negatieve invloed hebben op de patiënt en de naaste.  
Om naasten op een goede manier te kunnen betrekken bij het ziektemanagement 
van de patiënt is meer kennis nodig over de inwonende naasten zelf en hun percep-
tie van de patiënt. Daarom heeft dit proefschrift als doel om een algeheel inzicht te 
verschaffen over de thuisomgeving van patiënten met COPD, inclusief hun inwo-
nende naasten (Hoofdstuk 1). 
Omdat het onbekend is of en in welke mate de ervaring van informele zorgverle-
ning kan veranderen over de tijd, is er in Hoofdstuk 2 onderzocht of er verschillen 
waren in de ervaren zorglast en positieve aspecten van informele zorg gedurende 1 
jaar bij patiënten met COPD, chronisch hartfalen en chronisch nierfalen. Daarnaast 
zijn de determinanten van de verandering in zorglast en positieve aspecten van 
informele zorgverlening onderzocht. Een meerderheid van de mantelzorgers lieten 
verschillen in zorglast en positieve aspecten van informele zorg zien gedurende 1 
jaar, maar deze werden niet verklaard door patiënt-karakteristieken of veranderin-
gen hierin gedurende 1 jaar. Verder werd gevonden dat mantelzorgers van patiën-
ten die stierven gedurende het jaar meer zorglast ervaarden dan mantelzorgers van 
patiënten die het jaar overleefden. Vanwege de veranderingen in en het individuele 
karakter van de impact op mantelzorgers zouden zorgverleners regelmatig aan-
dacht moeten besteden aan informele zorgverleners, ongeacht de karakteristieken 
van de patiënt.  
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De Home Sweet Home studie, een observationeel, longitudinaal onderzoek bij pati-
enten met COPD en hun inwonende naasten werd ontworpen met als primaire doel 
om meer kennis te verkrijgen over de perceptieverschillen tussen patiënten met 
COPD en hun inwonende naaste over de gezondheidsstatus en probleemactivitei-
ten van de patiënten (Hoofdstuk 3). Patiënten met COPD en hun inwonende naas-
ten werden geworven door hun longarts of longverpleegkundige in vier ziekenhui-
zen in Nederland. De volgende primaire uitkomstmaten werden onderzocht in pati-
enten en de perceptie van hun inwonende naasten over de patiënt, tijdens huisbe-
zoeken op baseline, na een exacerbatie-gerelateerde ziekenhuisopname en na 12 
maanden: problematische ADL, ziekte-specifieke gezondheidsstatus, algemene 
gezondheidsstatus en kortademigheid. 
Gezondheidsstatus, morbiditeiten, zorgafhankelijkheid, en mobiliteit werden verge-
leken tussen patiënten en hun inwonende naasten in Hoofstuk 4. In 194 koppels 
vonden we dat patiënten een slechtere algemene gezondheidsstatus, meer zorgaf-
hankelijkheid, en een slechtere mobiliteit hadden dan hun inwonende naasten. We 
vonden echter ook dat 29% van de inwonende naasten een luchtwegobstructie 
had, 33% waren huidige rokers, en 92% had ten minste één chronische aandoening. 
Daarom concludeerden we dat inwonende naasten zelf regelmatig huidige rokers 
zijn en vaak nog niet gediagnosticeerde aandoeningen hebben. Dit moeten we in 
overweging nemen wanneer we hen als informele zorgverleners willen betrekken 
en ook wanneer we patiënten adviseren om een gezondere leefstijl te hanteren. 
Onze hypothese was dat inwonende naasten niet in staat zijn om de meest belang-
rijke problematische ADL’s (ook wel probleemactiviteiten) van de patiënten te be-
noemen. Daarom was ons doel in Hoofdstuk 5 om de mate van overeenstemming 
tussen de door de patiënt gerapporteerde en door de naaste gerapporteerde pro-
bleemactiviteiten van de patiënt te onderzoeken. We namen alle 194 patiënt-
naaste koppels mee in deze cross-sectionele analyse en onderzochten de pro-
bleemactiviteiten van de patiënt volgens patiënten en naasten afzonderlijk door 
middel van de Canadian Occupational Performance Measure (COPM). We vonden 
een slechte tot matige overeenkomst in de gerapporteerd probleemactiviteiten, en 
dezelfde scores voor uitvoering en tevredenheid werden gegeven in slechts 24% en 
18% van de gevallen. 
Hoofdstuk 5 vormde de basis van Hoofstuk 6, waarin we de oorzaken van deze per-
ceptieverschillen tussen patiënten en naasten over de probleemactiviteiten van de 
patiënt wilden ontdekken. We voerden een kwalitatief onderzoek uit bij tien kop-
pels met perceptieverschillen over de probleemactiviteiten van de patiënt. We 
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namen een interview met een open structuur af, in de aanwezigheid van de patiënt 
en de naaste. We identificeerden tien primaire oorzaken van perceptieverschillen, 
die gerelateerd waren aan de perceptie van zowel de patiënt als de naaste. Uitein-
delijk concludeerden we dat de naaste betrokken zou moeten worden bij het iden-
tificeren van de probleemactiviteiten van de patiënt om er zeker van te zijn dat alle 
belangrijke probleemactiviteiten ook daadwerkelijk geïdentificeerd worden. Daarbij 
kan het als middel dienen om de communicatie binnen een koppel te bevorderen. 
In Hoofdstuk 7 hebben we de kennishiaten van patiënten met COPD en hun inwo-
nende naasten beschreven. Daarvoor hebben we 34 stellingen over algemene ge-
zondheid en COPD-gerelateerde onderwerpen voorgelegd aan de patiënt en naaste 
afzonderlijk. Patiënten beantwoordden gemiddeld 37% en naasten 38% van de 
stellingen fout of met de antwoordoptie ‘weet niet’. Jongere patiënten, patiënten 
met een hoger opleidingsniveau, patiënten die voorheen hadden deelgenomen aan 
een longrevalidatie programma, patiënten met een beter cognitief functioneren, en 
patiënten die de diagnose COPD langer geleden kregen, beantwoordden meer stel-
lingen goed. Educatie over algemene gezondheid en COPD zou aangeboden moeten 
worden aan alle subgroepen van patiënten met COPD en hun inwonende naasten. 
De doelstelling van Hoofdstuk 8 was om de verschillen tussen mannelijke en vrou-
welijke partners van patiënten met COPD te onderzoeken aangaande hun eigen 
karakteristieken en hun perceptie over de karakteristieken van de patiënten. We 
includeerden hiervoor 188 patiënt-partner koppels, en vonden dat vrouwelijke 
partners zelf meer symptomen van angst en een slechtere gezondheidsstatus had-
den en dat ze andere copingstijlen gebruikten vergeleken met mannelijke partners. 
Verder dachten vrouwelijke partners dat mannelijke patiënten minder zorgafhanke-
lijk waren en meer symptomen van depressie hadden, terwijl deze man-vrouw ver-
schillen niet aanwezig waren bij de patiënten zelf. Ondanks dat veel onderzoeksvra-
gen nog onbeantwoord blijven, adviseren we dat zorgverleners aandacht zouden 
moeten hebben voor alle partners van patiënten met COPD, maar voor de vrouwe-
lijke partners in het bijzonder.  
Alles samengenomen laat dit proefschrift de noodzaak zien van, en de nog onbe-
antwoorde vragen over, het betrekken van inwonende naasten bij de behandeling 
en het ziektemanagement van de patiënt. In Hoofdstuk 9 werden de belangrijkste 
bevindingen van dit proefschrift grondig besproken. Zijn naasten in staat, en heb-
ben ze voldoende kennis over en inzicht in de patiënt om informele zorg te bieden? 
We hebben getracht deze vragen te beantwoorden door de resultaten van dit on-
derzoek te combineren en te vergelijken met de resultaten van (recent) in de litera-
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tuur gepubliceerde onderzoeken. Alleen door het verkrijgen van informatie over de 
thuissituatie van patiënten met COPD, dus door het verkrijgen van een holistisch 
beeld van de patiënt inclusief zijn inwonende naaste(n), kunnen naasten adequaat 
worden betrokken bij het ziektemanagement van de patiënt. Hoewel slechts enkele 
uitkomstmaten werden meegenomen en kosteneffectiviteits-studies nog missen, 
lieten recente interventiestudies waarbij naasten van patiënten met COPD betrok-
ken werden bij de behandeling of het ziektemanagement van de patiënt, veelbelo-
vende resultaten zien. 
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VALORIZATION 
Knowledge valorization refers to ‘the process of creating value from knowledge, by 
making knowledge suitable and/or available for social (and/or economic) use and by 
making knowledge suitable for translation into competitive products, services, pro-
cesses and new commercial activities’ (adapted definition based on the National 
Valorization Committee 2011:8). Therefore, this chapter will explain the possibilities 
and opportunities the results of this thesis gave for clinical purposes. Moreover, this 
chapter will build upon what is described in the paragraph ‘How should resident 
loved ones be involved in the patients’ treatment and disease management?’ in 
Chapter 9. Based on the guide to write this valorization addendum, all innovative 
ideas are described using the following headings: 
Relevance: What is the social and/or economic relevance of the research results? 
Target groups: To whom, in addition to the academic community, are the research 
results of interest and why? 
Activities/products: Into which concrete products, services, processes, activities or 
commercial activities will the results be translated and shaped? 
Innovation: To what degree can the results be called innovative in respect to the 
existing range of products, services, processes, activities and commercial activities?  
Involving resident loved ones during the assessment of patients’ goals and 
problematic activities of daily life 
Relevance  
Resident loved ones are unable to identify patients’ most important problematic 
activities of daily life (ADL). This is, however, important because resident loved ones 
are faced with these limitations as well. Especially when the disease gets more ad-
vanced, it can be necessary that resident loved ones provide informal care to the 
patient, like helping them with washing or dressing. Knowing what ADLs are prob-
lematic and important for the patient creates understanding for each other’s situa-
tion. Moreover, when resident loved ones are involved in the assessment of the 
goals of patients’ treatment, difficulties can be taken care of on time (e.g. caregiver 
burden, or physical limitations in resident loved ones themselves).  
Target groups 
Findings from the current study are important for all resident loved ones of patients 
with COPD. Healthcare providers could be seen as target group as well, because 
they should request active participation from resident loved ones during the pa-
tients’ assessment.  
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Activities/products 
The activity is that active participation of patients’ resident loved ones during the 
assessment of patients’ goals or treatment is requested. When asking patients to 
identify their most important problematic ADLs, active involvement of resident 
loved ones should be requested (e.g. together with the patient, or separate from 
the patient). For instance, when assessing patients’ problematic ADLs at the start of 
a pulmonary rehabilitation program (to provide directions for treatment), these 
should be assessed in resident loved ones about the patients’ problematic ADLs as 
well. Combining the results and discussing them together with the patient and resi-
dent loved one is important to make sure no possible treatment goals are missed. 
Innovation 
Active involvement of resident loved ones of patients with COPD is not necessarily 
innovative, however, it is innovative at this level. Because, this goes beyond allow-
ing the presence of a resident loved one during a consultation with a healthcare 
professional or to give resident loved ones the opportunity to spend a day together 
with the patient in the health care facility or pulmonary rehabilitation centre. An 
active involvement is requested, in order to treat not only the disease, but the per-
son who has the disease.  
Involving resident loved ones during education session(s) 
Relevance  
Patients with COPD and their resident loved ones have low levels of general health-
related and COPD-related knowledge. However, having sufficient levels of disease-
related knowledge is important to self-manage the disease, to cope with the dis-
ease and to prevent deterioration. Resident loved ones might be able to support 
patients with their disease management when they have sufficient levels of 
knowledge.  
Target groups 
The target group includes all patients with COPD and their resident loved ones. 
Younger patients, with a higher level of education and better cognitive functioning, 
who participated in a pulmonary rehabilitation program previously, and who were 
diagnosed with COPD longer ago reported higher knowledge levels. Therefore, 
education should be provided to all patients and loves ones, but especially to pa-
tients and resident loved ones of patients who got the diagnosis recently, who are 
not (yet) eligible for a pulmonary rehabilitation program, or who are older, and with 
lower levels of education and cognitive functioning. Especially for the latter, more 
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vulnerable group, it could be important that resident loved ones take part in educa-
tion sessions, together with, or perhaps on behalf of the patients themselves. In 
addition, patients who participated in a pulmonary rehabilitation program previous-
ly had higher levels of health and COPD-related knowledge compared to patients 
who did not attend a rehabilitation program before. However, the patients who 
participated in a pulmonary rehabilitation program previously still answered less 
than 70% of the statements correct. Therefore, the education provided during a 
pulmonary rehabilitation program should be evaluated to determine whether it can 
be improved.  
Health insurance companies could also be seen as target group, because their goal 
is better and affordable care. It might be possible that providing education sessions 
involving resident loved ones prevents the use of other (more expensive) 
healthcare services (for instance prevention of hospital admissions). Nevertheless, 
intervention studies should prove this.  
Activities/products 
Education sessions for all patients with COPD and their resident loved ones. These 
sessions could be provided in a hospital or pulmonary rehabilitation centre (e.g. pa-
tient academy), but could also be viewed online. A major advance of bringing patients 
and resident loved ones together ‘live’ in an education session is that it could also 
result in a supportive feeling of meeting others in the same situation. Moreover, 
these sessions could be provided by knowledgeable lecturers/(para)medics, or by 
patients themselves. The latter because patients are experts in their own condition, 
and therefore able to spread useful knowledge. Additionally, the impact on patients 
and resident loved ones of the different ways in which knowledge could be trans-
ferred should be examined. For instance, providing education in a different way to 
patients with lower levels of cognitive functioning.    
Innovation 
Education for patients is already part of a pulmonary rehabilitation program and 
transferring knowledge to patients by a general practitioner or a chest physician is 
already done in primary and secondary care. However, providing education sessions 
to groups of patients and targeting (especially) their resident loved ones, is the 
innovative part of this activity. 
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Involving resident loved ones during individual treatment sessions of patients 
Relevance 
Resident loved ones of patients with COPD have many (undiagnosed) morbidities 
themselves. Moreover, some resident loved ones suffer from health related prob-
lems due to the fact that they have a relative with COPD. For instance, having symp-
toms of anxiety and depression or physical limitations due to providing informal 
care to the patient.  
Target groups 
Resident loved ones of patients receiving individual treatment sessions. Healthcare 
providers could be seen as target groups as well, because they provide care and 
should invite patients’ resident loved ones during the treatment. 
Activities/products 
Treating not only the disease of the patient, but the whole client system of the 
patient with the disease, during individual treatment sessions. When resident loved 
ones are actively involved during the patients’ individual treatment, they gain 
knowledge in when and how they could help the patient, but also when patients 
are able to do activities by themselves. So patients are supported adequately by 
their resident loved ones, and resident loved ones receive advice and skills to sup-
port the patients. Another advantage could occur during the explanation of the use 
of a bronchodilator or other medication. Active involvement of resident loved ones 
during such a treatment can ensure that the medication is taken the right way and 
it could increase the likelihood of patient compliance. 
Innovation 
The involvement of resident loved ones at this level requires a new vision of the 
individual treatment of the person with COPD and its social system. Includ-
ing/’treating’ the resident loved ones’ health or health related problems, in order to 
increase the patient’s wellbeing, during the patients’ treatment is innovative. 
Involving resident loved ones during patients’ lifestyle change 
Relevance 
Resident loved ones of patients with COPD are often current smokers themselves. 
In addition, yet unpublished data analysed by a colleague showed that only 30% of 
the resident loved ones were physically active (defined as spending ≥30 min in 
moderate-to-vigorous physical activity on at least 5 days per week).  
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Target groups 
The target group includes all patients with COPD who have a resident loved one. 
Patients with a loved one, but not living together, might be a target group as well. 
However, additional research is needed to investigate the consequences for pa-
tients with COPD who have a (resident) loved one with an unhealthy lifestyle.  
Activities/products 
Resident loved ones’ lifestyle should be addressed when aiming at a behavioural 
change in patients with COPD. For instance, when patients with COPD are advised 
to quit smoking, they need support from their resident loved ones in order not to 
start smoking again, after a successful smoking cessation. This will be counteracted 
by resident loved ones when they continue smoking themselves, especially when 
they smoke inside the house. Another example is to stimulate physical activity in 
patients with COPD when their resident loved ones are sitting on the couch during a 
large part of the day.  
So, when aiming at behavioural change in patients with COPD, the social system of 
the patient should be included. First, the resident loved one’s lifestyle should be 
part of assessing the patient’s lifestyle. Second, the resident loved one should be 
involved during every step of behavioural change. So, starting with the step ‘pre-
contemplation’ until the step ‘maintenance’. Thus, resident loved ones should be 
included in the patients’ treatment regarding behavioural change (and be advised 
as well) because they are part of the patients’ lifestyle. 
Innovation 
Nowadays, an advice for behavioural change is most often provided to the patient 
only. This makes sense, because the assessment includes only the patient’s lifestyle. 
Including the resident loved ones’ lifestyle within the assessment of the patients’ 
lifestyle and within all steps of behavioural change for the patient is innovative. 
Other activities and/or products 
The findings presented in this thesis have led to several activities in the field of 
expertise. Besides the fact that the results of this thesis are published in profession-
al scientific journals, they are also presented during symposia and congresses. The 
results published in Chapter 2 were presented in Dutch during the ‘Vlaams-
Nederlands onderzoeksforum palliatieve zorg’ in 2015. The results of Chapter 4, 5 
and 7 were presented during the European Respiratory Society (ERS) Congress in 
2015 and 2016. A poster about Chapter 5 was presented during the patient organi-
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zation networking day at the ERS Congress 2016, organized by the European Lung 
Foundation. In addition, for the abstracts of Chapter 4 and 5 the ‘ERS Young Scien-
tist Sponsorship’ and the ‘ERS/ELF Travel Grant for best abstract in Patient Centered 
Research’ were received in 2015 and 2016, respectively. Moreover, parts of Chap-
ters 1, 4, 5 and 7 were presented in Dutch during the “Longdagen 2016”, organized 
by the Netherlands Respiratory Society (NRS), ‘Nederlandse Vereniging van Artsen 
voor Longziekten en Tuberculose’ (NVALT), and Lung Foundation Netherlands. 
The remaining data obtained from this study could be analysed and published in 
scientific journals. Furthermore, the remaining data and the data obtained in this 
thesis could provide the basis for further studies on the home environment of pa-
tients with COPD. 
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Het is zo ver, de eerste woorden van het dankwoord kunnen op papier gezet wor-
den. In dit (vaak meest gelezen) hoofdstuk wil ik graag iedereen bedanken die, op 
welke manier dan ook, heeft bijgedragen aan dit proefschrift. Ik kan en wil dan ook 
niet anders beginnen dan met het bedanken van alle patiënten en hun naasten die 
deel hebben genomen aan dit onderzoek. Zonder u geen huisbezoeken, data, arti-
kelen, Home Sweet Home studie en dus ook geen proefschrift. Heel erg bedankt 
voor de vele uren die ik (of één van mijn collega’s) bij u thuis mocht zijn, voor het 
invullen van alle vragenlijsten, het meedoen met de testen en alle telefoontjes die u 
gedurende een jaar hebt gekregen. Bedankt voor uw deelname en gastvrijheid!  
Ik wil mijn promotor, professor Wouters, bedanken voor zijn kritische blik en feed-
back tijdens het schrijven van dit proefschrift. Prof. Wouters en Ingrid Augustin, 
Raad van Bestuur van CIRO, wil ik beiden graag bedanken voor het gestelde ver-
trouwen in mij en mijn onderzoek, en de geboden mogelijkheid om de Home Sweet 
Home studie verder in de kliniek te implementeren. Ik ben er trots op dat ik dit 
onderzoek namens CIRO heb mogen uitvoeren. 
Beste (co-)promotoren, Beste Daisy en Martijn, bedankt voor jullie begeleiding, 
betrokkenheid en samenwerking in de afgelopen jaren. Ik heb ontzettend veel res-
pect voor jullie wetenschappelijke gedrevenheid. Jullie hebben het me niet altijd 
gemakkelijk gemaakt, maar dat heeft uiteindelijk wel geleid tot mooie artikelen. 
Bedankt voor jullie ideeën, geduld en vertrouwen.  
Aan de onderzoeksmedewerkers van de Home Sweet Home studie, Jeannet en Es-
ther, bedankt voor jullie tomeloze inzet voor de Home Sweet Home studie. Ik weet 
dat het niet altijd gemakkelijk was: de vele uren in de ziekenhuizen (soms zonder 
patiënten te zien), bij deelnemers thuis en in de auto. En dan ben ik ook nog eens 
niet de gemakkelijkste, iemand die graag de touwtjes zelf in handen houdt. Bedankt 
dat jullie me hebben laten inzien dat ik die touwtjes soms wat mag loslaten.  
Ivy, bedankt voor het invoeren van de baselinedata van mijn promotieonderzoek. 
Wat was het fijn om te zien hoe correct en snel je de vele data ingevoerd kreeg.  
De deelnemers aan dit onderzoek kwamen niet vanzelf. De artsen, (long)verpleeg-
kundigen en andere medewerkers van de deelnemende ziekenhuizen wil ik dan ook 
hartelijk bedanken voor hun inzet. Bedankt ook aan de lokale onderzoekers: Drs. 
Monique van Vliet (Zuyderland te Heerlen), Dr. Michiel de Vries (Zuyderland te 
Sittard-Geleen), Drs. Giny Clappers-Gielen (Elkerliek Ziekenhuis te Helmond) en Drs. 
Arent Jan Michels (St. Anna Ziekenhuis te Geldrop). Zonder de andere artsen en 
(long)verpleegkundigen te kort te doen wil ik Monique in het bijzonder bedanken. 
Dankwoord 
191 
Bedankt voor je inzet en voor het overbrengen van je enthousiasme over dit onder-
zoek naar je collega’s. Zonder jou inzet had de inclusieperiode veel langer geduurd.  
Beste co-auteurs, bedankt voor uw inhoudelijke feedback op de artikelen en voor 
de vele succeswensen bij het indienen van de artikelen naar de diverse journals.  
Hartelijk dank ook aan de leden van de beoordelingscommissie van dit proefschrift, 
bestaande uit Prof. dr. Kempen (voorzitter), Prof. dr. van der Weijden, Prof. dr. 
Beurskens, Dr. Trappenburg en Prof. dr. Rochester. Bedankt voor uw kritische be-
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